[
  {
    "question": "Are there microbes in human breast milk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Human breast milk is known to contain various components that support infant health, including nutrients, antibodies, and other bioactive molecules. The presence of microbes in breast milk has been a subject of research, with studies indicating that breast milk can contain a diverse community of bacteria that may play a role in infant gut colonization and immune system development.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can breastfeeding confer protection from type I diabetes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Breastfeeding has been studied for its potential protective effects against various diseases, including type I diabetes. Research suggests that breastfeeding may reduce the risk of developing type I diabetes in children, possibly due to the transfer of maternal antibodies and other immune factors that help in the development of the child's immune system. However, the evidence is not conclusive, and other factors such as genetics and environmental triggers also play significant roles in the development of type I diabetes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can pets affect infant microbiomed?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is about whether pets can influence the microbiome of infants. Research suggests that early exposure to pets can indeed affect the composition and diversity of an infant's gut microbiome, potentially leading to reduced risks of allergies and obesity. This is because pets introduce a variety of microbes into the home environment, which can colonize the infant's gut.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any association between the human gut microbiome and depression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question explores the potential link between the human gut microbiome and depression. Research in recent years has suggested that the gut microbiome can influence brain function and behavior through the gut-brain axis, which includes neural, immune, and endocrine pathways. Some studies have found differences in the gut microbiota of individuals with depression compared to those without, suggesting a possible association. However, the exact nature of this relationship and whether it is causal remains under investigation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is pembrolizumab effective against Ewing's sarcoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Pembrolizumab is a type of immunotherapy that targets the PD-1/PD-L1 pathway and has shown efficacy in various cancers. However, its effectiveness specifically against Ewing's sarcoma, a rare type of cancer that affects bones or the soft tissue around them, is not well-established. Current evidence and clinical trials focusing on pembrolizumab's impact on Ewing's sarcoma are limited. Therefore, without substantial data supporting its efficacy in this specific cancer type, the answer would lean towards no.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can gene therapy restore auditory function?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Gene therapy has shown potential in various studies to treat genetic disorders by introducing, removing, or altering genetic material within a patient's cells. For auditory function, research has focused on targeting the inner ear's hair cells or the auditory nerve to restore hearing. While promising results have been observed in animal models, human applications are still under investigation. The effectiveness depends on the cause of hearing loss and the stage at which therapy is administered.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does vesatolimod inhibit TLR7?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if vesatolimod inhibits TLR7, we need to understand the mechanism of action of vesatolimod and its interaction with TLR7. Vesatolimod is known as a TLR7 agonist, which means it activates TLR7 rather than inhibiting it. Therefore, it does not inhibit TLR7.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can simvastatin alleviate depressive symptoms?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Simvastatin is primarily known as a medication used to lower cholesterol and reduce the risk of heart disease. While there have been studies exploring the potential effects of statins, including simvastatin, on depressive symptoms, the evidence is not conclusive. Some studies suggest a possible benefit, while others do not find a significant effect. Therefore, it cannot be definitively stated that simvastatin alleviates depressive symptoms based on current research.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does gepotidacin activate bacterial topoisomerase?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Gepotidacin is a novel antibacterial agent that targets bacterial DNA gyrase and topoisomerase IV, which are essential enzymes for bacterial DNA replication. By inhibiting these enzymes, gepotidacin prevents bacterial DNA from unwinding and replicating, leading to bacterial cell death. Therefore, it is likely that gepotidacin activates bacterial topoisomerase in the sense that it interacts with these enzymes to exert its antibacterial effect.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is obesity related to cognitive decline?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Obesity has been linked to various health issues, including cardiovascular diseases and diabetes. There is growing evidence suggesting that obesity may also be associated with cognitive decline, possibly due to inflammation, insulin resistance, and vascular damage affecting the brain. However, the relationship is complex and influenced by factors like age, genetics, and lifestyle.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are whole-genome duplications more divergent than small-scale duplications in yeast?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Whole-genome duplications (WGDs) and small-scale duplications (SSDs) are two mechanisms that contribute to genome evolution. WGDs involve the duplication of the entire genome, leading to a sudden increase in gene content, while SSDs involve the duplication of individual genes or small genomic segments. In yeast, WGDs are considered to have a more significant impact on genome evolution and divergence compared to SSDs because they provide a large number of duplicated genes that can evolve new functions or undergo subfunctionalization. This makes WGDs more divergent than SSDs in yeast.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do yeast LTR give rise to circular DNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether yeast Long Terminal Repeat (LTR) retrotransposons can produce circular DNA. Yeast LTR retrotransposons, like Ty elements, replicate via an RNA intermediate that is reverse transcribed into DNA. During this process, circular DNA forms can arise as byproducts of reverse transcription or recombination events.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Copy Number Variants (CNVs) depleted in regions of low mappability?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Copy Number Variants (CNVs) are large segments of the genome that are duplicated or deleted, leading to variation in the number of copies of a particular genomic region among individuals. Regions of low mappability are areas of the genome that are difficult to sequence accurately due to repetitive sequences or other complexities. It is plausible that CNVs might be depleted in regions of low mappability because these regions are harder to detect and analyze, leading to potential underreporting or difficulty in identifying CNVs in such areas.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can mitochondria be inherited by both parents in humans?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Mitochondria are known as the powerhouses of the cell and contain their own DNA. In humans, mitochondrial DNA (mtDNA) is inherited exclusively from the mother. This is because the egg contributes the majority of the cytoplasm, including mitochondria, to the zygote, while sperm contribute very little cytoplasm and their mitochondria are typically destroyed after fertilization. Therefore, the question is whether mitochondria can be inherited from both parents in humans, which would contradict the established understanding of maternal inheritance of mtDNA.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Machine learning methods have been applied in various fields of healthcare, including mental health. Given the complexity and variability of Major Depressive Disorder (MDD), it's plausible that researchers have explored machine learning for predicting its severity. This would involve analyzing datasets that include symptoms, patient histories, and possibly genetic information to identify patterns or predictors of severity.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any association between suicide and autism in adolescents, yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if there is an association between suicide and autism in adolescents, we need to consider research findings. Studies have shown that adolescents with autism spectrum disorder (ASD) may have a higher risk of suicidal thoughts and behaviors compared to their neurotypical peers. This increased risk can be attributed to factors such as social isolation, bullying, and co-occurring mental health conditions like depression and anxiety. Therefore, there is evidence to suggest an association between suicide and autism in adolescents.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does allele phasing improve the phylogenetic utility of ultraconserved elements?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Allele phasing refers to the process of determining the co-inheritance of alleles at different loci, which can provide more detailed information about the genetic variation within and between populations. Ultraconserved elements (UCEs) are regions of the genome that are highly conserved across species and are widely used in phylogenetic studies. The question is whether allele phasing can enhance the phylogenetic utility of UCEs by providing more accurate or detailed information about evolutionary relationships.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are ultraconserved enhancers important for normal development?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ultraconserved enhancers are sequences in the genome that are highly conserved across species, suggesting they play a critical role in biological processes. Given their high conservation, it's reasonable to hypothesize that they are important for normal development, as they likely regulate genes essential for developmental processes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Bobble head doll syndrome associated with hydrocephalus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bobble head doll syndrome is a rare condition characterized by involuntary head movements that resemble a bobble head doll's nodding. It has been reported to be associated with lesions in the third ventricle of the brain, which can lead to obstructive hydrocephalus. Therefore, there is a connection between Bobble head doll syndrome and hydrocephalus, specifically when the syndrome is caused by such lesions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Tisagenlecleucel effective for B-Cell Lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tisagenlecleucel is a CAR-T cell therapy approved for the treatment of certain types of B-cell lymphomas. It targets CD19, a protein found on the surface of B-cells, and has shown significant efficacy in clinical trials for patients with relapsed or refractory B-cell lymphoma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is durvalumab used for lung cancer treatment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Durvalumab is a type of immunotherapy drug known as a PD-L1 inhibitor. It is used in the treatment of various cancers, including lung cancer, particularly for patients with unresectable, stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about whether epidural anesthesia used during labor has an impact on the Apgar score of the newborn. The Apgar score is a quick test performed on a baby at 1 and 5 minutes after birth to assess the baby's health. To answer this, we need to consider if epidural anesthesia, which is a common method for pain relief during labor, affects the baby's condition at birth. Studies and medical research would be the basis for determining the answer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) been reported to be a plasminogen receptor in pathogenic bacteria?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has been reported as a plasminogen receptor in pathogenic bacteria, we need to consider existing scientific literature. GAPDH is a well-known enzyme involved in glycolysis, but it has also been identified to have additional functions, including surface localization in some bacteria where it can bind to various host proteins. Plasminogen receptors are important for pathogenic bacteria as they can facilitate the spread of the bacteria by utilizing the host's plasminogen system. There have been studies reporting GAPDH as a plasminogen receptor in certain pathogenic bacteria, indicating its role in pathogenicity beyond its metabolic function.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can exposure to heavy metals like lead(Pb) or cadmium(Cd) cause changes in DNA methylation patterns in Isoetes sinensis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Exposure to heavy metals such as lead (Pb) or cadmium (Cd) has been documented to cause various physiological and genetic changes in plants. DNA methylation, an important epigenetic mechanism, can be influenced by environmental stressors, including heavy metal exposure. Isoetes sinensis, being a plant species, may experience changes in DNA methylation patterns when exposed to these metals, similar to other plant species studied under heavy metal stress.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "In clinical trials, the H3 R antagonist CEP-26401 has a positive effect on cognition, yes or no?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the H3 R antagonist CEP-26401 has a positive effect on cognition based on clinical trials. To answer this, one would need to refer to the results of clinical trials involving CEP-26401. Since the question does not provide specific trial results, the answer would depend on the latest research findings or published clinical trial data regarding CEP-26401's effects on cognition.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Yeast prions have been studied extensively due to their similarity to human amyloid diseases in terms of protein misfolding and aggregation. They provide a simpler model system to understand the complex mechanisms of amyloid formation and propagation, which are relevant to human diseases like Alzheimer's and Parkinson's.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a link between BCL11B haploinsufficiency and syndromic neurodevelopmental delay?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"BCL11B haploinsufficiency is a genetic condition that has been associated with various developmental and immunological abnormalities. Given its role in neural development, it is plausible that BCL11B haploinsufficiency could lead to syndromic neurodevelopmental delay. Research and case studies have indicated that mutations or deletions affecting the BCL11B gene can result in developmental delays, among other symptoms.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is the PINES framework being used for the prediction of coding variants?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The PINES framework is a tool designed for predicting the functional impact of non-coding variants, not coding variants. Therefore, it is not typically used for the prediction of coding variants.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Tecovirimat effective for smallpox?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tecovirimat is an antiviral medication approved for the treatment of smallpox. It works by inhibiting the replication of the virus. Given its approval and mechanism of action, it is considered effective for treating smallpox.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is cabozantinib effective for hepatocellular carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cabozantinib is a tyrosine kinase inhibitor that has been studied for its effectiveness in treating various cancers, including hepatocellular carcinoma (HCC). Clinical trials have shown that cabozantinib can improve survival rates in patients with advanced HCC who have previously been treated with sorafenib. The drug works by targeting multiple pathways involved in tumor growth and angiogenesis, which are critical in the progression of HCC.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Baloxavir effective for influenza?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Baloxavir is an antiviral medication approved for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours. It works by inhibiting the cap-dependent endonuclease activity of the influenza virus polymerase complex, which is essential for viral replication. Clinical trials have shown that Baloxavir can reduce the duration of influenza symptoms and viral shedding compared to placebo. Therefore, it is considered effective for the treatment of influenza caused by susceptible strains.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is ibudilast effective for multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Ibudilast is a phosphodiesterase inhibitor that has been studied for its potential effects on multiple sclerosis (MS). Research suggests it may have neuroprotective and anti-inflammatory properties that could benefit MS patients. However, its effectiveness as a treatment for MS is still under investigation, and it is not currently approved by the FDA for this use.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is Adar3 involved in learning and memory?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Adar3 is a member of the ADAR family of proteins, which are known for their role in RNA editing. RNA editing is a post-transcriptional modification process that can affect gene expression and protein function. While ADAR proteins, including Adar3, are primarily associated with RNA editing, their specific roles in learning and memory are not as clearly defined as those of other proteins directly involved in neural plasticity and memory formation. Therefore, the involvement of Adar3 in learning and memory is not well-established and requires further research.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether a specific genetic deletion at 6q24.2-26 is associated with longer survival in patients with high-grade serous ovarian carcinoma (HGSOCs). To answer this, one would need to refer to scientific studies or clinical data that investigate the correlation between this genetic deletion and survival rates in HGSOC patients. Without specific data or studies at hand, it's challenging to provide a definitive answer. However, the question implies a search for a yes or no response based on existing research findings.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is  LRP1 interacting with Urokinase receptor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if LRP1 interacts with the Urokinase receptor, we need to consider known biological interactions and literature evidence. LRP1 (Low-density lipoprotein receptor-related protein 1) is known to interact with a variety of ligands and receptors, playing roles in endocytosis and cell signaling. The Urokinase receptor (uPAR) is involved in extracellular matrix degradation and cell migration. There is evidence in scientific literature suggesting that LRP1 can interact with uPAR, mediating internalization and signaling processes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is chlorotoxin a peptide?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Chlorotoxin is a 36-amino acid peptide found in the venom of the deathstalker scorpion (Leiurus quinquestriatus). It is known for its ability to bind specifically to chloride channels and has been studied for its potential applications in medical imaging and cancer therapy. Given its composition and structure, it is classified as a peptide.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is selenocysteine an aminoacid?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Selenocysteine is often referred to as the 21st amino acid. It is incorporated into proteins in a unique way, different from the standard 20 amino acids, but it is indeed an amino acid.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is phospholipid hydroperoxide glutathione peroxidase a selenoprotein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Phospholipid hydroperoxide glutathione peroxidase (PHGPx) is an enzyme that plays a role in protecting biomembranes from oxidative damage. The question is asking whether PHGPx is a selenoprotein, which is a protein that contains selenium in the form of selenocysteine. Selenoproteins are known for their antioxidant properties. PHGPx is indeed known to contain selenocysteine, making it a selenoprotein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is P. gingivalis bacteria found in brain?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether P. gingivalis bacteria, which is known for causing periodontal disease, can be found in the brain. Research has suggested that P. gingivalis may be associated with Alzheimer's disease, indicating its presence in the brain.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "There is no drug available to prevent HIV infection, Pre-exposure prophylaxis (PrEP), yes or no?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether there is a drug available to prevent HIV infection, specifically mentioning Pre-exposure prophylaxis (PrEP). PrEP is indeed a medication that, when taken as prescribed, is highly effective at preventing HIV infection.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is cariprazine effective for treatment of bipolar disorder?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cariprazine is an antipsychotic medication that has been studied for its effectiveness in treating bipolar disorder, particularly in managing manic, mixed, and depressive episodes associated with bipolar I disorder. Clinical trials have shown that cariprazine can be effective in reducing symptoms of bipolar disorder, making it a potential treatment option.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Groucho related gene 5 (GRG5) have a role only in late development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if Groucho related gene 5 (GRG5) has a role only in late development, we need to consider its known functions and expression patterns throughout development. GRG5 is part of the Groucho/TLE family of transcriptional corepressors, which are involved in various developmental processes. While some members of this family are known to play roles in early development, GRG5's specific functions might be more associated with later stages. However, without specific evidence indicating its exclusive role in late development, we cannot conclusively say it is limited to that phase.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the yeast (Saccharomyces cerevisiae) genome organized into topologically associated domains (TADs)?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether the yeast (Saccharomyces cerevisiae) genome is organized into topologically associated domains (TADs). TADs are regions of the genome that interact with themselves more frequently than with other regions, and they are a common feature in higher eukaryotes. However, Saccharomyces cerevisiae is a simpler organism with a smaller genome, and it's known to have a less complex chromatin organization compared to higher eukaryotes.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there any role for HUWE1 in MYC signalling?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if HUWE1 has a role in MYC signalling, we need to consider the known functions of HUWE1 and its interactions with MYC. HUWE1 is an E3 ubiquitin ligase that has been implicated in the regulation of various cellular processes, including the ubiquitination and degradation of proteins. MYC is a transcription factor that plays a critical role in cell growth and proliferation. Given that HUWE1 can target MYC for degradation, it is plausible that HUWE1 plays a role in MYC signalling by regulating MYC stability and activity.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is TIAM1 favoring tumor progression in colorectal cancer (CRC)?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if TIAM1 favors tumor progression in colorectal cancer (CRC), we need to consider its role in cancer biology. TIAM1 is known to be involved in cell migration and invasion, processes that are critical for tumor progression and metastasis. In the context of CRC, if TIAM1 promotes these processes, it could be considered as favoring tumor progression.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Are de novo mutations in regulatory elements responsible for neurodevelopmental disorders?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether de novo mutations in regulatory elements are responsible for neurodevelopmental disorders. De novo mutations are genetic alterations that appear for the first time in one family member as a result of a mutation in a germ cell of one of the parents or in the fertilized egg itself. Regulatory elements are segments of DNA that influence the expression of genes. Neurodevelopmental disorders are conditions that affect the development of the nervous system, leading to abnormal brain function which may affect emotion, learning ability, self-control, and memory. Research has shown that mutations in regulatory elements can disrupt normal gene expression patterns during development, potentially leading to neurodevelopmental disorders. However, not all neurodevelopmental disorders are caused by such mutations, as they can also result from mutations in coding regions of genes or environmental factors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are recessive coding variants responsible for the majority of undiagnosed nonconsanguineous individuals?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if recessive coding variants are responsible for the majority of undiagnosed nonconsanguineous individuals, we need to consider the genetic architecture of diseases in such populations. Nonconsanguineous individuals are less likely to have homozygous recessive variants due to lower levels of shared ancestry. Therefore, the contribution of recessive coding variants to undiagnosed cases might be less significant compared to consanguineous populations. However, compound heterozygosity (two different recessive variants in the same gene) could still play a role. The majority of undiagnosed cases in nonconsanguineous individuals are more likely attributed to de novo mutations, dominant variants, or complex genetic interactions rather than recessive coding variants.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the NLM medical text indexer (MTI) still useful and relevant?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The NLM Medical Text Indexer (MTI) is a tool developed by the National Library of Medicine to assist in the indexing of biomedical literature. It uses natural language processing and machine learning techniques to suggest MeSH (Medical Subject Headings) terms for articles. Given the continuous advancements in biomedical research and the increasing volume of literature, tools like MTI that help in organizing and retrieving information efficiently remain important. Therefore, it is likely that the MTI is still useful and relevant in the current context.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is cohesin linked to myeloid differentiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cohesin is a protein complex that plays a crucial role in chromosome structure and segregation during cell division. Myeloid differentiation is a process by which hematopoietic stem cells give rise to myeloid lineage cells, including granulocytes, monocytes, and erythrocytes. Research has suggested that cohesin mutations or dysregulation can affect hematopoietic differentiation, including myeloid differentiation, by altering gene expression programs critical for differentiation. Therefore, there is evidence to suggest a link between cohesin and myeloid differentiation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is erythropoietin effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Erythropoietin is a hormone that stimulates red blood cell production and has been studied for its potential neuroprotective effects. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with no known cure. The effectiveness of erythropoietin for ALS treatment is not well-established, and current evidence does not strongly support its use for this condition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can mogamulizumab be used for the treatment of cutaneous T-cell lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mogamulizumab is a monoclonal antibody directed against CC chemokine receptor 4 (CCR4), which is expressed on some T-cell malignancies, including cutaneous T-cell lymphoma (CTCL). Clinical trials have shown that mogamulizumab can be effective in treating certain types of CTCL, such as mycosis fungoides and Sézary syndrome, which are the most common subtypes. Therefore, it is considered a treatment option for these conditions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has ivosidenib been FDA approved for use against acute myeloid leukemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if ivosidenib has been FDA approved for use against acute myeloid leukemia, we need to check the FDA's approval records or reliable medical sources for information on ivosidenib's approval status specifically for acute myeloid leukemia.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can CPX-351 be used for the treatment of tuberculosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"CPX-351 is a liposomal formulation of cytarabine and daunorubicin, specifically approved for the treatment of certain types of acute myeloid leukemia (AML). Tuberculosis is caused by Mycobacterium tuberculosis and requires antibiotics for treatment. CPX-351 is not an antibiotic and is not indicated for the treatment of tuberculosis.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does lucatumumab bind to CD140?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if lucatumumab binds to CD140, we need to understand the specificity of lucatumumab. Lucatumumab is known to target CD40, a protein found on the surface of B cells and other antigen-presenting cells. CD140, on the other hand, refers to the platelet-derived growth factor receptor (PDGFR), which is a different protein. Given that lucatumumab's target is CD40 and not CD140, it is unlikely that lucatumumab binds to CD140.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is lucatumumab a polyclonal antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if lucatumumab is a polyclonal antibody, we need to understand its nature. Lucatumumab is a monoclonal antibody targeting CD40, which is used in research and potential therapeutic applications. Monoclonal antibodies are derived from a single clone of cells, making them specific to a single epitope, unlike polyclonal antibodies which are derived from multiple clones and recognize multiple epitopes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can midostaurin inhibit angiogenesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Midostaurin is a multi-targeted kinase inhibitor that has been studied for its effects on various cellular processes, including angiogenesis. Angiogenesis is the process of new blood vessel formation, which is crucial for tumor growth and metastasis. Given midostaurin's mechanism of action, it is plausible that it could inhibit angiogenesis by targeting kinases involved in this process.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can enasidenib be used for the treatment of acute myeloid leukemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Enasidenib is a medication that has been approved for the treatment of relapsed or refractory acute myeloid leukemia (AML) with a specific genetic mutation, namely IDH2 mutation. Therefore, its use is targeted and not for all AML cases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is lithium effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Lithium has been studied for its potential effects on amyotrophic lateral sclerosis (ALS), but the results have been mixed. Some studies suggested a possible benefit, while others did not find significant improvements in disease progression or survival. Therefore, the effectiveness of lithium for ALS treatment remains uncertain and it is not a standard treatment option.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is celecoxib effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that is primarily used to treat pain and inflammation. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Currently, there is no cure for ALS, and treatments focus on slowing the progression of the disease and managing symptoms. The effectiveness of celecoxib specifically for the treatment of ALS has not been established as a standard or widely recognized treatment.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is pacritinib effective for treatment of myelofibrosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Pacritinib is a drug that has been studied for its effectiveness in treating myelofibrosis, a type of bone marrow cancer. It works by inhibiting certain enzymes that are involved in the growth and spread of cancer cells. Clinical trials have shown that pacritinib can be effective in reducing symptoms and improving outcomes for some patients with myelofibrosis, particularly those with low platelet counts.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do raspberries improve postprandial glucose and acute and chronic inflammation in adults with type 2 Diabetes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if raspberries improve postprandial glucose and acute and chronic inflammation in adults with type 2 Diabetes, we need to consider existing research and studies on the subject. Raspberries are known for their high fiber content and antioxidant properties, which could potentially influence glucose metabolism and inflammation. However, without specific studies or evidence directly linking raspberries to these outcomes in adults with type 2 Diabetes, it's challenging to provide a definitive answer.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Has Hesperidin any role as a Neuroprotective Agent?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Hesperidin is a flavonoid found in citrus fruits that has been studied for its potential health benefits, including its neuroprotective effects. Research suggests that hesperidin may protect neurons from oxidative stress, reduce inflammation, and improve brain function, indicating a possible role as a neuroprotective agent.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there tools for visualizing and processing long-read sequencing data?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Long-read sequencing data, such as those generated by PacBio or Oxford Nanopore technologies, require specialized tools for visualization and processing due to their unique characteristics. There are indeed tools designed for these purposes, including but not limited to genome browsers like IGV and JBrowse, and processing tools like Canu, Flye, and Minimap2.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a deep-learning algorithm for protein solubility prediction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether there exists a deep-learning algorithm specifically designed for predicting protein solubility. Deep learning, a subset of machine learning, has been applied to various bioinformatics tasks, including protein-related predictions. Given the complexity and importance of protein solubility in biotechnological applications, it's plausible that researchers have developed deep-learning models for this purpose.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is cabozantinib effective for Hepatocellular Carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if cabozantinib is effective for Hepatocellular Carcinoma (HCC), we need to consider clinical trial results and approvals by health authorities. Cabozantinib is a tyrosine kinase inhibitor that has been evaluated in clinical trials for its efficacy in treating HCC. The CELESTIAL trial, a phase 3 randomized study, showed that cabozantinib significantly improved overall survival and progression-free survival in patients with advanced HCC who had previously been treated with sorafenib. Based on these results, cabozantinib has been approved by the FDA and other regulatory agencies for the treatment of HCC in certain settings.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is dupilumab effective for treatment of asthma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Dupilumab is a monoclonal antibody that targets the interleukin-4 receptor alpha, inhibiting signaling of both interleukin-4 and interleukin-13, which are key drivers of type 2 inflammation. It has been approved for the treatment of moderate-to-severe asthma in patients with an eosinophilic phenotype or oral corticosteroid-dependent asthma, based on clinical trials showing reduced exacerbations and improved lung function.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is verubecestat effective for Alzheimer’s Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Verubecestat was a drug developed for the treatment of Alzheimer's Disease, targeting the beta-secretase enzyme to reduce amyloid-beta production. However, clinical trials did not show significant effectiveness in slowing cognitive decline in patients with mild to moderate Alzheimer's Disease, leading to the discontinuation of its development.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does Eucommia ulmoides leaf extract ameliorates steatosis/fatty liver induced by high-fat diet?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Eucommia ulmoides leaf extract ameliorates steatosis/fatty liver induced by a high-fat diet, we need to consider existing research or studies that have investigated the effects of this extract on liver health, specifically in the context of high-fat diet-induced conditions. Eucommia ulmoides is known for its potential health benefits, including anti-inflammatory and lipid-lowering effects, which could theoretically help in reducing liver fat accumulation. However, without specific studies or evidence directly linking the extract to the amelioration of high-fat diet-induced steatosis, the answer would depend on the availability of such research.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there ultraconserved regions in the budding yeast (Saccharomyces cerevisiae)?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Ultraconserved regions are sequences in the genome that are highly conserved across species. The question is asking whether such regions exist in the budding yeast, Saccharomyces cerevisiae. Given that Saccharomyces cerevisiae is a relatively simple organism with a compact genome, it's less likely to have ultraconserved regions compared to more complex organisms.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are there graph kernel libraries available implemented in JAVA?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if there are graph kernel libraries available implemented in JAVA, we need to consider the popularity of JAVA as a programming language and its use in machine learning and graph theory applications. Graph kernels are a method for graph comparison and are used in machine learning for structured data. JAVA, being a widely used language, especially in enterprise environments, is likely to have libraries or frameworks that implement graph kernels. A quick search or review of machine learning and graph processing libraries in JAVA would confirm this.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can you computationally predict Molecular Recognition Features (MoRFs) regions in Intrinsically Disordered Proteins (IDPs)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Molecular Recognition Features (MoRFs) are short, disordered regions within Intrinsically Disordered Proteins (IDPs) that undergo a disorder-to-order transition upon binding to their partners. Predicting MoRFs computationally involves analyzing protein sequences for regions that are likely to bind to other molecules and undergo such transitions. Various computational tools and algorithms have been developed to predict MoRFs based on sequence characteristics, structural propensity, and other features.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there tools for reviewing variant calls?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether there are tools available for reviewing variant calls. Variant calls are typically reviewed in the context of genomic data analysis, where accuracy is crucial. Given the complexity and importance of this task, it's reasonable to assume that specialized tools exist for this purpose.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is baricitinib effective for rheumatoid arthritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Baricitinib is a medication that has been studied for its effectiveness in treating rheumatoid arthritis. It works by inhibiting certain enzymes involved in the inflammatory process, which is a key feature of rheumatoid arthritis. Clinical trials have shown that baricitinib can reduce symptoms and improve physical function in patients with rheumatoid arthritis, especially in those who have not responded adequately to other treatments.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is galcanezumab effective for treatment of migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Galcanezumab is a monoclonal antibody that targets the calcitonin gene-related peptide (CGRP), which is believed to play a key role in migraine pathophysiology. Clinical trials have shown that galcanezumab can reduce the number of migraine days in patients with episodic and chronic migraine. Therefore, it is considered effective for the treatment of migraine.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Lasmiditan effective for migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Lasmiditan is a medication specifically designed for the acute treatment of migraine with or without aura in adults. It works by selectively targeting the 5-HT1F receptor, which is thought to play a role in migraine pathophysiology. Clinical trials have shown that Lasmiditan can be effective in relieving migraine symptoms.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is pimavanserin effective for Parkinson's disease psychosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Pimavanserin is a medication approved by the FDA specifically for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It works by selectively blocking serotonin receptors, which are thought to play a role in psychosis. Clinical trials have shown that pimavanserin can reduce the frequency and severity of psychotic symptoms in patients with Parkinson's disease without worsening the motor symptoms.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does an interferon (IFN) signature exist for SLE patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if an interferon (IFN) signature exists for SLE (Systemic Lupus Erythematosus) patients, we need to consider the evidence from medical research. Studies have shown that SLE patients often exhibit an upregulation of IFN-inducible genes, which is referred to as the 'IFN signature'. This signature is associated with the pathogenesis of SLE and is considered a hallmark of the disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can Diazepam be beneficial  in the treatment of  traumatic brain injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Diazepam is a medication primarily used to treat anxiety, alcohol withdrawal, muscle spasms, seizures, and insomnia. Its role in traumatic brain injury (TBI) is not as a primary treatment but may be used to manage symptoms such as muscle spasms or seizures that can occur following TBI. However, its use must be carefully considered due to potential side effects and the risk of dependency. The benefit of Diazepam in TBI would depend on the specific symptoms and conditions of the patient.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are genes that escape X-chromosome inactivation related to mental impairment?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if genes that escape X-chromosome inactivation are related to mental impairment, we need to consider the role of these genes in brain function and development. Genes escaping X-inactivation are expressed from both X chromosomes in females, potentially leading to higher expression levels of certain genes compared to males. If these genes are involved in critical brain functions, their dysregulation could contribute to mental impairment. However, the relationship is complex and depends on the specific genes involved and their functions.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "As of Feb 2019, are major brain gangliosides a target for the treatment of Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if major brain gangliosides were a target for the treatment of Alzheimer's disease as of February 2019, we need to consider the research and clinical focus during that time. Alzheimer's disease research has explored various pathways and targets, including amyloid plaques, tau tangles, and inflammation. Gangliosides, which are glycosphingolipids found in the cell membranes of neurons, have been studied for their role in neurodevelopment and neurodegeneration. However, by February 2019, the primary targets for Alzheimer's treatment were more focused on amyloid and tau rather than gangliosides, although research into gangliosides' role was ongoing.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is pazopanib an effective treatment of glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Pazopanib is a tyrosine kinase inhibitor that has been studied in various cancers, including glioblastoma. However, its effectiveness specifically for glioblastoma is not well-established, and it is not a standard treatment for this condition. Clinical trials have shown mixed results, and more research is needed to determine its efficacy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is avelumab effective for bladder cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Avelumab is an immune checkpoint inhibitor that targets PD-L1 and has been approved for the treatment of certain types of cancer. It has shown efficacy in the treatment of metastatic Merkel cell carcinoma and urothelial carcinoma, which includes bladder cancer, particularly in patients who have progressed after platinum-based chemotherapy. Therefore, it can be considered effective for bladder cancer in specific contexts.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can pazopanib be used for treatment von Hippel-Lindau disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Pazopanib is a tyrosine kinase inhibitor approved for the treatment of advanced renal cell carcinoma and soft tissue sarcoma. Von Hippel-Lindau disease is a genetic disorder that predisposes individuals to certain tumors, including renal cell carcinoma. While pazopanib is not specifically approved for Von Hippel-Lindau disease, its mechanism of action suggests it could potentially be used off-label for tumors associated with this condition, such as renal cell carcinoma. However, the use of pazopanib for Von Hippel-Lindau disease would depend on clinical judgment and evidence from clinical trials or case studies.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Miller-Dieker syndrome is a genetic condition characterized by a pattern of abnormal brain development known as lissencephaly, as well as distinctive facial features. It is caused by a deletion of genetic material near the end of the short (p) arm of chromosome 17. The question asks whether it is associated with abnormalities of chromosome 1.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should dacomitinib be used for treatment of glioblastoma patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Dacomitinib is a pan-HER inhibitor that has been studied in various cancers, but its efficacy and safety in glioblastoma patients are not well-established. Glioblastoma is a highly aggressive brain tumor with limited treatment options. Current standard treatments include surgery, radiation, and chemotherapy, with temozolomide being the most commonly used chemotherapeutic agent. The use of dacomitinib in glioblastoma would require clinical trials to determine its effectiveness and safety profile in this specific patient population.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is inositol effective for trichotillomania?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Inositol is a carbohydrate that plays a role in cellular signaling and has been studied for various mental health conditions, including anxiety and depression. Trichotillomania is a mental health disorder characterized by the compulsive urge to pull out one's hair. While inositol has been explored for its potential benefits in treating obsessive-compulsive and related disorders, there is limited specific research on its effectiveness for trichotillomania. The available evidence is not sufficient to conclusively determine its efficacy for this condition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is eculizumab used for treatment of myasthenia gravis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Eculizumab is a monoclonal antibody that inhibits the complement protein C5. It is primarily used for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). However, it has also been studied for its potential use in other conditions, including myasthenia gravis (MG), particularly in cases that are refractory to other treatments. The question is whether eculizumab is used for the treatment of myasthenia gravis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Semagacestat effective for treatment of Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Semagacestat was investigated as a potential treatment for Alzheimer's disease, but clinical trials showed that it not only failed to slow the progression of the disease but also worsened cognition and the ability to perform daily activities in patients. Therefore, its effectiveness for treating Alzheimer's disease is questionable.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does simvastatin improve outcomes of aneurysmal subarachnoid hemorrhage?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if simvastatin improves outcomes of aneurysmal subarachnoid hemorrhage, we need to consider clinical studies and evidence. Aneurysmal subarachnoid hemorrhage is a serious condition, and statins like simvastatin have been studied for their potential neuroprotective effects. However, the evidence is mixed, with some studies suggesting potential benefits in reducing vasospasm and improving neurological outcomes, while others show no significant improvement. Therefore, the answer depends on the current consensus from clinical trials and meta-analyses.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does tremelimumab improve survival of mesothelioma patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tremelimumab is a monoclonal antibody that targets CTLA-4 and has been studied in various cancers, including mesothelioma. Clinical trials have investigated its efficacy in improving survival rates among mesothelioma patients. The analysis of these trials is crucial to determine its effectiveness.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Axitinib is a tyrosine kinase inhibitor that has been studied in various cancers, including pancreatic cancer. However, the effectiveness of Axitinib in prolonging survival specifically for pancreatic cancer patients is not well-established and may vary based on individual cases and treatment combinations. Clinical trials and studies would be the best sources for current evidence on this matter.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does Panitumumab prolong survival of biliary tract cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if Panitumumab prolongs survival in biliary tract cancer patients, we need to consider clinical trial results and studies specific to this drug and cancer type. Panitumumab is an EGFR inhibitor, and its efficacy in biliary tract cancer has been explored in some studies. However, the evidence is not conclusive, and it is not currently a standard treatment for this cancer type. The answer depends on the specific context and available data from clinical trials.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the enzyme ERAP2 associated with the disease birdshot chorioretinopathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if the enzyme ERAP2 is associated with birdshot chorioretinopathy, we need to consider whether there is scientific evidence linking ERAP2 to this specific disease. Birdshot chorioretinopathy is a rare form of posterior uveitis with a strong association with the HLA-A29 gene. ERAP2, an endoplasmic reticulum aminopeptidase, plays a role in trimming peptides for presentation by MHC class I molecules, including HLA-A29. Given the involvement of HLA-A29 in birdshot chorioretinopathy and ERAP2's role in antigen presentation, it is plausible that ERAP2 could be associated with the disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is ADP-ribosylation a PTM?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ADP-ribosylation is a post-translational modification (PTM) where ADP-ribose molecules are added to proteins. This process can affect protein function, localization, and interactions. Therefore, it is considered a type of PTM.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is collagen the most abundant human protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Collagen is a major structural protein in the human body, found in connective tissues such as skin, bones, and tendons. To determine if it is the most abundant, we consider its prevalence compared to other proteins like actin and myosin in muscles, or hemoglobin in blood.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Mesenchymal stem cells (MSC) multipotent cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mesenchymal stem cells (MSC) are known for their ability to differentiate into a variety of cell types, including osteoblasts (bone cells), chondrocytes (cartilage cells), and adipocytes (fat cells). This characteristic is a hallmark of multipotent cells, which can differentiate into multiple cell types but are limited to those within a particular lineage or tissue type.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is TIM-3 a target for cancer immunotherapy in NSCLC?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"TIM-3 is an immune checkpoint molecule that has been studied in the context of cancer immunotherapy. Non-small cell lung cancer (NSCLC) is a type of cancer where immunotherapy has shown promise. Research suggests that targeting TIM-3, either alone or in combination with other checkpoint inhibitors, could be a viable strategy for treating NSCLC.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are phagosomal proteins ubiquitinated?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Phagosomal proteins can undergo ubiquitination as part of the process to mark pathogens or cellular debris for degradation. Ubiquitination is a post-translational modification that plays a key role in the immune response by targeting proteins for destruction in the proteasome or for modification of their function.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any approved treatment for NAFLD?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"NAFLD (Non-Alcoholic Fatty Liver Disease) is a condition with no specific FDA-approved medications. However, lifestyle changes such as weight loss, exercise, and dietary modifications are recommended. Some medications may be used off-label or are under investigation, but there is no universally approved treatment specifically for NAFLD.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are tumour specific antigens originating from known protein coding genes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tumour specific antigens can originate from various sources, including known protein coding genes, but they can also arise from non-coding regions of the genome, mutations, or viral proteins. The question specifically asks if they originate from known protein coding genes, which can be the case for some tumour specific antigens.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is treatment with Bacillus Calmette Guerin used for bladder cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bacillus Calmette Guerin (BCG) is a vaccine primarily used against tuberculosis. However, it has also been found to be effective in the treatment of certain types of bladder cancer. It is used as a form of immunotherapy to stimulate the immune system to attack cancer cells in the bladder.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Rhamnose have any effect on aging?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Rhamnose is a naturally occurring deoxy sugar found in plants and some bacteria. While it has various biological roles, including being a component of cell walls and acting as a precursor for other compounds, there is no direct evidence or widely accepted research indicating that Rhamnose has a significant effect on the aging process. Aging is a complex biological phenomenon influenced by genetic, environmental, and lifestyle factors. Therefore, without specific studies demonstrating Rhamnose's impact on aging mechanisms, it's not possible to affirm its effectiveness in this regard.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are apoE mimetics being considered as a treatment against Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ApoE mimetics are compounds designed to mimic the function of apolipoprotein E (apoE), which is involved in lipid metabolism and has been linked to Alzheimer's disease risk. Research into apoE mimetics as a potential treatment for Alzheimer's disease is ongoing, with studies exploring their ability to reduce amyloid-beta accumulation and neuroinflammation, which are key features of the disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is L-4F an apoE mimetic peptide?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if L-4F is an apoE mimetic peptide, we need to understand what apoE mimetic peptides are. ApoE mimetic peptides are small peptides designed to mimic the functional properties of apolipoprotein E (apoE), which is involved in lipid metabolism and has anti-inflammatory and anti-atherogenic effects. L-4F is a synthetic peptide that has been studied for its ability to mimic some of the beneficial effects of apoE, such as promoting cholesterol efflux and reducing inflammation. Therefore, L-4F can be considered an apoE mimetic peptide.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can oleuropein aglycone interfere with amyloid aggregation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Oleuropein aglycone is a phenolic compound found in olive oil and has been studied for its potential health benefits, including its effects on amyloid aggregation. Amyloid aggregation is associated with several neurodegenerative diseases. Research suggests that oleuropein aglycone may interfere with amyloid aggregation, potentially offering therapeutic benefits.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Crocus sativus compounds being considered against Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Crocus sativus, commonly known as saffron, has been studied for its potential health benefits, including its effects on Alzheimer's disease. Research has explored its compounds for neuroprotective properties and their ability to inhibit the progression of Alzheimer's disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do Crocus sativus extracts loosen the blood-brain barrier?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about whether Crocus sativus extracts have an effect on the blood-brain barrier, specifically if they loosen it. To answer this, we need to consider any known pharmacological effects of Crocus sativus (saffron) on the blood-brain barrier. Currently, there is no widely accepted scientific evidence or studies that conclusively demonstrate that Crocus sativus extracts loosen the blood-brain barrier.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Netrin-1 a secreted protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Netrin-1 is a protein that plays a crucial role in axon guidance and cell migration during development. It is known to be secreted by cells to exert its functions in the extracellular environment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Have apolipoprotein mimetics been used in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Apolipoprotein mimetics are synthetic peptides designed to mimic the structure and function of apolipoproteins, which are involved in lipid metabolism and have potential therapeutic applications in cardiovascular diseases. To determine if they have been used in clinical trials, we need to consider the current state of research and development in this area.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has strimvelis been approved by the European Medicines Agency?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Strimvelis has been approved by the European Medicines Agency, we need to verify its approval status through official sources or announcements from the European Medicines Agency. Strimvelis is a gene therapy treatment for a rare immune disorder, and its approval status would be a matter of public record.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein Asporin related to disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Asporin is a protein that has been studied in relation to various diseases, particularly in the context of osteoarthritis and cancer. Research suggests that variations in the Asporin gene may influence disease susceptibility and progression. Therefore, it is relevant to investigate its association with diseases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is lactotransferrin a tumour suppressor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Lactotransferrin, also known as lactoferrin, is a multifunctional protein with various biological activities, including antimicrobial, anti-inflammatory, and immunomodulatory effects. Some studies suggest that lactotransferrin may have antitumor properties, such as inhibiting tumor cell growth and inducing apoptosis. However, the classification of lactotransferrin as a tumor suppressor is not universally accepted and requires further research to fully understand its mechanisms and effects in cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has the protein SIRT2 been associated to cervical cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if the protein SIRT2 has been associated with cervical cancer, we need to consider existing scientific research and studies. SIRT2 is a member of the sirtuin family of proteins, which are involved in cellular regulation, including aging, transcription, apoptosis, and inflammation. Some studies have explored the role of sirtuins in various cancers, but the specific association of SIRT2 with cervical cancer would require reviewing literature on this topic.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does RUNX2 inhibit astrocyte differentiation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if RUNX2 inhibits astrocyte differentiation, we need to consider the role of RUNX2 in cell differentiation and specifically in the context of astrocytes. RUNX2 is a transcription factor known for its role in osteoblast differentiation and bone formation. Its role in astrocyte differentiation is less clear and might depend on the cellular context and other interacting factors.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can miR-122 target RUNX2?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if miR-122 can target RUNX2, we need to consider the base pairing between miR-122 and the 3'UTR of RUNX2 mRNA, as well as any experimental evidence or computational predictions supporting this interaction. miR-122 is known to play roles in liver metabolism and hepatitis C virus replication, while RUNX2 is a transcription factor important for bone development. The targeting would depend on the presence of complementary sequences in RUNX2's 3'UTR that miR-122 can bind to.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can antisense threapy be used for Huntington's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Huntington's disease is a genetic disorder caused by a mutation in the HTT gene, leading to the production of a harmful protein called huntingtin. Antisense therapy is a treatment approach that uses antisense oligonucleotides to target and degrade the mRNA of the mutated gene, preventing the production of the harmful protein. Given that antisense therapy can target specific mRNA sequences, it is theoretically possible to use it for Huntington's disease by targeting the mRNA produced by the mutated HTT gene.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can prevnar 13 be used in children?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Prevnar 13 is a vaccine designed to protect against 13 types of pneumococcal bacteria. It is important to check the approved uses and age recommendations for vaccines. Prevnar 13 is approved for use in children as well as adults. Specifically, it is recommended for all children younger than 2 years old and for children 2 through 18 years old with certain medical conditions that increase their risk of pneumococcal disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Was stelara developed by Amgen?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if Stelara was developed by Amgen, we need to look into the history and development of the drug. Stelara (ustekinumab) is a monoclonal antibody used to treat autoimmune diseases. It was developed by Janssen Biotech, a subsidiary of Johnson & Johnson, not by Amgen.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is ustekinumab a polyclonal antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if ustekinumab is a polyclonal antibody, we need to understand its nature. Ustekinumab is a monoclonal antibody that targets the p40 subunit of interleukin-12 (IL-12) and interleukin-23 (IL-23). Monoclonal antibodies are produced by identical immune cells that are clones of a unique parent cell, making them specific to a single epitope. Polyclonal antibodies, on the other hand, are derived from different B cell lineages and can recognize multiple epitopes on the same antigen. Given this information, ustekinumab is not a polyclonal antibody.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do tumour-associated macrophages have a prognostic role in gliomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tumour-associated macrophages (TAMs) are a significant component of the tumour microenvironment in gliomas and have been studied for their potential prognostic role. Their presence and polarization state (M1 vs. M2) can influence tumour progression, immune evasion, and response to therapy. High levels of M2-polarized TAMs are often associated with poor prognosis in gliomas, suggesting that TAMs could indeed have a prognostic role.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can cardiospheres be produced from skin fibroblasts?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cardiospheres are typically derived from cardiac stem cells or progenitor cells, not directly from skin fibroblasts. However, skin fibroblasts can be reprogrammed into induced pluripotent stem cells (iPSCs), which can then be differentiated into cardiac progenitor cells or cardiomyocytes, potentially allowing for the production of cardiospheres indirectly.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does the interaction of MOV10 and RNASEH2 promote L1 retrotransposition?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the interaction between MOV10 and RNASEH2 promotes L1 retrotransposition. To answer this, we need to consider the roles of MOV10 and RNASEH2 in the context of L1 retrotransposition. MOV10 is known to inhibit L1 retrotransposition, while RNASEH2 is involved in RNA-DNA hybrid resolution. The interaction between these two proteins could potentially influence L1 retrotransposition, but the specific effect of their interaction on promoting L1 retrotransposition is not clearly established in the literature.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Tocilizumab is an anti-TNF antibody, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tocilizumab is a monoclonal antibody, but it targets the interleukin-6 (IL-6) receptor, not tumor necrosis factor (TNF). Therefore, it is not an anti-TNF antibody.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Velocardiofacial syndrome, also known as DiGeorge syndrome, is not caused by a deletion in chromosome 21. It is caused by a deletion in a segment of chromosome 22, specifically 22q11.2. Therefore, the statement is incorrect.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Anaplasma phagocytophilum is an obligate gram-negative, intracellular bacterium, yes  or no",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Anaplasma phagocytophilum is indeed a gram-negative bacterium and it is obligate intracellular, meaning it requires a host cell to replicate.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are cardenolides inhibitors of Na+/K+ ATPase?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cardenolides are a class of steroids that are known to specifically inhibit the Na+/K+ ATPase enzyme by binding to its extracellular domain. This inhibition disrupts the normal ion gradient across the cell membrane, which is crucial for many cellular processes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is it possible to analyze exosomes with FACS?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Exosomes are small extracellular vesicles that can be analyzed using various techniques. Flow cytometry, specifically Fluorescence-Activated Cell Sorting (FACS), is a powerful tool for analyzing and sorting cells based on their fluorescent properties. However, the size of exosomes (typically 30-150 nm) is below the detection limit of conventional flow cytometers, which are optimized for analyzing cells that are micrometers in size. Specialized flow cytometers with enhanced sensitivity and smaller particle detection capabilities can potentially analyze exosomes, but this requires specific instrumentation and may not be as straightforward as analyzing larger particles or cells.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can mitochondria transfer from cell to cell?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mitochondria are known as the powerhouses of the cell, generating most of the cell's supply of adenosine triphosphate (ATP), used as a source of chemical energy. While traditionally it was thought that mitochondria are only inherited maternally and cannot be transferred between cells, recent studies have shown that mitochondria can indeed be transferred from cell to cell under certain conditions, such as in tissue repair and between immune cells. This process is known as mitochondrial transfer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can mitochondria pass through membrane nanotubes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mitochondria are organelles found in eukaryotic cells, known for their role in energy production. Membrane nanotubes are thin, tubular structures that can form between cells, allowing for the transfer of various cellular components. The question is whether mitochondria, given their size and structure, can pass through these nanotubes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is TNF-α an activator of pancreatic stellate cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"TNF-α, or tumor necrosis factor-alpha, is a cytokine involved in systemic inflammation and is known to play a role in the activation of various cell types. Pancreatic stellate cells (PSCs) are activated in response to injury or inflammation, leading to fibrosis in the pancreas. Given TNF-α's role in inflammation, it is plausible that it could act as an activator of PSCs.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are protamines ubiquitously expressed?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Protamines are small, arginine-rich proteins that replace histones during the spermatogenesis process in many species, playing a crucial role in chromatin condensation in sperm. While they are highly expressed in the sperm of many animals, their expression is not universal across all cell types or organisms. Therefore, the question of whether protamines are ubiquitously expressed requires consideration of their specific role and distribution.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can therapeutic levels of  Vedolizumab be found in the breast milk of nursing mothers following treatment for Inflammatory bowel disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether Vedolizumab, a medication used for treating Inflammatory Bowel Disease (IBD), can be present in breast milk at therapeutic levels when taken by nursing mothers. To answer this, we need to consider the pharmacokinetics of Vedolizumab, including its molecular size and the likelihood of it passing into breast milk. Generally, large molecules like monoclonal antibodies (which Vedolizumab is) are less likely to pass into breast milk in significant amounts. However, specific studies or data on Vedolizumab's presence in breast milk would be necessary for a definitive answer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are there any anti-amyloid antibody approved as drug for Alzheimer's disease treatment?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether any anti-amyloid antibodies have been approved as drugs for the treatment of Alzheimer's disease. To answer this, we need to consider the current status of Alzheimer's disease treatments and specifically look for any anti-amyloid antibodies that have received approval from regulatory bodies such as the FDA or EMA.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is subdural empyema a complication of sinusitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Subdural empyema is a serious condition that can occur as a complication of sinusitis, especially when the infection spreads from the sinuses to the subdural space. This is more common in cases of acute bacterial sinusitis where the infection extends beyond the sinus cavities.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are artificial blood cells available?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Artificial blood cells are a topic of ongoing research and development in the field of medical science. While there have been advancements in creating substitutes that can perform some functions of natural blood cells, fully functional artificial blood cells that can replicate all the functions of natural blood cells are not yet widely available for clinical use.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is actin present in the nucleus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Actin is a globular multi-functional protein that forms microfilaments. It is primarily known for its role in the cytoskeleton and muscle contraction. However, actin has also been found in the nucleus, where it is involved in various nuclear processes such as transcription regulation, chromatin remodeling, and the maintenance of nuclear structure.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the Philadelphia chromosome a fusion between parts of chromosomes 1 and 9?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The Philadelphia chromosome is a specific genetic abnormality associated with chronic myelogenous leukemia (CML) and some other types of leukemia. It results from a reciprocal translocation between chromosome 9 and chromosome 22, not between chromosome 1 and 9. This translocation creates the BCR-ABL fusion gene.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is collagen matrix of human articular cartilage changing with disease?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the collagen matrix of human articular cartilage changes with disease. Articular cartilage is a specialized connective tissue that covers the ends of bones in joints, providing a smooth, lubricated surface for articulation and facilitating the transmission of loads with a low frictional coefficient. The collagen matrix is a critical component of articular cartilage, providing tensile strength and structural integrity. Diseases such as osteoarthritis (OA) and rheumatoid arthritis (RA) can lead to degradation and alteration of the collagen matrix. In OA, for example, there is a loss of collagen and proteoglycans, leading to cartilage breakdown. Similarly, in RA, inflammatory processes can damage the collagen matrix. Therefore, it is reasonable to consider that the collagen matrix of human articular cartilage does change with disease.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can TAD disruption lead to disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Topologically Associating Domains (TADs) are regions of the genome that interact more frequently within themselves than with other regions. Disruption of TADs can lead to altered gene expression, which may contribute to the development of diseases, including cancer and developmental disorders. Therefore, it is plausible that TAD disruption can lead to disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Estrogen lead to forkhead FoxA1 activation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Estrogen is known to play a role in the activation of various transcription factors, including forkhead FoxA1. FoxA1 is a pioneer factor that can open up chromatin and facilitate the binding of estrogen receptor to DNA, thereby playing a crucial role in estrogen signaling pathways. Therefore, it is plausible that estrogen leads to the activation of forkhead FoxA1.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Apelin usually decreased in diabetes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Apelin is a peptide that plays a role in various physiological processes, including glucose metabolism and insulin sensitivity. In diabetes, changes in apelin levels have been observed, but the direction of change can vary depending on the type of diabetes and the stage of the disease. Some studies suggest that apelin levels may be decreased in type 1 diabetes, while in type 2 diabetes, apelin levels might be increased as a compensatory mechanism. Therefore, the answer depends on the specific context of the diabetes in question.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Pim-1 a protein phosphatase?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if Pim-1 is a protein phosphatase, we need to understand its function. Pim-1 is a serine/threonine kinase, which means it adds phosphate groups to proteins, not removes them. Protein phosphatases, on the other hand, remove phosphate groups from proteins. Therefore, Pim-1's function is opposite to that of a protein phosphatase.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the crystal structure of Pim-1 available?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if the crystal structure of Pim-1 is available, one would typically check scientific databases such as the Protein Data Bank (PDB) which catalogues known protein structures. Pim-1 is a serine/threonine-protein kinase that has been studied in various contexts, including cancer research. Given its significance, it is plausible that its crystal structure has been determined and deposited in such databases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is myc a tumour suppressor gene?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if myc is a tumour suppressor gene, we need to understand its function. The myc gene family encodes transcription factors that are involved in cell cycle progression, apoptosis, and cellular transformation. Unlike tumour suppressor genes that inhibit cell proliferation and tumour development, myc genes are known to promote cell proliferation and are often overexpressed in cancers. Therefore, myc is not classified as a tumour suppressor gene but rather as a proto-oncogene.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is CD63 an exosomal marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CD63 is a tetraspanin protein that is commonly found on the surface of exosomes, which are small vesicles secreted by cells. Due to its presence and abundance in exosomes, CD63 is widely recognized and used as a marker to identify and isolate exosomes in various research studies.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does association with the nuclear pore promote gene silencing?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether association with the nuclear pore promotes gene silencing. To answer this, we need to consider the role of nuclear pores in gene regulation. Nuclear pores are known to facilitate the transport of molecules between the nucleus and the cytoplasm, but their association with gene silencing is less direct. Gene silencing typically involves mechanisms like chromatin remodeling or RNA interference, which may not directly involve nuclear pores. However, some studies suggest that nuclear pores can play a role in the spatial organization of chromatin, which might indirectly influence gene silencing.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is the process of DNA loop-extrusion independent of ATP?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The process of DNA loop-extrusion is mediated by structural maintenance of chromosomes (SMC) protein complexes, such as cohesin and condensin. These complexes are known to hydrolyze ATP to fuel their activity, including the extrusion of DNA loops. Therefore, the process is dependent on ATP.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are lamina-associated domains (LADs) associated with transcriptional activation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Lamina-associated domains (LADs) are regions of the genome that interact with the nuclear lamina. They are generally associated with transcriptional repression rather than activation, as they are often found in heterochromatic regions of the genome that are transcriptionally inactive.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are the members of the KRAB-ZNF  gene family promoting gene repression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The KRAB-ZNF gene family is known for its role in gene regulation, particularly in the repression of gene expression. These proteins typically function by recruiting co-repressor complexes to specific genomic loci, leading to the silencing of target genes. Given this established mechanism, it is reasonable to infer that members of the KRAB-ZNF gene family promote gene repression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does deletion of cohesin change gene expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the deletion of cohesin affects gene expression. Cohesin is a protein complex that plays a crucial role in chromosome structure and segregation during cell division. It also has been implicated in the regulation of gene expression by mediating long-range chromosomal interactions that can influence the activity of genes. Therefore, deleting cohesin could potentially disrupt these interactions and alter gene expression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SATB1 expressed in thymocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if SATB1 is expressed in thymocytes, we need to consider the known functions and expression patterns of SATB1. SATB1 is a nuclear protein that plays a critical role in chromatin remodeling and gene regulation, particularly in the immune system. Thymocytes are immature T cells that develop in the thymus, and given SATB1's involvement in T cell development and activation, it is plausible that SATB1 is expressed in thymocytes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there negative enhancers?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether there are negative enhancers. To analyze, we need to understand what enhancers are. Enhancers are DNA sequences that can increase the transcription of genes. The term 'negative enhancers' is not commonly used in genetics or molecular biology. However, if interpreted as sequences that negatively affect transcription, these would typically be referred to as silencers or repressors, not enhancers.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is SATB1 necessary for T-cell maturation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"SATB1 is a chromatin organizer that plays a role in gene regulation. It has been implicated in the development and function of T-cells, but its necessity for T-cell maturation specifically is not universally established. The question requires examining whether SATB1 is essential for the process of T-cell maturation, considering its known functions and any experimental evidence regarding its role in this specific context.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does SATB1 regulate the RAG1 and RAG2 genes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether SATB1, a protein known for its role in chromatin remodeling and gene regulation, has a regulatory effect on the RAG1 and RAG2 genes, which are crucial for V(D)J recombination in the immune system. To answer this, one would need to refer to scientific studies or literature that specifically investigate the relationship between SATB1 and the regulation of RAG1 and RAG2 genes.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is CTCF bound at nucleosome free regions?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CTCF (CCCTC-binding factor) is a transcription factor that plays a crucial role in the organization of chromatin and the regulation of gene expression. It is known to bind to specific DNA sequences and can be found in various regions of the genome, including nucleosome free regions (NFRs). NFRs are areas of the genome where nucleosomes are absent, allowing for the binding of transcription factors and other regulatory proteins. Given CTCF's role in chromatin organization and its ability to bind to DNA in regions accessible to regulatory proteins, it is plausible that CTCF could bind at nucleosome free regions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does metformin alleviate atherosclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Metformin is a medication primarily used to treat type 2 diabetes. It has been studied for its potential effects on atherosclerosis, a condition characterized by the buildup of plaques in the arteries. Some research suggests that metformin may have beneficial effects on cardiovascular health, including potentially slowing the progression of atherosclerosis, due to its anti-inflammatory and metabolic effects. However, the evidence is not conclusive, and more research is needed to fully understand its impact on atherosclerosis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does GRHL2 over-expression lead to EMT?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"GRHL2 is known as a suppressor of epithelial-mesenchymal transition (EMT), and its over-expression typically maintains epithelial characteristics rather than promoting EMT. Therefore, it is unlikely that GRHL2 over-expression leads to EMT.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is PRDM9 essential for meiosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"PRDM9 is a gene that plays a crucial role in meiosis by specifying the locations of recombination hotspots, which are essential for genetic diversity and proper chromosome segregation. Its function is particularly important in ensuring the correct pairing and recombination of homologous chromosomes during meiosis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does the chromatin remodeling complex, RSC target H2A.Z nucleosomes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether the chromatin remodeling complex RSC specifically targets nucleosomes that contain the histone variant H2A.Z. To answer this, we need to consider the known functions and targets of the RSC complex and the role of H2A.Z in chromatin structure. RSC is known to be involved in nucleosome positioning and remodeling, and H2A.Z is a histone variant associated with actively transcribed regions of the genome. There is evidence suggesting that RSC does interact with H2A.Z-containing nucleosomes, possibly to facilitate transcription or other chromatin-related processes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the tyrosine kinase BTK implicated in autoimmunity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the tyrosine kinase BTK (Bruton's tyrosine kinase) is involved in autoimmunity. BTK plays a crucial role in B cell development and activation. Given that B cells are key players in the immune system and their dysregulation can lead to autoimmune diseases, it's plausible that BTK could be implicated in autoimmunity.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is induction of interferon by TLR7 higher in males?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To answer this question, we need to consider whether there is scientific evidence indicating that the induction of interferon by TLR7 is higher in males compared to females. TLR7 is a toll-like receptor that plays a role in the immune system by recognizing single-stranded RNA. Some studies suggest that there might be sex differences in immune responses, including those mediated by TLR7, due to hormonal differences or genetic factors. However, the specific question about interferon induction by TLR7 being higher in males would require referencing specific research findings.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does CXorf21 escape X chromosome inactivation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if CXorf21 escapes X chromosome inactivation, we need to understand the mechanism of X chromosome inactivation and whether CXorf21 is known to be an exception to this process. X chromosome inactivation is a process by which one of the copies of the X chromosome present in female mammals is inactivated to prevent an overdose of the genes it contains. However, some genes escape this inactivation and remain active on both X chromosomes. CXorf21 is a gene located on the X chromosome, and its behavior regarding X chromosome inactivation would depend on specific studies or evidence indicating whether it escapes inactivation or not. Without specific studies or data mentioning CXorf21 in the context of escaping X chromosome inactivation, it's challenging to definitively answer this question.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is SATB1 positioned close to AT-rich sequences?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"SATB1 is known to bind to AT-rich sequences and organize chromatin. Therefore, it is positioned close to AT-rich sequences due to its binding affinity.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Niraparib effective for ovarian cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Niraparib is a PARP inhibitor that has been studied for its effectiveness in treating ovarian cancer, particularly in patients with BRCA mutations or those who have responded to platinum-based chemotherapy. Clinical trials have shown that Niraparib can significantly prolong progression-free survival in these patients.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is palbociclib effective for glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Palbociclib is a CDK4/6 inhibitor that has shown efficacy in certain cancers, but its effectiveness for glioblastoma, a highly aggressive brain tumor, is not well-established. Glioblastoma has a complex biology and often resists standard treatments. Research on palbociclib's effectiveness for glioblastoma is limited and results are not conclusive.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can LB-100 sensitize ovarian carcinoma to cisplatin?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether LB-100 can make ovarian carcinoma more sensitive to cisplatin. LB-100 is a known inhibitor of protein phosphatase 2A (PP2A), which has been studied for its potential to enhance the effectiveness of certain chemotherapy drugs, including cisplatin, in various cancers. To answer this, we need to consider if there is evidence or studies showing that LB-100 increases the sensitivity of ovarian carcinoma cells to cisplatin.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has LB-100 been tested in clinical trials?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether LB-100 has been tested in clinical trials. To answer this, one would need to refer to the latest clinical trial databases or publications to check for any records or results of LB-100 being tested in clinical settings.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can LB-100 downregulate miR-33?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if LB-100 can downregulate miR-33, we need to consider whether there is any scientific evidence or studies that demonstrate LB-100's effect on miR-33 levels. Without specific studies or data indicating that LB-100 has an effect on miR-33, we cannot confirm its downregulation.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can PRL3-zumab inhibit PRL3+ cancer cells in vitro and in vivo?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if PRL3-zumab can inhibit PRL3+ cancer cells in vitro and in vivo, we need to consider the mechanism of action of PRL3-zumab, which is an antibody designed to target PRL3, a protein often overexpressed in certain cancers. If PRL3-zumab effectively binds to PRL3 on cancer cells, it could potentially inhibit their growth or survival in both laboratory (in vitro) and living organism (in vivo) settings. The answer would depend on the evidence from scientific studies demonstrating its efficacy in these contexts.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The Risk Assessment and Prediction Tool (RAPT) is designed to assess the risk of hospital readmission and predict discharge destinations for patients. Its accuracy depends on various factors including the data quality, the specific population it is applied to, and how it is implemented. While RAPT can provide valuable insights, its predictions may not be 100% accurate due to the complexity of individual patient circumstances and unforeseen variables.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is AZD5153 active in prostate cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if AZD5153 is active in prostate cancer, we need to consider whether there is any clinical or preclinical evidence supporting its efficacy in this type of cancer. AZD5153 is a bromodomain and extraterminal (BET) inhibitor, which has been studied in various cancers. However, specific activity in prostate cancer would depend on research findings or trials targeting this disease.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is GRG5 involved only in late embryonic mouse development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if GRG5 is involved only in late embryonic mouse development, we need to consider its role throughout the entire developmental process. GRG5 is a member of the Groucho-related gene family, which are known to play roles in transcriptional repression and developmental processes. However, the specific involvement of GRG5 might not be limited to late embryonic stages; it could also play roles in early development or other stages. Without specific evidence indicating its exclusive role in late embryonic development, we cannot conclusively say it is involved only in that stage.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does BNN27 promote memory loss?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if BNN27 promotes memory loss, we need to analyze the available scientific evidence or studies related to BNN27 and its effects on memory. Without specific studies or data indicating that BNN27 causes memory loss, we cannot conclude that it does.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is BNN20 involved in Parkinson's disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if BNN20 is involved in Parkinson's disease, we need to consider whether there is any scientific evidence or research linking BNN20 to Parkinson's disease. BNN20 is a compound, and its involvement would typically be through therapeutic effects, research studies, or molecular interactions related to Parkinson's disease. Without specific knowledge or references to studies linking BNN20 to Parkinson's disease, it's challenging to confirm its involvement.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Has istadefylline been considered as a treatment for Parkinson's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Istadenylline is a drug that has been researched for its potential effects on Parkinson's disease, primarily due to its action as an adenosine A2A receptor antagonist, which could help in managing symptoms of the disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is amantadine ER the first approved treatment for akinesia?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether amantadine ER is the first approved treatment for akinesia. To answer this, we need to know the history of treatments approved for akinesia and whether amantadine ER was indeed the first. Akinesia is a symptom of Parkinson's disease and related disorders, characterized by the inability to initiate movement. Historically, treatments for Parkinson's disease symptoms, including akinesia, have evolved over time. Amantadine, in its extended-release (ER) form, is known to be used for treating dyskinesia in Parkinson's disease patients, but its status as the first approved treatment for akinesia specifically is unclear without referencing specific regulatory approval timelines and earlier treatments.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has amantadine ER been approved by the FDA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if amantadine ER has been approved by the FDA, we need to consider the FDA's approval status for extended-release formulations of amantadine. Amantadine is a medication that has been used for various purposes, including as an antiviral and for Parkinson's disease. The extended-release (ER) formulation is designed to provide a longer duration of action. Checking the FDA's database or official announcements would provide the most accurate information regarding its approval status.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is pimavanserin a typical antipsychotic?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Pimavanserin is an atypical antipsychotic used primarily to treat hallucinations and delusions associated with Parkinson's disease psychosis. It differs from typical antipsychotics in its mechanism of action, as it selectively targets serotonin receptors rather than dopamine receptors.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has ProSavin undergone phase IV clinical trials by 2018?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if ProSavin had undergone phase IV clinical trials by 2018, we need to look into the clinical trial phases it has completed. ProSavin is a gene therapy product developed for the treatment of Parkinson's disease. Clinical trials are conducted in phases to assess safety and efficacy. Phase IV trials, also known as post-marketing surveillance trials, are conducted after a drug has been approved for public use. As of the information available up to 2018, ProSavin was still in the experimental stages and had not received approval for widespread use, which means it would not have undergone phase IV trials by that time.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does ProSavin use an adenoviral vector?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"ProSavin is a gene therapy product designed for the treatment of Parkinson's disease. It uses a lentiviral vector, not an adenoviral vector, to deliver genes into the brain cells.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is BCL11B involved in schizophrenia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if BCL11B is involved in schizophrenia, we need to consider whether there is scientific evidence linking this gene to the disorder. BCL11B is a transcription factor that plays a role in the development of the nervous system. Some studies have suggested that variations in genes involved in neural development could be associated with schizophrenia. However, the specific involvement of BCL11B in schizophrenia would require direct evidence from genetic association studies or functional studies demonstrating its role in the pathology of the disorder.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are CD8+ (cytotoxic) T cells and  CD4+ Helper T cells generated in the thyroid and express the T-cell receptor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"CD8+ (cytotoxic) T cells and CD4+ Helper T cells are generated in the thymus, not the thyroid. They do express the T-cell receptor (TCR) as part of their development and function in the immune system. The question seems to confuse the thyroid with the thymus, which are different organs with distinct functions.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do MAIT cells have a role in multiple myeloma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"MAIT (Mucosal-Associated Invariant T) cells are a subset of T cells that play a role in immune responses, particularly against microbial infections. Multiple myeloma is a cancer of plasma cells. The question is whether MAIT cells have a role in multiple myeloma. To answer this, we need to consider if MAIT cells are involved in the immune response against cancer cells, specifically plasma cells in multiple myeloma, or if they have any documented interaction or effect in the context of this disease.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is the BAGEL algorithm used for arrayed CRISPR screens?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The BAGEL algorithm is a computational tool designed for the analysis of CRISPR screen data. It is specifically used to identify essential genes from such screens by comparing the abundance of guide RNAs between conditions. While it is primarily associated with pooled CRISPR screens, the question pertains to its use in arrayed CRISPR screens. Arrayed screens involve testing individual guide RNAs or gene knockouts in separate wells or spots, which differs from the pooled approach where all guide RNAs are introduced together. The applicability of BAGEL to arrayed screens would depend on whether the algorithm's methodology can be adapted or is suitable for the analysis of data generated from arrayed formats.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Ubrogepant effective for migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ubrogepant is a medication specifically designed for the acute treatment of migraine with or without aura in adults. It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) receptor antagonists. Clinical trials have demonstrated its effectiveness in relieving migraine pain and associated symptoms such as nausea and sensitivity to light and sound within two hours of administration. Therefore, based on clinical evidence, Ubrogepant can be considered effective for migraine treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is modified vaccinia Ankara effective for smallpox?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Modified vaccinia Ankara (MVA) is a highly attenuated strain of vaccinia virus that has been used as a vaccine against smallpox. It is considered safe and has been shown to induce immune responses that are protective against smallpox in various studies.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Apremilast effective for Behçet’s Syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Apremilast is a phosphodiesterase 4 inhibitor that has been studied for its effectiveness in treating various inflammatory conditions, including Behçet’s Syndrome. Clinical trials have shown that Apremilast can reduce the symptoms of Behçet’s Syndrome, such as oral ulcers, in some patients. However, its effectiveness may vary from person to person, and it is not a cure for the condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Selinexor effective for multiple myeloma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Selinexor is a selective inhibitor of nuclear export (SINE) compound that has been studied for its effectiveness in treating multiple myeloma. Clinical trials have shown that it can be effective, especially in combination with other drugs, for patients with relapsed or refractory multiple myeloma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does teplizumab hold promise for diabetes prevention?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Teplizumab is a monoclonal antibody that has been studied for its potential to delay the onset of type 1 diabetes in at-risk individuals. Clinical trials have shown that it can significantly delay the clinical diagnosis of type 1 diabetes, suggesting it holds promise for diabetes prevention.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does nintedanib hold promise for lung disease associated with systemic sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Nintedanib is a tyrosine kinase inhibitor that has been studied for its effects on lung diseases, including those associated with systemic sclerosis. It has shown promise in slowing the progression of interstitial lung disease, which is a common complication of systemic sclerosis. Clinical trials have demonstrated its efficacy in reducing the decline in lung function in patients with systemic sclerosis-associated interstitial lung disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is mesothelioma caused by asbestos exposure?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mesothelioma is a type of cancer that is primarily caused by exposure to asbestos. Asbestos fibers, when inhaled, can lodge in the lining of the lungs, abdomen, or heart, leading to the development of mesothelioma over time. This connection has been well-documented in medical and scientific research.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Hemochromatosis type 4 is caused by a mutation in a recessive gene?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Hemochromatosis type 4, also known as ferroportin disease, is caused by mutations in the SLC40A1 gene. This condition is inherited in an autosomal dominant manner, not recessive. Therefore, it does not require two copies of the mutated gene to manifest the disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Huntington's disease is caused by expansion of a CTG repeat in the HTT gene on Chromosome 4?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Huntington's disease is a genetic disorder caused by a mutation in the HTT gene. The mutation involves the expansion of a CAG trinucleotide repeat in the HTT gene, not a CTG repeat. This gene is located on chromosome 4.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can radiation induced meningiomas be treated with radiosurgery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Radiation-induced meningiomas are tumors that develop as a result of previous radiation exposure. Radiosurgery is a form of radiation therapy that focuses high-powered energy on a small area of the body. Given that radiosurgery is effective for treating various types of tumors, including meningiomas, it is plausible that it could also be used for radiation-induced meningiomas. However, the effectiveness may depend on factors such as the size and location of the tumor, as well as the patient's overall health.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an increased risk of meningiomas in atomic bomb survivors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether atomic bomb survivors have an increased risk of developing meningiomas. Meningiomas are a type of brain tumor that is usually benign but can cause serious health issues depending on their size and location. Studies on atomic bomb survivors have shown increased risks for various types of cancers due to radiation exposure. Given that meningiomas are known to be associated with radiation exposure, it is plausible that atomic bomb survivors might have an increased risk of developing these tumors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiation for tinea capitis increases brain tumor risk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tinea capitis is a fungal infection of the scalp, and in the past, radiation was used as a treatment. Studies have shown that radiation therapy for tinea capitis can increase the risk of developing brain tumors later in life. This is due to the exposure of the brain to ionizing radiation during treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can secondary glioblastoma be caused by brain irradiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Secondary glioblastoma is a type of brain tumor that can develop from lower-grade gliomas. Brain irradiation is a known risk factor for the development of secondary cancers, including glioblastoma, due to the DNA damage it can cause in healthy cells. Therefore, it is plausible that brain irradiation could lead to the development of secondary glioblastoma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does head ct increase brain tumor risk?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about whether a head CT scan increases the risk of developing a brain tumor. To answer this, we need to consider the radiation exposure from CT scans and its potential effects on the brain. While CT scans do expose patients to ionizing radiation, which is a known risk factor for cancer, the amount of radiation from a single head CT is relatively low. The risk of developing a brain tumor from a head CT is considered to be very small, especially when weighed against the benefits of the diagnostic information it provides. However, repeated exposure to CT scans could potentially increase the risk.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there an increased risk for meningiomas in childhood leukemia survivors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether childhood leukemia survivors have an increased risk of developing meningiomas. To answer this, we need to consider the effects of treatments like radiation therapy, which is commonly used for leukemia and is known to increase the risk of secondary tumors, including meningiomas, especially when the radiation is directed near the brain.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can radiotherapy cause radiation induced osteosarcoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Radiotherapy is a common treatment for cancer that uses high doses of radiation to kill cancer cells and shrink tumors. However, it can also damage healthy cells, leading to side effects. One rare but serious side effect is the development of a secondary cancer, such as radiation-induced osteosarcoma, which is a type of bone cancer. This occurs due to the DNA damage caused by radiation, which can lead to mutations in bone cells. The risk of developing radiation-induced osteosarcoma depends on factors like the dose of radiation received and the area treated.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Chernobyl survivors at increased risk for breast cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether survivors of the Chernobyl nuclear disaster are at an increased risk for breast cancer. To answer this, we need to consider the effects of radiation exposure, which is a known risk factor for various cancers, including breast cancer. Studies on populations exposed to radiation, such as atomic bomb survivors, have shown an increased risk of breast cancer. Given that Chernobyl survivors were exposed to significant levels of radiation, it is plausible that they may also have an increased risk for breast cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiotherapy for Hodgkin disease increases risk for lung cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Radiotherapy for Hodgkin disease involves the use of high-energy radiation to kill cancer cells. However, this treatment can also affect nearby healthy tissues, including the lungs. Studies have shown that patients who undergo radiotherapy for Hodgkin disease may have an increased risk of developing secondary cancers, including lung cancer, due to the exposure of lung tissue to radiation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiotherapy for cervical cancer increases risk of colon cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if radiotherapy for cervical cancer increases the risk of colon cancer, we need to consider the proximity of the colon to the cervix and the potential for radiation to affect nearby tissues. Radiotherapy is a common treatment for cervical cancer, but it can expose surrounding organs, including the colon, to radiation. This exposure might increase the risk of secondary cancers, such as colon cancer, due to DNA damage in the cells of the colon. However, the actual risk depends on various factors, including the dose of radiation and the individual's health.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiotherapy for prostate cancer increase bladder cancer risk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if radiotherapy for prostate cancer increases bladder cancer risk, we need to consider studies and data that examine the long-term effects of radiotherapy on the bladder. Radiotherapy targets the prostate but can also affect nearby tissues, including the bladder. Some research suggests that there may be an increased risk of secondary cancers, including bladder cancer, following radiotherapy due to radiation exposure to adjacent organs. However, the increase in risk is generally considered to be small and must be weighed against the benefits of treating the primary prostate cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a role for MRPL53 in cancer?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"MRPL53 is a mitochondrial ribosomal protein that is involved in protein synthesis within mitochondria. While its specific role in cancer is not extensively documented, mitochondrial dysfunction and alterations in mitochondrial protein synthesis have been implicated in cancer progression. Therefore, it is plausible that MRPL53 could have a role in cancer, but further research is needed to confirm this.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is there a role for TET proteins in invariant natural killer T cells (iNKT) cell fate?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether TET proteins play a role in the fate determination of invariant natural killer T cells (iNKT). TET proteins are known to be involved in DNA demethylation, which is a critical process in cell differentiation and fate determination. Given that iNKT cells are a specialized subset of T cells with unique developmental pathways, it is plausible that TET proteins could influence their fate by regulating gene expression through DNA demethylation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Uc.63+ promote sensitivity to treatment in prostate cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether Uc.63+ promotes sensitivity to treatment in prostate cancer. To answer this, we need to consider if there is any scientific evidence or studies that support the idea that Uc.63+ increases the effectiveness of treatments for prostate cancer. Without specific studies or data mentioning Uc.63+ in the context of prostate cancer treatment sensitivity, it's challenging to affirm its role.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do de novo truncating mutations in WASF1 cause cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether de novo truncating mutations in the WASF1 gene are causative of cancer. To answer this, we need to consider the role of WASF1 in cellular processes and any documented evidence linking its mutations to cancer. WASF1 is involved in actin cytoskeleton regulation and cell migration, processes often dysregulated in cancer. However, the specific impact of de novo truncating mutations in WASF1 on cancer development would require reviewing scientific literature or databases for documented cases or studies.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does the Mcm2-Ctf4-Polα axis play a role in transfer of histones to leading strand DNA at the replication forks?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether the Mcm2-Ctf4-Polα axis is involved in the process of transferring histones to the leading strand DNA at replication forks. To answer this, we need to consider the known functions of the Mcm2-Ctf4-Polα axis in DNA replication and histone dynamics. The Mcm2-Ctf4-Polα axis is known to be involved in the initiation of DNA replication and has been implicated in the transfer of parental histones to the newly synthesized DNA strands, particularly the leading strand. This suggests that the axis does play a role in this process.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is AND-1/Ctf4 essential for proliferation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"AND-1/Ctf4 is known to play a role in DNA replication and sister chromatid cohesion, which are critical processes for cell proliferation. To determine if it is essential for proliferation, we need to consider whether cells can proliferate in its absence. Studies have shown that deletion or inhibition of AND-1/Ctf4 leads to defects in DNA replication and cell cycle progression, suggesting that it is essential for normal proliferation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a BRCA mutation analysis in the Greek population?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether there is a BRCA mutation analysis conducted specifically within the Greek population. To answer this, one would need to know if such studies or analyses have been performed and documented in scientific literature or health databases focusing on the Greek population.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can Patient-derived organoids (PDOs) recapitulate patient responses in the clinic?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Patient-derived organoids (PDOs) are 3D cell cultures derived from patient tissues that can mimic the structural and functional characteristics of the original tumors or organs. They have been increasingly used in preclinical research to predict patient responses to therapies. Studies have shown that PDOs can retain the genetic and phenotypic features of the original tumors, making them a promising tool for personalized medicine. However, the extent to which they can fully recapitulate patient responses in the clinic depends on various factors, including the complexity of the tumor microenvironment and the ability to maintain the organoids' characteristics over time.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Verubecestat effective for Alzheimer's Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Verubecestat was a drug developed for the treatment of Alzheimer's Disease, targeting the beta-secretase enzyme to reduce amyloid-beta production. However, clinical trials were discontinued due to lack of efficacy and potential worsening of cognitive function in patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The LINCS L1000 data set is known for containing gene expression data, specifically focusing on the effects of various drugs on human cells. It's a widely used resource in the field of bioinformatics and pharmacology for studying drug responses at the gene expression level.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is bortezomib a Proteasome inhibitor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bortezomib is a medication that is used in the treatment of multiple myeloma and mantle cell lymphoma. It works by inhibiting the proteasome, a complex that breaks down proteins in cells. By inhibiting the proteasome, bortezomib causes an accumulation of proteins that leads to cancer cell death. Therefore, bortezomib is classified as a proteasome inhibitor.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are breaks in double stranded DNA associated with ionizing radiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ionizing radiation is known to cause breaks in the DNA strands, including single-strand breaks (SSBs) and double-strand breaks (DSBs). These breaks are a direct result of the energy deposition by ionizing radiation, which can lead to the cleavage of the phosphodiester bonds in the DNA backbone. Therefore, breaks in double-stranded DNA are indeed associated with ionizing radiation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Thymoquinone is ineffective against radiation induced enteritis, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Thymoquinone is a compound found in black seed oil that has been studied for its potential health benefits, including anti-inflammatory and antioxidant properties. Radiation induced enteritis is inflammation of the intestines caused by radiation therapy. The effectiveness of thymoquinone against radiation induced enteritis would depend on scientific evidence from studies. Without specific studies or evidence indicating its effectiveness, it's challenging to confirm its efficacy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Autophagy is a cellular process where cells degrade and recycle their own components. It is not a process where a virus obtains nutrients from its host. Viruses obtain nutrients by hijacking the host's cellular machinery to replicate themselves, not through autophagy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are stretch enhancers transcribed more than super-enhancers?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To answer this question, we need to understand what stretch enhancers and super-enhancers are. Stretch enhancers are long genomic regions with enhancer activity, while super-enhancers are clusters of enhancers with high transcription factor density and activity. The question asks whether stretch enhancers are transcribed more than super-enhancers. Generally, super-enhancers are associated with higher levels of transcription due to their dense clustering and high activity. Therefore, it is unlikely that stretch enhancers are transcribed more than super-enhancers.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the FIP virus thought to be a mutated strain for the Feline enteric Coronavirus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether the Feline Infectious Peritonitis (FIP) virus is considered a mutated form of the Feline enteric Coronavirus (FECV). FIP is known to arise from mutations in the FECV, which is a common virus in cats. The mutation allows the virus to spread beyond the intestines and cause the more severe disease FIP.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is poliosis circumscripta another term for a white or unpigmented patch of hair or skin?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Poliosis circumscripta refers to a localized area of white or unpigmented hair, which may or may not be associated with an underlying skin condition. It is a specific term used to describe the lack of pigment in the hair rather than the skin itself. Therefore, while it is related to unpigmented patches, it is specifically about hair.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are stem cell transplants used to treat acute kidney injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Stem cell transplants are a form of regenerative medicine that have been explored for various conditions, including organ damage. Acute kidney injury (AKI) involves sudden kidney damage or failure, and treatment typically focuses on addressing the underlying cause and supporting kidney function. Research into stem cell therapy for AKI is ongoing, but it is not a standard treatment currently.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Do circular exons increase gene expression?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Circular exons, or circular RNAs (circRNAs), are a type of RNA molecule that forms a covalently closed continuous loop. While some studies suggest that circRNAs can influence gene expression by acting as miRNA sponges or by interacting with RNA-binding proteins, the direct impact of circular exons on increasing gene expression is not universally established and can vary depending on the context and specific circRNA.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are there lncRNAs that control the extent of neuronal outgrowth?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether long non-coding RNAs (lncRNAs) are involved in regulating the extent of neuronal outgrowth. LncRNAs are known to play various roles in gene regulation, including in the nervous system. Research has shown that lncRNAs can influence neuronal development and plasticity, which includes processes like neuronal outgrowth. Therefore, it is plausible that some lncRNAs control the extent of neuronal outgrowth.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Selumetinib effective for low-grade glioma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Selumetinib is a MEK inhibitor that has been studied for its effectiveness in treating various types of cancers, including low-grade glioma. Clinical trials have shown that it can be effective in certain cases, particularly in pediatric patients with neurofibromatosis type 1 (NF1)-associated low-grade glioma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does gavestinel improve outcomes of stroke patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Gavestinel is a drug that was investigated for its potential to improve outcomes in stroke patients by acting as a neuroprotectant. However, clinical trials did not demonstrate a significant improvement in outcomes for stroke patients treated with gavestinel compared to those who received a placebo.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Enlimomab improve stroke outcomes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Enlimomab is a monoclonal antibody that was investigated for its potential to improve stroke outcomes by targeting intercellular adhesion molecule-1 (ICAM-1), which plays a role in the inflammatory response following a stroke. However, clinical trials did not show a significant improvement in stroke outcomes and instead indicated potential harm, such as increased mortality and adverse events. Therefore, the effectiveness of Enlimomab in improving stroke outcomes is not supported by clinical evidence.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should tirilazad be used for treatment of ischemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tirilazad is a drug that was investigated for its potential to treat ischemic stroke by acting as a lipid peroxidation inhibitor. However, clinical trials did not demonstrate significant efficacy in improving outcomes for ischemic stroke patients, and it is not currently recommended or widely used for this purpose.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Aptiganel effective for treatment of stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Aptiganel is a drug that was investigated for its potential to treat stroke by acting as a neuroprotective agent. However, clinical trials did not demonstrate significant efficacy in improving outcomes for stroke patients, and it was associated with adverse effects.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should Lubeluzole be used for treatment of ischemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Lubeluzole was investigated as a potential treatment for ischemic stroke due to its neuroprotective properties. However, clinical trials did not demonstrate significant benefits in improving outcomes for stroke patients, and it was associated with serious side effects. Therefore, its use for ischemic stroke treatment was not supported by evidence.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a vaccine for peanut allergy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether there is a vaccine available specifically for peanut allergy. Currently, there is no vaccine for peanut allergy, but there are treatments like oral immunotherapy that can help reduce sensitivity.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Have toll-like receptor 2 activators been found in food?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Toll-like receptor 2 (TLR2) activators are known to be present in various pathogens and synthetic compounds. The question is whether such activators have been identified in food items. Research has indicated that certain food-derived components can activate TLR2, suggesting that yes, TLR2 activators have been found in food.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Rad4/XPC a DNA damage sensing protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Rad4/XPC is known to be involved in the nucleotide excision repair pathway, which is a mechanism to repair DNA damage. It specifically recognizes and binds to damaged DNA, initiating the repair process. Therefore, it can be considered a DNA damage sensing protein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there interactions between short and long noncoding RNAs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether there are interactions between short and long noncoding RNAs. To answer this, we need to consider the biological roles and mechanisms of these RNAs. Short noncoding RNAs, such as microRNAs (miRNAs), and long noncoding RNAs (lncRNAs) are known to play critical roles in gene regulation. There is evidence that lncRNAs can act as sponges for miRNAs, thereby modulating their activity. Additionally, lncRNAs can interact with other RNA species to form complexes that influence gene expression. Therefore, based on current biological knowledge, interactions between short and long noncoding RNAs do occur.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is indinavir effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Indinavir is a protease inhibitor used primarily in the treatment of HIV. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with no known cure and limited treatment options. There is no established evidence or clinical trials supporting the use of indinavir for ALS treatment.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is golimumab effective for sarcoidosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Golimumab is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α), which is involved in the inflammatory process of sarcoidosis. While TNF-α inhibitors like infliximab have shown efficacy in treating sarcoidosis, the evidence specifically for golimumab is limited. Clinical trials and studies focusing on golimumab's effectiveness for sarcoidosis are not as extensive as those for other TNF-α inhibitors. Therefore, the effectiveness of golimumab for sarcoidosis is not well-established.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is marimastat effective for small-cell lung cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Marimastat is a matrix metalloproteinase inhibitor that has been studied in various cancers, including small-cell lung cancer. However, its effectiveness specifically for small-cell lung cancer is not well-established, and clinical trials have not shown significant benefits.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are astronauts in higher risk for developing cancer?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Astronauts are exposed to higher levels of cosmic radiation in space compared to on Earth. Cosmic radiation is known to increase the risk of cancer. Therefore, astronauts are at a higher risk for developing cancer due to their exposure to this radiation.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is g-H2AX a marker for double strand breaks?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"g-H2AX is a histone variant that becomes phosphorylated at the site of DNA double-strand breaks (DSBs) and is widely used as a marker for DSBs in cells. The presence of g-H2AX foci is indicative of DSBs and is used in research to detect and quantify DNA damage.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does natalizumab improve disease course of secondary progressive multiple sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Natalizumab is a medication primarily used for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. However, its effectiveness specifically in improving the disease course of secondary progressive multiple sclerosis (SPMS) without relapses is less clear. The question asks whether natalizumab improves the disease course of SPMS, which requires considering its approved uses and clinical evidence.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are multipotent adult progenitor cells effective for treatment of stroke?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Multipotent adult progenitor cells (MAPCs) have been studied for their potential in treating various diseases, including stroke, due to their ability to differentiate into multiple cell types and modulate the immune system. Research suggests that MAPCs can promote tissue repair and reduce inflammation, which are critical factors in stroke recovery. However, the effectiveness of MAPCs for stroke treatment is still under investigation, with some studies showing promising results in animal models and early clinical trials, but more research is needed to confirm their efficacy and safety in humans.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is ozanezumab effective for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if ozanezumab is effective for amyotrophic lateral sclerosis (ALS), we need to consider clinical trial results and research studies. Ozanezumab is a monoclonal antibody that targets the protein semaphorin 3A, which is thought to play a role in ALS. However, clinical trials have not shown significant efficacy in improving outcomes for ALS patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are gut microbiota profiles altered by irradiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether irradiation affects gut microbiota profiles. Research has shown that irradiation, such as that used in cancer treatment, can indeed alter the composition and diversity of gut microbiota. This is due to the sensitivity of microorganisms to radiation, which can kill or inhibit the growth of certain bacteria, leading to changes in the gut microbiota profile.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are genomic regulatory blocks (GRBs) any different than TADs?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Genomic regulatory blocks (GRBs) and topologically associating domains (TADs) are both concepts related to the organization and regulation of the genome, but they serve different purposes. GRBs are regions of the genome that contain clusters of genes and their regulatory elements, often spanning large distances, and are thought to be units of gene regulation. TADs, on the other hand, are self-interacting genomic regions that are insulated from neighboring regions, and they play a role in the three-dimensional organization of the genome, influencing gene expression by bringing regulatory elements into proximity with their target genes. While there may be overlap between GRBs and TADs in some cases, they are distinct concepts with different implications for gene regulation and genome organization.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is Nivolumab (Opdivo) a PD-L1 inhibitor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Nivolumab (Opdivo) is a type of immunotherapy drug known as a checkpoint inhibitor. It works by targeting the PD-1 (Programmed Death-1) receptor on T cells, not the PD-L1 (Programmed Death-Ligand 1) protein. Therefore, it is not a PD-L1 inhibitor but a PD-1 inhibitor.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is PF-05190457 an inverse agonist of the ghrelin receptor?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if PF-05190457 is an inverse agonist of the ghrelin receptor, we need to understand its mechanism of action on the receptor. An inverse agonist not only blocks the receptor's activity but also reduces its baseline activity. Without specific pharmacological data on PF-05190457's effect on the ghrelin receptor, we cannot conclusively answer this question.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if overexpression of LY6K is associated with better prognosis for non-small cell lung cancer patients, we need to consider the role of LY6K in cancer progression. LY6K is a member of the LY6 family, which has been implicated in various cancers. However, the specific impact of LY6K overexpression on prognosis can vary depending on the cancer type. For non-small cell lung cancer, studies have suggested that LY6K may be involved in tumor progression and poor prognosis, rather than a better prognosis. Therefore, it is unlikely that overexpression of LY6K is associated with better prognosis for these patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does the BRAFV600E mutation have an effect on clinical response to radioiodine therapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The BRAFV600E mutation is known to be associated with more aggressive forms of thyroid cancer, which may influence the response to radioiodine therapy. Studies have suggested that tumors with this mutation may have reduced uptake of radioiodine, potentially leading to a poorer clinical response.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does metformin has as an antitumor effect?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Metformin, a widely used medication for type 2 diabetes, has been studied for its potential antitumor effects. Research suggests that it may inhibit cancer cell growth and proliferation through various mechanisms, including activation of AMP-activated protein kinase (AMPK), reduction of insulin levels, and modulation of metabolic pathways. However, the evidence is primarily from preclinical and observational studies, and clinical trials are ongoing to confirm its efficacy and safety as an antitumor agent.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if xaliproden improves the prognosis of amyotrophic lateral sclerosis (ALS), we need to review clinical trial data and research studies that evaluate its efficacy and safety in ALS patients. Xaliproden is a neuroprotective agent that has been investigated for its potential to slow disease progression in ALS. However, the results from clinical trials have been mixed, and it has not been widely approved for the treatment of ALS. Therefore, based on current evidence, it is unclear if xaliproden significantly improves the prognosis of ALS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is celecoxib effective for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if celecoxib is effective for amyotrophic lateral sclerosis (ALS), we need to consider its mechanism of action and any clinical evidence supporting its use in ALS. Celecoxib is a COX-2 inhibitor with anti-inflammatory properties. ALS is a neurodegenerative disease with inflammatory components, but there is limited evidence to suggest that celecoxib significantly impacts the progression or symptoms of ALS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should Pentoxifylline be used for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Pentoxifylline is a medication that improves blood flow by decreasing its viscosity. While it has been used in various conditions related to blood flow, its effectiveness in treating ALS is not well-established. Current treatments for ALS focus on managing symptoms and slowing disease progression, with no cure available. The use of Pentoxifylline for ALS would require clinical evidence supporting its efficacy and safety in this specific condition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does clinical trial data support the use of minocycline for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if clinical trial data supports the use of minocycline for amyotrophic lateral sclerosis (ALS), we need to review the outcomes of relevant clinical trials. Minocycline has been studied in the context of ALS due to its neuroprotective properties. However, some clinical trials have shown that minocycline may not be beneficial and could potentially worsen outcomes for ALS patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Dexmecamylamine effective for depression?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Dexmecamylamine is a nicotinic antagonist that has been studied for various conditions, including depression. However, its effectiveness for depression is not well-established, and it is not a commonly prescribed treatment for this condition. The question requires a straightforward answer based on current knowledge and evidence.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is NicVAX vaccine effective for smoking cessation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about the effectiveness of the NicVAX vaccine for smoking cessation. NicVAX is designed to help smokers quit by stimulating the immune system to produce antibodies that bind to nicotine, preventing it from reaching the brain and thus reducing the pleasure derived from smoking. However, clinical trials have shown mixed results regarding its effectiveness.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Figitumumab effective for non-small cell lung cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Figitumumab was investigated as a potential treatment for non-small cell lung cancer (NSCLC) in clinical trials. However, the development of Figitumumab was discontinued due to insufficient efficacy and safety concerns in phase III trials. Therefore, it is not considered an effective treatment for NSCLC.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Semagacestat effective for Alzheimer's Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Semagacestat was investigated as a potential treatment for Alzheimer's Disease, but clinical trials showed that it not only failed to slow disease progression but also worsened cognition and increased the risk of skin cancer. Therefore, its development for Alzheimer's Disease was discontinued.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Systemic Lupus Erythematosus cause seizures?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect various organs and systems in the body, including the nervous system. Seizures can occur in SLE patients due to the disease's impact on the brain, such as inflammation or the formation of blood clots. Therefore, it is possible for SLE to cause seizures.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is MAGE-A3 immunotherapeutic effective for non-small-cell lung cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"MAGE-A3 is a tumor-specific antigen that has been explored as a target for immunotherapy in various cancers, including non-small-cell lung cancer (NSCLC). Clinical trials have investigated the efficacy of MAGE-A3 immunotherapeutic in NSCLC, but results have been mixed, with some studies showing limited effectiveness.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Impetigo a viral infection that affects the skin?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Impetigo is a skin infection, but it is important to determine whether it is caused by a virus or bacteria. Impetigo is primarily caused by bacteria, specifically Staphylococcus aureus or Streptococcus pyogenes, not by a virus.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is αCGRP a member of the CGRP family?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether αCGRP is a member of the CGRP (Calcitonin Gene-Related Peptide) family. To answer this, we need to know that the CGRP family includes two main members: αCGRP and βCGRP, which are derived from different genes but share similar structures and functions. Therefore, αCGRP is indeed a member of the CGRP family.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do genes with monoallelic expression contribute proportionally to genetic diversity in humans?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Genes with monoallelic expression, such as those subject to genomic imprinting or X-chromosome inactivation in females, do not contribute to genetic diversity in the same way as biallelically expressed genes. Since only one allele is expressed, the other allele's contribution to diversity is masked. However, the presence of monoallelic expression itself adds a layer of complexity to genetic regulation and can influence phenotypic diversity. Therefore, while they may not contribute proportionally in terms of allele expression, they play a role in the overall genetic and phenotypic diversity.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is deletion at 6q24.2-26 associated with shorter survival for ovarian cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether a specific genetic deletion at 6q24.2-26 is linked to shorter survival rates in ovarian cancer patients. To answer this, one would need to refer to scientific studies or medical research that has investigated the correlation between this genetic deletion and survival outcomes in ovarian cancer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does promoter shape vary across populations?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the shape of promoters differs among different populations. Promoters are regions of DNA that initiate the transcription of a particular gene. Their shape can influence gene expression. Variations in promoter sequences, which could affect their shape, are known to exist across populations due to genetic diversity. Therefore, it is plausible that promoter shape varies across populations.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the CADM2 gene associated with differences in information processing speed?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The CADM2 gene has been studied in the context of cognitive functions and behaviors, including information processing speed. Research suggests that variations in the CADM2 gene may influence cognitive traits, but a direct and definitive association with information processing speed requires further investigation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is KAT2A involved in Acute myeloid leukemia (AML)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if KAT2A is involved in Acute myeloid leukemia (AML), we need to consider whether there is scientific evidence linking KAT2A to AML. KAT2A, also known as GCN5, is a histone acetyltransferase that plays a role in transcriptional regulation. Research has shown that alterations in histone modifications and the enzymes responsible for these modifications, including KAT2A, can contribute to the development of various cancers, including AML. Therefore, it is plausible that KAT2A is involved in AML.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether AhR ligands are considered attractive drug targets for pharmaceutical development because they induce Cyp1a1. AhR ligands are known to activate the aryl hydrocarbon receptor (AhR), which in turn can induce the expression of Cyp1a1, an enzyme involved in the metabolism of various compounds. This induction is a key feature that makes AhR ligands interesting for drug development, as it can be leveraged for therapeutic purposes, such as in the treatment of certain diseases or in detoxification processes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Glucoraphanin from broccoli can help reduce obesity , yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Glucoraphanin is a compound found in broccoli that has been studied for its potential health benefits, including effects on obesity. Research suggests that it may help in reducing obesity by influencing metabolism and reducing inflammation. However, the extent of its effectiveness can vary based on individual health conditions and lifestyle factors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has saracatinib been tested in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Saracatinib is a drug that has been investigated for its potential therapeutic effects. To determine if it has been tested in clinical trials, one would need to refer to clinical trial databases or published research studies.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does saracatinib promote oncogenesis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if saracatinib promotes oncogenesis, we need to review its mechanism of action and any available clinical or preclinical data. Saracatinib is a Src kinase inhibitor, and Src kinases are involved in various cellular processes, including cell proliferation and survival, which are relevant to cancer. However, the promotion of oncogenesis would imply that saracatinib could contribute to the development or progression of cancer, which is contrary to its intended use as a therapeutic agent targeting cancer pathways. Without specific evidence indicating that saracatinib promotes oncogenesis, the answer would likely be no.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has MLE4901 been tested in phase III clinical trials?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if MLE4901 has been tested in phase III clinical trials, we would need to refer to the latest clinical trial databases or publications that detail the progress of MLE4901 through clinical trial phases. Without specific information on MLE4901's development stage, we cannot confirm its phase III testing status.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does ESN364 activate the hypothalamic-pituitary-gonadal axis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if ESN364 activates the hypothalamic-pituitary-gonadal (HPG) axis, we need to understand its mechanism of action. ESN364 is a selective estrogen receptor degrader (SERD) that works by degrading estrogen receptors, which could potentially influence the HPG axis. However, without specific studies or evidence showing that ESN364 directly activates the HPG axis, we cannot conclusively say it does.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is traditional Chinese medicine associated with a decreased risk of heart failure in breast cancer patients receiving doxorubicin treatment?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if traditional Chinese medicine is associated with a decreased risk of heart failure in breast cancer patients receiving doxorubicin treatment, we need to consider existing research and clinical studies. Doxorubicin is known for its cardiotoxic effects, which can lead to heart failure. Traditional Chinese medicine has been explored for its potential cardioprotective effects in various contexts. However, the specific association between traditional Chinese medicine and a decreased risk of heart failure in breast cancer patients undergoing doxorubicin treatment would require evidence from clinical trials or observational studies that directly address this question. Without specific studies or data, it's challenging to definitively answer this question.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is the protein ABCG2 (ATP-Binding Cassette, subfamily G, member 2, transporter) excreting uric acid?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ABCG2 is known as a transporter protein that plays a significant role in the excretion of various substances, including uric acid. It is involved in the transport of uric acid across cell membranes, which can influence serum uric acid levels. Given this function, it is reasonable to consider that ABCG2 excretes uric acid.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein ABCG2 transmembrane?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if the protein ABCG2 is transmembrane, we need to understand its structure. ABCG2 is a member of the ATP-binding cassette (ABC) transporter family, which are known for their role in transporting various molecules across cellular membranes. ABC transporters typically have transmembrane domains that allow them to span the membrane multiple times, facilitating the transport process. Given that ABCG2 functions as a transporter, it is reasonable to infer that it has transmembrane domains.\", \"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can brain derived exosomes carry APP molecules?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether brain-derived exosomes can carry APP (Amyloid Precursor Protein) molecules. Exosomes are small vesicles released by cells that can carry proteins, lipids, and nucleic acids. APP is a protein that is known to be involved in Alzheimer's disease. Research has shown that exosomes can carry APP and its metabolites, suggesting that brain-derived exosomes can indeed carry APP molecules.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can Flotillin be used as exosomal marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Flotillin is a protein associated with lipid rafts and has been studied in the context of exosomes. Exosomes are small vesicles released by cells, and specific markers are used to identify them. The question is whether Flotillin can serve as one of these markers.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has the Spanich flu virus been reconstructed?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The Spanish flu virus, which caused the 1918 pandemic, has been the subject of scientific study. Researchers have reconstructed the virus from genetic material obtained from preserved tissue samples of victims to understand its virulence and transmission.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Li–Fraumeni syndrome a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Li–Fraumeni syndrome is indeed a rare hereditary disorder that predisposes carriers to cancer development. However, it is not autosomal recessive; it is autosomal dominant. This means that only one copy of the altered gene in each cell is sufficient to increase the risk of cancer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are ICAMS, Intracellular Adhesion Molecules, part of the immunoglobulin superfamily?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if ICAMS (Intracellular Adhesion Molecules) are part of the immunoglobulin superfamily, we need to understand the characteristics of the immunoglobulin superfamily. The immunoglobulin superfamily includes proteins that contain immunoglobulin domains, which are involved in cell adhesion, binding, and recognition processes. ICAMS, specifically ICAM-1, ICAM-2, etc., are known to have immunoglobulin-like domains and are involved in cell adhesion, which aligns with the definition of the immunoglobulin superfamily.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The Paramyxovirus genome is known to be a single-stranded, negative-sense RNA. It is not segmented, which distinguishes it from other viruses like Orthomyxoviruses that have segmented genomes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a vaccine for rotavirus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Rotavirus is a common cause of severe diarrhea among infants and young children. The question is asking whether there is a vaccine available to prevent rotavirus infections.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors(MPNST) rare in neurofibromatosis patients?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors (MPNST) are indeed a rare occurrence, even in patients with neurofibromatosis. Neurofibromatosis increases the risk of developing MPNST, but the spinal intradural primary form is particularly uncommon compared to other locations and types of tumors associated with the condition.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Does AZD3759 cross the blood brain barrier?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"AZD3759 is a drug designed to target EGFR mutations in non-small cell lung cancer (NSCLC) with the intention of treating brain metastases. Its development was focused on ensuring it could cross the blood-brain barrier (BBB) to reach the central nervous system (CNS) effectively. Given its design purpose and the pharmacological properties aimed at BBB penetration, it is likely that AZD3759 can cross the blood-brain barrier.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is PTEN a tumour suppressor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"PTEN is a gene that provides instructions for making a protein which is involved in the regulation of the cell cycle, preventing cells from growing and dividing too rapidly or in an uncontrolled way. Mutations in the PTEN gene have been associated with the development of various types of cancer, suggesting that it plays a role in suppressing tumor formation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is MLL3 part of the ASCOM complex?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The ASCOM complex is a histone methyltransferase complex that includes several members, one of which is MLL3 (Mixed Lineage Leukemia 3). MLL3 is indeed a part of the ASCOM complex, contributing to its function in transcriptional regulation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are astrocytes part of the blood brain barrier?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Astrocytes are a type of glial cell in the central nervous system that play a role in supporting neurons, maintaining extracellular ion balance, and contributing to the blood-brain barrier (BBB). The BBB is a selective barrier that prevents certain substances in the blood from entering the brain. While the primary structural component of the BBB is the endothelial cells of the brain's capillaries, astrocytes contribute to the BBB's function by surrounding these blood vessels and regulating their permeability.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein MCL-1 anti-apoptotic?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"MCL-1 is a member of the BCL-2 family of proteins, which are known to regulate apoptosis. Specifically, MCL-1 has been characterized for its role in inhibiting apoptosis, making it an anti-apoptotic protein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are bacteria in the genus Clostridium facultative anaerobes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether bacteria in the genus Clostridium are facultative anaerobes. Facultative anaerobes can grow with or without oxygen. However, Clostridium species are known to be obligate anaerobes, meaning they cannot survive in the presence of oxygen.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has ORMD-0801 been tested in patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether ORMD-0801, a specific drug, has undergone testing in human patients. To answer this, one would need to refer to clinical trial databases or published research studies to see if there are any records of ORMD-0801 being tested in patients.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Was vivotif licensed in Europe and the US at the same time?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Vivotif was licensed in Europe and the US at the same time, we need to check the licensing dates of Vivotif in both regions. Vivotif is an oral typhoid vaccine. It's important to verify the specific dates when it was approved by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA).\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can AGY be used as antidiuretic replacement therapy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"AGY is not a recognized or standard abbreviation for any known antidiuretic medication or therapy in medical literature or practice. Common antidiuretic replacement therapies include desmopressin (DDAVP), which is a synthetic analogue of the natural hormone arginine vasopressin. Without specific information on what AGY refers to, it's not possible to confirm its use in antidiuretic replacement therapy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Have the rotavirus vaccines changed the predominant rotavirus genotypes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the introduction of rotavirus vaccines has led to a change in the predominant genotypes of the rotavirus. To answer this, we need to consider studies and data that compare the prevalence of rotavirus genotypes before and after the widespread use of vaccines. Some research suggests that vaccination can lead to shifts in predominant genotypes due to immune pressure, but the extent and significance of these changes can vary by region and over time.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can leuprorelin acetate be used as androgen deprivation therapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Leuprorelin acetate is a gonadotropin-releasing hormone (GnRH) agonist, which is commonly used in androgen deprivation therapy (ADT) for conditions like prostate cancer. It works by reducing the production of testosterone, which is an androgen. Therefore, it is indeed used as a form of androgen deprivation therapy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can MVA85A confer immunity against smallpox?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether the MVA85A vaccine can provide immunity against smallpox. MVA85A is a vaccine developed to boost the immune response to tuberculosis, not smallpox. Smallpox is caused by the variola virus, and the vaccine specifically designed for smallpox is different, known as the smallpox vaccine or vaccinia vaccine. Therefore, MVA85A is not intended for nor does it confer immunity against smallpox.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the drug Exubera currently (March 2020) available?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Exubera was an inhaled insulin product that was approved by the FDA in 2006 but was discontinued in 2007 due to poor sales. Therefore, to determine if Exubera is available in March 2020, we need to consider its discontinuation status.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has the drug Afrezza been approved by the FDA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if the drug Afrezza has been approved by the FDA, we need to check the FDA's official records or reliable medical sources. Afrezza is a rapid-acting inhaled insulin used to improve blood sugar control in adults with diabetes. The FDA's approval status can be confirmed through their database or press releases.\", \"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine produced by different companies?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether the Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine are produced by different companies. To answer this, we need to know if these two vaccines have different manufacturers.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Daptacel be used instead of IPOL?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if Daptacel can be used instead of IPOL, we need to consider their purposes and compositions. Both are vaccines, but they are used for different diseases. Daptacel is a vaccine for diphtheria, tetanus, and pertussis (DTaP), while IPOL is a vaccine for polio. Since they target different diseases, one cannot be used as a substitute for the other.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can CMB305 be used against sarcomas?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"CMB305 is a vaccine designed to target specific antigens, primarily those associated with certain types of cancer. To determine if it can be used against sarcomas, one would need to know if sarcomas express the antigens targeted by CMB305. Without specific information on the antigen expression profile of sarcomas in relation to CMB305's targets, it's challenging to give a definitive answer.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Has ZP-PTH been tested in a phase II clinical trial?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if ZP-PTH has been tested in a phase II clinical trial, we need to look for any published clinical trial data or reports that mention ZP-PTH undergoing phase II testing. Without specific information on ZP-PTH's clinical trial progress, it's challenging to confirm. However, assuming that ZP-PTH is a hypothetical or less-known compound, and there's no widely known information about its phase II trials, the answer might lean towards no.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is SARS virus interacting with ACE2 encoded protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether the SARS virus interacts with the ACE2 encoded protein. To answer this, we need to know that the SARS virus, specifically SARS-CoV, is known to use the ACE2 receptor to enter host cells. The ACE2 protein is encoded by the ACE2 gene and serves as a functional receptor for the SARS virus.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is ACE2 expressed on cell surfaces?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ACE2 (Angiotensin-converting enzyme 2) is known to be expressed on the surfaces of certain cell types, including those in the lungs, heart, kidneys, and intestines. It serves as a receptor for the SARS-CoV-2 virus, which causes COVID-19.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is cathepsin L active in endosomes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cathepsin L is a lysosomal cysteine protease that is known to be active in acidic environments, such as those found in lysosomes and endosomes. Endosomes are membrane-bound compartments that sort and transport materials internalized by the cell, and they undergo a maturation process that involves acidification. This acidification activates proteases like cathepsin L, which are then involved in protein degradation and processing within the endosomal-lysosomal system.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is endotrophin derived from collagen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Endotrophin is a peptide that is derived from the C-terminal propeptide of collagen type VI. Collagen type VI is a member of the collagen family, which is a major structural protein in the extracellular matrix. Therefore, endotrophin is indeed derived from collagen, specifically from collagen type VI.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Protoporphyrinogen oxidase localized to the mitochondrium?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Protoporphyrinogen oxidase is an enzyme involved in the heme biosynthesis pathway. The question is asking whether this enzyme is localized to the mitochondrion. From biological studies, it is known that certain steps of the heme biosynthesis pathway occur in the mitochondrion, and Protoporphyrinogen oxidase is one of the enzymes that functions within this organelle.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is aggrephagy a variant of autophagy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Aggrephagy is a selective form of autophagy that specifically targets protein aggregates for degradation. Autophagy is a broader process that involves the degradation and recycling of cellular components. Since aggrephagy is a specific type of autophagy, it can be considered a variant of autophagy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does protein ALEX1 contain armadillo repeats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if protein ALEX1 contains armadillo repeats, we would typically consult a protein database or use bioinformatics tools to analyze its sequence for the presence of such motifs. Without specific data or analysis results, we cannot definitively answer the question.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is Bcl-2-like protein 1 an pro apoptotic protein?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Bcl-2-like protein 1, also known as Bcl-xL, is a member of the Bcl-2 family of proteins. The Bcl-2 family includes both anti-apoptotic and pro-apoptotic proteins. Bcl-xL is known for its anti-apoptotic function, as it inhibits apoptosis by preventing the release of cytochrome c from the mitochondria. Therefore, it is not a pro-apoptotic protein.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do nematodes contain a CTCF gene?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if nematodes contain a CTCF gene, we need to consider what the CTCF gene is and whether it is present in nematodes. CTCF is a highly conserved zinc finger protein that plays a key role in chromatin organization and gene regulation in many eukaryotes. Nematodes, being a diverse phylum of organisms, include species like Caenorhabditis elegans, which is a model organism in biological research. Research has shown that C. elegans does not have a direct ortholog of the CTCF gene found in vertebrates, but it does have other proteins that may perform similar functions.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does steroid 5A-Reductase deficiency lead to hermaphroditism?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Steroid 5A-Reductase deficiency is a condition that affects the production of dihydrotestosterone (DHT), which is crucial for the development of male genitalia in utero. Individuals with this deficiency may have ambiguous genitalia at birth, which can be considered a form of intersex condition. However, hermaphroditism, strictly defined, refers to individuals who have both ovarian and testicular tissue, which is not a characteristic of 5A-Reductase deficiency. Therefore, while the condition can lead to ambiguous genitalia, it does not result in true hermaphroditism.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is the TFR1 gene dispensable for erythropoiesis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The TFR1 gene encodes the transferrin receptor 1, which is crucial for iron uptake in cells, including erythroid precursors. Iron is essential for hemoglobin synthesis and erythropoiesis. Given its role in iron acquisition, the TFR1 gene is likely critical for erythropoiesis.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are somatic mutations positioned towards the nuclear periphery?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Somatic mutations are changes in the DNA sequence that occur after conception and can be influenced by various factors, including the cell's environment and its position within the tissue. The nuclear periphery is known to have a distinct chromatin environment that could influence mutation rates or the visibility of mutations. However, the question of whether somatic mutations are specifically positioned towards the nuclear periphery requires examining evidence on the spatial distribution of mutations within the nucleus.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is Mediator present at super enhancers?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Mediator is present at super enhancers, we need to understand the role of Mediator in transcription regulation. Mediator is a multi-protein complex that acts as a bridge between transcription factors and RNA polymerase II, playing a crucial role in the regulation of gene expression. Super enhancers are clusters of enhancers that drive high levels of gene expression, often in cell identity and disease. Given Mediator's role in transcription, it is plausible that it is present at super enhancers to facilitate the high levels of gene expression associated with these regions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Tcf3 associated with the Wnt pathway?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Tcf3 is associated with the Wnt pathway, we need to understand the roles of both Tcf3 and the Wnt pathway. Tcf3 (Transcription factor 3) is a member of the TCF/LEF family of transcription factors, which are known to interact with β-catenin, a key component of the Wnt signaling pathway. The Wnt pathway is a critical signaling cascade involved in various biological processes, including cell proliferation and differentiation. Given that Tcf3 can bind to β-catenin and mediate Wnt target gene expression, it is reasonable to associate Tcf3 with the Wnt pathway.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Nanog repressed in pluripotent stem cells?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Nanog is a transcription factor that is crucial for maintaining pluripotency in stem cells. Its expression is typically high in pluripotent stem cells and decreases as cells differentiate. Therefore, it is not repressed in pluripotent stem cells.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do nematodes contain architectural proteins like CTCF?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Nematodes are a diverse animal phylum, and their genome organization can vary. CTCF is a well-known architectural protein in vertebrates that plays a key role in genome organization, such as forming chromatin loops. To determine if nematodes contain architectural proteins like CTCF, we need to consider if similar proteins with analogous functions are present in nematodes.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Do polycomb group proteins (PcG) mediate the formation of chromatin loops?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Polycomb group proteins (PcG) are known to play a role in gene silencing and the maintenance of chromatin structure. They are involved in the formation of higher-order chromatin structures, which could include chromatin loops. However, the direct mediation of chromatin loop formation by PcG proteins is not fully established and may involve other factors or mechanisms.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are super enhancers structurally insulated in chromatin loops?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Super enhancers are large clusters of enhancers that drive high expression of genes critical for cell identity and disease. Chromatin loops are structures that bring distal regulatory elements, such as enhancers, into close proximity with their target genes. The question is whether super enhancers are structurally insulated within these loops, meaning they are isolated from other regulatory elements to prevent unwanted interactions. This would imply a mechanism for their specific and potent activity.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are there negative enhancers?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether there are negative enhancers. Enhancers are DNA sequences that can increase the transcription of genes. The term 'negative enhancers' is not commonly used in genetics, but it could refer to sequences that suppress gene expression, which are more accurately described as silencers or repressors.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are enhancers directional in their targeting of gene promoters?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Enhancers are regulatory DNA sequences that can increase the transcription of genes. They can act over long distances and are not strictly directional in their targeting of gene promoters, meaning they can influence the transcription of genes located upstream or downstream relative to their own position. However, the effectiveness of an enhancer can depend on its orientation and the specific context of the chromatin environment.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the zelda transcription factor a chromatin remodeller?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the Zelda transcription factor is a chromatin remodeller. To answer this, we need to understand the functions of the Zelda transcription factor and chromatin remodellers. Zelda is known for its role in early embryonic development in Drosophila, where it binds to DNA to regulate gene expression. Chromatin remodellers, on the other hand, are complexes that modify chromatin structure to regulate access to DNA. While Zelda influences gene expression, it does not directly alter chromatin structure.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is methotrexate used for the treatment of Rheumatoid Arthritis (RA)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Methotrexate is a medication commonly used in the treatment of various conditions, including cancer and autoimmune diseases. Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joints. Given its mechanism of action, which includes suppressing the immune system and reducing inflammation, methotrexate is indeed used as a treatment for RA.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can ATAC-Seq be employed in single-cell mode?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ATAC-Seq (Assay for Transposase-Accessible Chromatin using sequencing) is a technique used to assess genome-wide chromatin accessibility. Initially developed for bulk samples, advancements in technology have enabled its application at the single-cell level, known as single-cell ATAC-Seq (scATAC-Seq). This allows for the examination of chromatin accessibility in individual cells, providing insights into cellular heterogeneity.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is yeast fbp1 affected by glucose starvation stress?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the yeast gene fbp1 is affected by glucose starvation stress. To answer this, we need to consider the role of fbp1 in yeast metabolism. fbp1 encodes fructose-1,6-bisphosphatase, an enzyme involved in gluconeogenesis, the pathway that synthesizes glucose from non-carbohydrate sources. Under glucose starvation conditions, yeast cells activate gluconeogenesis to produce glucose for survival. Therefore, it is likely that fbp1 expression is upregulated in response to glucose starvation stress to meet the cell's glucose needs.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does an antiphlogistic promotes inflammation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"An antiphlogistic is a substance that reduces inflammation or swelling, which is the opposite of promoting inflammation. Therefore, it is unlikely that an antiphlogistic promotes inflammation.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can SMAD6 variants cause craniosynostosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if SMAD6 variants can cause craniosynostosis, we need to consider the role of SMAD6 in bone development and any documented associations between SMAD6 variants and craniosynostosis. SMAD6 is a negative regulator of BMP signaling, which is crucial for bone formation and development. Mutations in genes involved in BMP signaling have been linked to craniosynostosis. There is evidence in the literature that SMAD6 variants are associated with an increased risk of craniosynostosis, particularly in conjunction with other genetic factors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can propofol cause green urine?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Propofol is a widely used anesthetic and sedative. While it has various side effects, green urine is not commonly associated with its use. The color of urine can change due to a variety of factors, including medications, diet, and medical conditions. However, propofol is not known to cause green urine specifically.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can radiosurgery be used for the DNET tumors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"DNET (Dysembryoplastic Neuroepithelial Tumor) is a benign brain tumor that typically occurs in children and young adults. Radiosurgery is a form of radiation therapy that focuses high-powered energy on a small area of the body. Given the benign nature of DNET tumors and their usual treatment through surgical resection, the question is whether radiosurgery is a viable option for these tumors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Was golimumab tested for diabetes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if golimumab was tested for diabetes, we need to consider the primary uses and clinical trials associated with golimumab. Golimumab is a monoclonal antibody used to treat autoimmune diseases like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is not primarily known for diabetes treatment or testing. Therefore, it is unlikely that golimumab was tested for diabetes.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Nelson's syndrome is a rare disorder that occurs in some patients who have had both adrenal glands removed (bilateral adrenalectomy) as part of treatment for Cushing's disease. It is characterized by the enlargement of a pituitary tumor (corticotroph adenoma) and elevated levels of ACTH. Cabergoline is a dopamine agonist that is primarily used to treat hyperprolactinemia and Parkinson's disease. While it is not the first-line treatment for Nelson's syndrome, there have been cases where cabergoline has been used off-label to manage ACTH levels in Nelson's syndrome, especially when other treatments are not effective or tolerated.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is proton beam therapy used for treatment of craniopharyngioma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Proton beam therapy is a type of radiation therapy that uses protons rather than X-rays to treat cancer. It is known for its precision in targeting tumors while minimizing damage to surrounding healthy tissues. Craniopharyngioma is a rare type of brain tumor that is typically benign but can be challenging to treat due to its location near critical structures in the brain. Given the precision of proton beam therapy, it is considered a viable treatment option for craniopharyngioma, especially in cases where preserving surrounding healthy tissue is crucial.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can Panitumumab cause trichomegaly?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Panitumumab is a monoclonal antibody used in the treatment of metastatic colorectal cancer. Trichomegaly, or excessive eyelash growth, is a known side effect of certain medications, including some targeted cancer therapies. To determine if Panitumumab can cause trichomegaly, we need to review its side effect profile and any reported cases of trichomegaly associated with its use.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1), we need to consider the role of the KMT2D gene in KS1. Kabuki syndrome type 1 is primarily caused by mutations in the KMT2D gene, which encodes a histone methyltransferase involved in epigenetic regulation. Missense mutations in KMT2D can lead to KS1, but the specific impact of mutations in exons 38 or 39 would depend on whether these mutations disrupt the gene's function. Given that KS1 is associated with various mutations across the KMT2D gene, including missense mutations, it is plausible that missense variants in exons 38 or 39 could cause KS1 if they impair the protein's function.\", \"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is tirabrutinib effective for lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tirabrutinib is a Bruton's tyrosine kinase (BTK) inhibitor that has been studied for its effectiveness in treating various types of lymphoma, including mantle cell lymphoma and Waldenström's macroglobulinemia. Clinical trials have shown promising results in some patients, indicating its potential as a treatment option.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is fusobacterium associated with Lemierre's syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Lemierre's syndrome is a rare condition characterized by thrombophlebitis of the internal jugular vein, typically following an oropharyngeal infection. Fusobacterium necrophorum is the most commonly implicated bacterium in this syndrome. Therefore, it is reasonable to associate Fusobacterium with Lemierre's syndrome.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is progeria caused by an autosomal recessive gene?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Progeria, specifically Hutchinson-Gilford Progeria Syndrome (HGPS), is not caused by an autosomal recessive gene. It is caused by a dominant mutation in the LMNA gene, which means only one copy of the mutated gene is sufficient to cause the disorder. This mutation is usually not inherited but occurs as a new mutation in the affected individual.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there a genetic cause of craniostenosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Craniostenosis, also known as craniosynostosis, is a condition where one or more of the fibrous sutures in an infant skull prematurely fuses by turning into bone. This can lead to an abnormal head shape. The causes of craniostenosis can be both genetic and environmental. Genetic causes include mutations in specific genes such as FGFR2, FGFR3, TWIST1, and others, which are known to be associated with craniosynostosis syndromes. Therefore, there is a genetic component to craniostenosis in some cases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is acupotomy used to treat muscle stiffness?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Acupotomy is a modern form of acupuncture that combines traditional acupuncture techniques with small surgical knives to treat various conditions, including musculoskeletal disorders. Muscle stiffness is a common musculoskeletal issue that can be addressed through various treatments, including physical therapy, medication, and alternative therapies like acupuncture. Given that acupotomy is an advanced form of acupuncture aimed at treating similar conditions, it is plausible that it could be used to treat muscle stiffness.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is carpal tunnel syndrome a type of nerve entrapment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Carpal tunnel syndrome is a condition that occurs when the median nerve, which runs from the forearm into the palm of the hand, becomes pressed or squeezed at the wrist. This is a classic example of nerve entrapment, where a nerve is compressed or irritated by surrounding tissues.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any role of genotoxic pks + E. coli in cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether genotoxic pks + E. coli plays any role in cancer. Genotoxic pks + E. coli refers to certain strains of Escherichia coli that produce a genotoxin called colibactin, which is encoded by the pks island. Colibactin has been shown to cause DNA damage in host cells, which is a known mechanism that can lead to cancer. Therefore, it is plausible that genotoxic pks + E. coli could play a role in the development of cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is avelumab effective for urothelial carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Avelumab is a monoclonal antibody that targets PD-L1 and is used in immunotherapy. It has been approved for the treatment of certain types of cancer, including urothelial carcinoma, particularly in cases where the disease has progressed after platinum-based chemotherapy. The effectiveness of avelumab in urothelial carcinoma is supported by clinical trials showing improved outcomes in some patients.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does a comet assay measure radiation induced mutations?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The comet assay, also known as single cell gel electrophoresis, is primarily used to measure DNA damage at the level of individual cells. While it can detect DNA strand breaks which may be caused by radiation, it does not specifically measure mutations. Instead, it assesses the extent of DNA damage, which can be an indicator of potential mutations but is not a direct measurement of mutations themselves.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"MIS-C (Multisystem Inflammatory Syndrome in Children) is a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. It has been observed in children who have been infected with COVID-19 or have been around someone with COVID-19. Given this information, it is important to determine if MIS-C is directly a complication of COVID-19.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SLIC-CAGE used for quantification of translation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"SLIC-CAGE is a method primarily used for the identification of transcription start sites and the analysis of promoter activity, not specifically for the quantification of translation. Therefore, it is not directly used for quantifying translation processes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is adenosine signaling prognostic for cancer outcome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Adenosine signaling has been implicated in various cancer processes, including tumor growth, immune evasion, and metastasis. Given its role in these critical pathways, it's plausible that adenosine signaling could serve as a prognostic marker for cancer outcomes. However, the specific prognostic value would depend on the type of cancer, the context of adenosine signaling within the tumor microenvironment, and other individual patient factors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does bleomycin cause lung toxicity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bleomycin is a chemotherapy agent known for its potential to cause lung toxicity, including pneumonitis and pulmonary fibrosis. The risk is dose-dependent and can be influenced by factors such as age, renal function, and concurrent use of oxygen therapy or other drugs. Monitoring pulmonary function is recommended during treatment with bleomycin.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there sex differences in oncogenic mutational processes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether there are differences between sexes in the processes that lead to mutations causing cancer. To answer this, we need to consider biological and epidemiological studies that compare mutation rates, types, or cancer incidence between males and females. Some cancers are more prevalent in one sex, which might suggest differences in mutational processes or exposure to risk factors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is co-loss of BRCA2-RB1 associated with better prognosis for prostate cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the co-loss of BRCA2 and RB1 genes is associated with a better prognosis for prostate cancer patients. To answer this, we need to consider the roles of BRCA2 and RB1 in cancer. BRCA2 is involved in DNA repair, and its loss can lead to genomic instability. RB1 is a tumor suppressor gene, and its loss is associated with more aggressive cancer phenotypes. The co-loss of both genes might indicate a more aggressive cancer, which typically has a worse prognosis. However, specific studies on prostate cancer patients with co-loss of BRCA2-RB1 would be needed to confirm this.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a role for Dickkopf-1 (DKK1) in prostate cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Dickkopf-1 (DKK1) is a secreted protein that plays a role in the Wnt signaling pathway, which is involved in various cellular processes including proliferation and differentiation. In prostate cancer, the Wnt pathway has been implicated in tumor progression and metastasis. DKK1, as an inhibitor of the Wnt pathway, could potentially have a role in modulating these processes in prostate cancer. Therefore, it is plausible that DKK1 has a role in prostate cancer, possibly as a tumor suppressor or a modulator of tumor microenvironment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Benralizumab effective for Chronic Spontaneous Urticaria?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Benralizumab is a monoclonal antibody that targets the interleukin-5 receptor (IL-5R), primarily used in the treatment of severe eosinophilic asthma. Chronic Spontaneous Urticaria (CSU) is a condition characterized by the sudden appearance of hives, angioedema, or both, for a period exceeding six weeks, without any specific external trigger. The effectiveness of Benralizumab for CSU is not well-established, as it is not a standard treatment for this condition. Current treatments for CSU primarily include antihistamines and omalizumab, an anti-IgE monoclonal antibody, which is approved for CSU.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is belimumab effective for the lupus nephritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Belimumab is a monoclonal antibody that inhibits B-lymphocyte stimulator (BLyS), which is approved for the treatment of active, autoantibody-positive systemic lupus erythematosus (SLE) in adults. However, its effectiveness specifically for lupus nephritis, a severe complication of SLE, has been a subject of research. Clinical trials have shown mixed results, with some indicating potential benefits when used in combination with standard therapy, while others suggest limited efficacy compared to standard treatments alone. Therefore, the effectiveness of belimumab for lupus nephritis may depend on the specific patient population and treatment context.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is liraglutide effective for weight reduction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Liraglutide is a medication that has been approved for weight management in addition to its use for type 2 diabetes. It works by mimicking a hormone that targets areas of the brain involved in appetite regulation, leading to reduced hunger and calorie intake. Clinical trials have shown that liraglutide can lead to significant weight loss when used in conjunction with diet and exercise.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Eflornithine and Sulindac are effective for prevention of progression in Familial Adenomatous Polyposis?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Eflornithine and Sulindac are effective for preventing the progression of Familial Adenomatous Polyposis (FAP), we need to consider clinical studies and research findings. Eflornithine is an ornithine decarboxylase inhibitor, and Sulindac is a nonsteroidal anti-inflammatory drug (NSAID). Both have been studied for their potential chemopreventive effects in FAP. Clinical trials have shown that the combination of Eflornithine and Sulindac can reduce the risk of adenoma progression in patients with FAP, suggesting they may be effective in preventing disease progression.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is ofatumumab effective for multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ofatumumab is a monoclonal antibody that targets CD20, a protein found on the surface of B cells. It has been approved for the treatment of relapsing forms of multiple sclerosis (MS) based on clinical trials showing its effectiveness in reducing relapses and slowing disease progression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Olaparib effective for prostate cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Olaparib is a PARP inhibitor that has been studied for its effectiveness in treating various cancers, including prostate cancer, especially in patients with specific genetic mutations like BRCA. Clinical trials have shown promising results for Olaparib in treating prostate cancer in certain cases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has tocilizumab been assessed against Covid-19?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tocilizumab is an immunosuppressive drug primarily used to treat rheumatoid arthritis and systemic juvenile idiopathic arthritis. During the COVID-19 pandemic, it was investigated for its potential to treat severe cases of COVID-19, particularly in patients experiencing cytokine release syndrome (CRS), a severe immune reaction. Various studies and clinical trials have been conducted to assess its efficacy and safety in this context.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is tocilizumab a tumor necrosis factor inhibitor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if tocilizumab is a tumor necrosis factor (TNF) inhibitor, we need to understand its mechanism of action. Tocilizumab is a monoclonal antibody that targets the interleukin-6 (IL-6) receptor, inhibiting IL-6-mediated signaling. TNF inhibitors, on the other hand, specifically target tumor necrosis factor-alpha (TNF-α). Since tocilizumab does not target TNF-α, it is not a TNF inhibitor.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is tofacitinib a JAK inhibitor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tofacitinib is a medication that has been studied for its effects on the immune system. It is known to target certain enzymes involved in the signaling pathways of the immune system. The question is asking whether tofacitinib is specifically a JAK inhibitor, which would mean it inhibits the Janus kinase enzymes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does the use of bDMARDs during pregnancy impact neonatal development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the use of biologic disease-modifying antirheumatic drugs (bDMARDs) during pregnancy affects the development of the newborn. To answer this, we need to consider existing research and guidelines on the safety of bDMARDs during pregnancy. Some studies suggest that certain bDMARDs may cross the placenta and could potentially affect neonatal development, but the evidence is not conclusive for all bDMARDs. The impact may vary depending on the specific drug, dosage, and timing during pregnancy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is tocilizumab a csDMARD?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if tocilizumab is a csDMARD, we need to understand what csDMARDs are. Conventional synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) are a group of medications used to treat rheumatic diseases by slowing disease progression. Examples include methotrexate, sulfasalazine, and leflunomide. Tocilizumab, on the other hand, is a biologic DMARD (bDMARD) that targets the interleukin-6 receptor. Since it is not a conventional synthetic drug but a biologic, it does not fall under the csDMARD category.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is vocimagene amiretrorepvec effective for glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Glioblastoma is a highly aggressive brain tumor with limited treatment options. Vocimagene amiretrorepvec is a novel oncolytic virus therapy designed to target cancer cells. To determine its effectiveness for glioblastoma, one would need to review clinical trial results or research studies specifically evaluating its impact on glioblastoma patients. Without specific data, it's challenging to definitively say whether it's effective.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does addition of valproic acid improve survival of patients with diffuse intrinsic pontine glioma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive and difficult-to-treat brain tumor. Valproic acid has been studied for its potential anti-tumor effects in various cancers, including gliomas. However, the specific impact of valproic acid on the survival of patients with DIPG is not well-established and requires further research. Current evidence does not conclusively show that valproic acid improves survival in DIPG patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is capmatinib effective for glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Glioblastoma is a highly aggressive brain tumor, and capmatinib is a MET inhibitor. The effectiveness of capmatinib for glioblastoma would depend on whether the tumor has MET alterations that can be targeted by the drug. Current evidence or clinical trials specifically addressing capmatinib's efficacy in glioblastoma would be needed to answer this question definitively.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Cerebrolysin is a nootropic drug with neuroprotective and neurotrophic properties, often used in the treatment of stroke and traumatic brain injury. However, its use in aneurysmal subarachnoid hemorrhage (aSAH) is not well-established in clinical guidelines. The question requires an understanding of current evidence and recommendations regarding cerebrolysin's efficacy and safety in aSAH.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Tranexamic acid effective for intracerebral haemorrhage?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tranexamic acid is an antifibrinolytic agent that has been studied for its potential to reduce bleeding in various conditions, including intracerebral haemorrhage. The effectiveness of Tranexamic acid specifically for intracerebral haemorrhage has been evaluated in clinical trials, with mixed results. Some studies suggest a potential benefit in reducing hematoma expansion, while others do not show a significant impact on clinical outcomes such as mortality or functional recovery. Therefore, the answer depends on the specific context and the latest clinical evidence.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can thiotepa be recommended for treatment of osteosarcoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Thiotepa is a chemotherapy drug that has been used in the treatment of various cancers, but its effectiveness and recommendation for osteosarcoma specifically needs to be evaluated based on current medical guidelines and research. Osteosarcoma is typically treated with a combination of surgery and chemotherapy, with drugs like methotrexate, doxorubicin, and cisplatin being more commonly recommended. The use of thiotepa for osteosarcoma would depend on specific clinical scenarios, resistance to other treatments, or as part of a clinical trial.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does hypofractionated radiotherapy offers any benefit for DIPG?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive and difficult to treat brain tumor. Hypofractionated radiotherapy, which delivers higher doses of radiation over fewer sessions compared to conventional radiotherapy, has been explored as a treatment option. The potential benefits include shorter treatment duration and possibly reduced side effects, but its effectiveness in improving survival or quality of life for DIPG patients remains under investigation.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is isradipine effective for Parkinson's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Isradipine is a calcium channel blocker primarily used for treating high blood pressure. There has been some research into its potential neuroprotective effects in Parkinson's disease, but its effectiveness is not conclusively proven.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should nerinetide be used for treatment of ischaemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Nerinetide is a neuroprotective agent that has been studied for its potential use in treating ischaemic stroke. The question revolves around whether it is effective and safe for this purpose. Clinical trials and research studies would be the basis for determining its suitability.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Lanabecestat effective for Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Lanabecestat was investigated as a potential treatment for Alzheimer's disease, but clinical trials did not show significant effectiveness in slowing the progression of the disease. The trials were discontinued due to lack of efficacy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should minocycline be used for mild Alzheimer disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about the appropriateness of using minocycline for mild Alzheimer's disease. Minocycline is an antibiotic with anti-inflammatory properties that has been studied for its potential neuroprotective effects. However, current evidence does not strongly support its use for Alzheimer's disease, especially in mild cases, as its efficacy and safety for this purpose have not been conclusively established.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is MK-1602 a CGRP antagonist?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if MK-1602 is a CGRP antagonist, we need to verify its classification and mechanism of action. MK-1602 is known in the pharmaceutical industry as a calcitonin gene-related peptide (CGRP) receptor antagonist, which means it blocks the CGRP receptor to prevent migraine attacks.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has ubrogepant entered clinical phase III trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if ubrogepant has entered clinical phase III trials, we need to check the latest clinical trial data or official announcements from the drug's developer. Ubrogepant is a medication developed for the treatment of migraine. As of my last update, it had indeed progressed to phase III trials, which is a significant step in the drug development process.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there small molecule CGRPs under development for the treatment of migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether there are small molecule CGRPs (Calcitonin Gene-Related Peptide) being developed for migraine treatment. Small molecule CGRP antagonists are indeed a focus in migraine therapy research, offering an alternative to monoclonal antibody treatments.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is eptinezumab a small molecule?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if eptinezumab is a small molecule, we need to understand its classification. Eptinezumab is a monoclonal antibody, which is a type of biologic drug. Biologic drugs are generally large, complex molecules, often proteins, and are not considered small molecules. Small molecules are typically low molecular weight compounds that can easily diffuse across cell membranes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is gabapentin effective for chronic pelvic pain?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Gabapentin is a medication originally developed to treat epilepsy, but it is also used for various types of neuropathic pain. Chronic pelvic pain can sometimes be neuropathic in nature, so gabapentin might be considered as a treatment option. However, its effectiveness can vary depending on the underlying cause of the pain and individual patient factors.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Does trimetazidine protect from myocardial injury after percutaneous coronary intervention?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Trimetazidine is an anti-ischemic agent that has been studied for its potential to protect the myocardium during and after percutaneous coronary intervention (PCI). The question is whether it effectively reduces myocardial injury post-PCI. Various studies have shown mixed results, with some indicating a protective effect and others showing no significant benefit.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does inactivation of CYLD help in colorectal cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if inactivation of CYLD helps in colorectal cancer, we need to understand the role of CYLD in cancer. CYLD is a tumor suppressor gene, and its inactivation is generally associated with the promotion of cancer progression by enhancing cell proliferation and survival. In colorectal cancer, inactivation of CYLD could potentially remove its tumor-suppressive effects, thereby aiding cancer development and progression. Therefore, inactivation of CYLD is unlikely to help in colorectal cancer but rather may contribute to its aggressiveness.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a role for TFII-I in megakaryopoiesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"TFII-I is a transcription factor known for its role in various cellular processes, including gene expression regulation. Megakaryopoiesis is the process by which megakaryocytes are produced from hematopoietic stem cells, leading to platelet formation. Given TFII-I's involvement in gene regulation, it's plausible that it could play a role in megakaryopoiesis by regulating genes essential for this process.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is istiratumab effective for pancreatic cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if istiratumab is effective for pancreatic cancer, we need to consider available clinical trials and research findings. Istiratumab is a monoclonal antibody targeting CD73, which is involved in immune suppression in the tumor microenvironment. While it has been studied in various cancers, specific efficacy for pancreatic cancer would require evidence from clinical trials focusing on this type of cancer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does erenumab target the calcitonin gene-related peptide?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Erenumab is a monoclonal antibody designed for the prevention of migraine. It works by blocking the calcitonin gene-related peptide (CGRP) receptor, which is involved in migraine attacks. Therefore, erenumab indirectly targets the CGRP pathway by inhibiting its receptor rather than the peptide itself.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is there a link between rare variants in PPARG and type 1 diabetes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if there's a link between rare variants in PPARG and type 1 diabetes, we need to consider existing research and genetic studies. PPARG is a gene that has been more commonly associated with type 2 diabetes and insulin resistance. Type 1 diabetes, on the other hand, is primarily an autoimmune condition with different genetic and environmental factors. While rare variants in many genes can contribute to disease susceptibility, the specific link between PPARG rare variants and type 1 diabetes is not well-established in the literature.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there an association of alterations in ADCY7 and ulcerative colitis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if there is an association between alterations in ADCY7 and ulcerative colitis, we need to consider existing research and studies that have investigated this relationship. ADCY7 is a gene that encodes adenylate cyclase 7, an enzyme involved in cyclic AMP (cAMP) production, which plays a role in various cellular processes. Ulcerative colitis is a chronic inflammatory bowel disease, and genetic factors are known to contribute to its pathogenesis. If studies have found a significant link or correlation between genetic variations in ADCY7 and the incidence or severity of ulcerative colitis, then the answer would be 'yes'. Otherwise, it would be 'no'.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there high nucleotide diversity in the Drosophila suzukii species?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks about the nucleotide diversity in the Drosophila suzukii species. Nucleotide diversity refers to the degree of variation within a species' DNA sequences. Drosophila suzukii, also known as the spotted wing drosophila, is a species known for its invasive nature and rapid adaptation to new environments, which might suggest a certain level of genetic diversity. However, to accurately answer whether there is high nucleotide diversity, one would need to refer to specific genetic studies or genomic data on this species.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Αre plants from the genus Strychnos the original source of curare?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether plants from the genus Strychnos are the original source of curare. Curare is a well-known poison used by indigenous peoples of South America, primarily for hunting. It is derived from various plant species, and while Strychnos is one of the genera associated with curare, it is not the sole source. Other genera, such as Chondrodendron, are also significant sources. Therefore, the answer depends on whether 'original source' implies the sole source or one of the primary sources.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does Curare function by stimulating the acetylcholine receptor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Curare is a substance known for its muscle relaxant properties. It works by blocking the acetylcholine receptor at the neuromuscular junction, not by stimulating it. This blockade prevents acetylcholine from binding to its receptor, leading to muscle paralysis.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is AZD9668 a VEGF mRNA drug?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if AZD9668 is a VEGF mRNA drug, we need to understand what AZD9668 is and its mechanism of action. AZD9668 is known as a neutrophil elastase inhibitor, not directly related to VEGF mRNA. VEGF mRNA drugs are those that target vascular endothelial growth factor at the mRNA level. Since AZD9668 does not target VEGF mRNA, the answer is no.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has AZD9668 been tested in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if AZD9668 has been tested in clinical trials, we need to look into the history of its development and any published research or trial data. AZD9668 is a drug that was under investigation for the treatment of respiratory diseases, such as chronic obstructive pulmonary disease (COPD). A search through clinical trial databases and scientific literature would provide the necessary information to answer this question.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are TAMs good anticancer therapeutic targets?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tumor-associated macrophages (TAMs) play a complex role in cancer progression and therapy. They can promote tumor growth, angiogenesis, and immune suppression, but also have the potential to be reprogrammed to attack tumor cells. The effectiveness of targeting TAMs as an anticancer therapeutic strategy depends on the ability to modulate their function towards an antitumor phenotype.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tocilizumab (Actemra) is a monoclonal antibody that specifically targets the interleukin-6 (IL-6) receptor. By binding to the IL-6 receptor, it inhibits IL-6-mediated signaling, which is involved in inflammatory processes. Therefore, Tocilizumab is indeed used to block or antagonize the IL-6 receptor.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are PDXK mutations linked to polyneuropathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if PDXK mutations are linked to polyneuropathy, we need to consider whether there is scientific evidence or studies that establish a connection between mutations in the PDXK gene and the development of polyneuropathy. PDXK is involved in vitamin B6 metabolism, which is crucial for nervous system function. Mutations affecting this gene could potentially lead to neurological disorders, including polyneuropathy, due to impaired vitamin B6 metabolism.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do bacteria release extracellular vesicles?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bacteria are known to communicate and interact with their environment in various ways. One of these methods is through the release of extracellular vesicles, which are small, membrane-bound particles that can carry proteins, lipids, and nucleic acids. These vesicles play roles in intercellular communication, nutrient acquisition, and pathogenicity. Given this understanding, it is reasonable to consider whether bacteria release extracellular vesicles as part of their biological processes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Gram positive bacteria able to release extracellular vesicles?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Gram positive bacteria have a thick peptidoglycan layer in their cell walls, which was traditionally thought to prevent the release of extracellular vesicles. However, recent studies have shown that Gram positive bacteria can indeed produce and release extracellular vesicles, which play roles in communication, virulence, and immune modulation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the apilimod inhibitor effective against SARS-CoV-2?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if the apilimod inhibitor is effective against SARS-CoV-2, we need to consider any available scientific studies or research findings that have tested its efficacy against the virus. Apilimod is known to inhibit PIKfyve, a kinase involved in endosomal trafficking, which some viruses, including SARS-CoV-2, exploit for entry and replication in host cells. Therefore, theoretically, apilimod could have antiviral effects against SARS-CoV-2 by disrupting these processes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Hunter's disease is associated with the X Chromosome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Hunter's disease, also known as Mucopolysaccharidosis II (MPS II), is a genetic disorder caused by the deficiency of the enzyme iduronate-2-sulfatase. This condition is inherited in an X-linked recessive pattern, which means the gene associated with the disease is located on the X chromosome. Therefore, it is more common in males, who have only one X chromosome.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Toll-like receptors (TLRs) induced by microbes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Toll-like receptors (TLRs) are a class of proteins that play a key role in the innate immune system. They are capable of recognizing molecules that are broadly shared by pathogens but distinguishable from host molecules, collectively referred to as pathogen-associated molecular patterns (PAMPs). Microbes, including bacteria, viruses, and fungi, produce these PAMPs. Therefore, TLRs are indeed induced by microbes as part of the immune response to detect and respond to microbial infections.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can Freund's complete adjuvant induce arthritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Freund's complete adjuvant (FCA) is known to induce arthritis in animal models, particularly in rats, as part of experimental studies to study arthritis and test potential treatments. FCA contains inactivated and dried mycobacteria, which enhances the immune response, leading to inflammation and arthritis in susceptible animals.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can saponins be used as adjuvant?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Saponins are known for their ability to stimulate the immune system and have been studied for their potential use as adjuvants in vaccines. They can enhance the body's immune response to antigens, making them a candidate for adjuvant use.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is phosphoenolpyruvate carboxykinase 1 (PCK1) the rate-limiting enzyme in gluconeogenesis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Phosphoenolpyruvate carboxykinase 1 (PCK1) is an important enzyme in the gluconeogenesis pathway, which converts oxaloacetate to phosphoenolpyruvate. While it plays a critical role in the pathway, the rate-limiting enzyme in gluconeogenesis is generally considered to be fructose-1,6-bisphosphatase (FBPase) or glucose-6-phosphatase (G6Pase), depending on the context. Therefore, PCK1 is not the rate-limiting enzyme in gluconeogenesis.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is histone variant H3.3K27M associated with gliomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Histone variant H3.3K27M is a mutation that has been studied in the context of gliomas, particularly pediatric glioblastomas and diffuse intrinsic pontine gliomas (DIPGs). Research suggests that this mutation plays a significant role in the development and progression of these types of gliomas by altering chromatin structure and gene expression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do honey contain diastases/amylases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Honey naturally contains enzymes, including diastases (amylases), which help break down starch into sugars. These enzymes are introduced into honey by bees during the honey-making process.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is HbA1c an ideal biomarker of well-controlled diabetes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"HbA1c is a commonly used biomarker to assess long-term glucose control in diabetes, reflecting average blood glucose levels over the past 2-3 months. While it is widely accepted and convenient, it may not always be ideal for all individuals, as factors like anemia, hemoglobin variants, and other conditions can affect its accuracy. Therefore, the question of whether HbA1c is an ideal biomarker for well-controlled diabetes requires consideration of its limitations and the context of the individual's health.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is erabutoxin b usually found in plants?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Erabutoxin b is a type of neurotoxin that is typically associated with certain species of sea snakes, not plants. It is not commonly found in plants.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is autism thought to be related to the  Arginine Vasopressin Peptide (AVP)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with various genetic and environmental factors contributing to its etiology. Research has explored the potential role of neuropeptides, including Arginine Vasopressin (AVP), in the development and manifestation of ASD. Some studies suggest that AVP may influence social behavior and stress responses, which are areas of difficulty for individuals with ASD. However, the exact relationship between AVP and autism is not fully understood and remains a subject of ongoing research.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Ixodes a species of tick?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether Ixodes is a species of tick. Ixodes is actually a genus of ticks, not a single species. Within the genus Ixodes, there are many species, such as Ixodes scapularis (the black-legged tick) and Ixodes ricinus (the castor bean tick). Therefore, Ixodes itself is not a species but a genus that includes multiple species of ticks.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are mucins glycosylated proteins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mucins are a family of high molecular weight, heavily glycosylated proteins produced by epithelial tissues in most animals. Glycosylation is a process where carbohydrate molecules are attached to proteins, which is a key feature of mucins. Therefore, mucins are indeed glycosylated proteins.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are mucin overexpression associated with disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mucin overexpression has been studied in various contexts and has been associated with several diseases, including certain types of cancer, inflammatory diseases, and respiratory conditions. The role of mucin overexpression can vary depending on the specific type of mucin and the disease context.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are interferons defensive proteins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Interferons are a group of signaling proteins made and released by host cells in response to the presence of several viruses. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses. Therefore, interferons can be considered as defensive proteins because they play a crucial role in the immune response against viral infections.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is YKL-40 used as a biomarker for Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"YKL-40, also known as Chitinase-3-like protein 1 (CHI3L1), has been studied in the context of neurodegenerative diseases, including Alzheimer's disease. Research suggests that YKL-40 levels are elevated in the cerebrospinal fluid of individuals with Alzheimer's disease, indicating its potential role as a biomarker for neuroinflammation and possibly the disease itself. However, its specificity and sensitivity as a standalone biomarker for Alzheimer's disease are still under investigation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is G3BP1 found in stress granules?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"G3BP1 is a protein known to be a key component of stress granules, which are dense aggregations in the cytoplasm that form in response to stress. The question is asking whether G3BP1 is found in stress granules. Given the known biological functions and components of stress granules, it is reasonable to conclude that G3BP1 is indeed found in stress granules.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has FTY720  been considered for the treatment of stroke?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"FTY720, also known as Fingolimod, is a drug primarily used in the treatment of multiple sclerosis. Its mechanism involves modulating the immune system. Given its effects on the immune system and potential neuroprotective properties, researchers have explored its applicability in stroke treatment. Studies in animal models have shown promising results, suggesting that FTY720 may reduce brain damage and improve recovery after stroke. However, clinical trials in humans are necessary to confirm its efficacy and safety for this indication.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is FTY720 FDA approved?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"FTY720, also known as Fingolimod, is a medication used to treat multiple sclerosis. It is important to verify its FDA approval status to answer the question.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does the royal jelly contain proteins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Royal jelly is a secretion used in the nutrition of larvae and adult queens in honeybee colonies. It is known to be rich in nutrients, including proteins. Therefore, it is likely that royal jelly contains proteins.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are the major royal jelly proteins similar to the yellow proteins?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether the major royal jelly proteins share similarities with the yellow proteins. To answer this, we need to consider the biological functions and structural characteristics of both protein types. Major royal jelly proteins are key components of royal jelly, which is produced by honeybees and plays a crucial role in the development of queen bees. Yellow proteins, on the other hand, are a diverse group of proteins often involved in pigmentation and other functions in various organisms. Without specific data on the sequence or structural similarities between these two protein groups, it's challenging to definitively state their similarity. However, based on general knowledge, they are distinct in their primary roles and origins.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is the Apis mellifera genome available?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether the genome of Apis mellifera, commonly known as the honey bee, is available for research or reference. To answer this, one would need to know if the genome has been sequenced and made publicly accessible.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has the olive tree pollen proteome been studied?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether the proteome of olive tree pollen has been the subject of scientific study. To answer this, one would need to refer to scientific literature or databases that catalog research on plant proteomes, specifically focusing on olive trees and their pollen.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is hemoglobin antimicrobial?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Hemoglobin is primarily known for its role in oxygen transport in the blood. However, there have been studies suggesting that hemoglobin and its degradation products may have antimicrobial properties under certain conditions. This is not its primary function, but it can contribute to the body's defense mechanisms against pathogens.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there antimicrobial proteins in royal jelly?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Royal jelly is a secretion produced by honeybees, known for its nutritional and medicinal properties. It has been studied for its potential antimicrobial effects, which could be attributed to various proteins and peptides present in it. Research has identified specific proteins in royal jelly that exhibit antimicrobial activity against a range of bacteria and fungi.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Amblyopia affect the eye?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Amblyopia, commonly known as lazy eye, is a vision development disorder where an eye fails to achieve normal visual acuity, even with prescription eyeglasses or contact lenses. It typically begins during infancy and early childhood. The question is asking whether Amblyopia affects the eye. Considering that Amblyopia involves reduced vision that is not correctable by glasses or contact lenses and is not due to any obvious eye disease, it indeed affects the eye's visual capabilities.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is atenolol metabolized by CYP2D6?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if atenolol is metabolized by CYP2D6, we need to consider the metabolic pathways of atenolol. Atenolol is a beta-blocker that is primarily excreted unchanged by the kidneys, with minimal hepatic metabolism. It is not significantly metabolized by the cytochrome P450 enzyme system, including CYP2D6.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is cadherin a plasma membrane marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if cadherin is a plasma membrane marker, we need to understand what cadherin is and its location in the cell. Cadherins are a class of type-1 transmembrane proteins that play a key role in cell adhesion, ensuring that cells within tissues are bound together. They are indeed located in the plasma membrane, where they mediate cell-cell adhesion. Therefore, cadherin can be considered a plasma membrane marker because of its specific localization and function in the plasma membrane.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an upper limit on the functional fraction of the human genome?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether there is a maximum limit to the portion of the human genome that has a functional role. To analyze this, we consider that while the entire genome is transcribed, not all transcripts have known functions. The concept of 'functional fraction' is debated, with estimates varying widely. Some argue that up to 80% may have biochemical functions, while others suggest a much lower percentage. The idea of an 'upper limit' implies a cap on functionality, which is not currently supported by evidence, as our understanding of genome functionality is still evolving.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are synonymous sites in primates and rodents functionally constrained?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether synonymous sites in primates and rodents are functionally constrained. Synonymous sites are positions in the DNA sequence where mutations do not change the amino acid sequence of the encoded protein. Functional constraint refers to the degree to which a site is under selective pressure to remain unchanged. To answer this, we need to consider evolutionary biology studies that compare the rate of synonymous mutations between species and assess whether these sites show signs of selective pressure.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Does IL18 signaling have a role in thymus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"IL18 signaling is known to play a role in immune responses and inflammation. The thymus is a primary lymphoid organ involved in the development of T cells, which are crucial for immune responses. Given the involvement of IL18 in immune regulation, it is plausible that IL18 signaling could have a role in the thymus, potentially in T cell development or selection processes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is metoprolol metabolized by CYP2D6?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Metoprolol is a beta-blocker commonly used to treat high blood pressure and heart conditions. Its metabolism is primarily mediated by the cytochrome P450 enzyme CYP2D6. This enzyme plays a significant role in the oxidative metabolism of metoprolol, leading to its clearance from the body. Therefore, variations in CYP2D6 activity can affect metoprolol's pharmacokinetics.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the glucocorticoid receptor a transcription factor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The glucocorticoid receptor (GR) is a protein that, upon binding to glucocorticoids, can translocate to the nucleus and regulate the transcription of target genes. This function is characteristic of transcription factors, which are proteins that control the rate of transcription of genetic information from DNA to messenger RNA.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has dupilumab been FDA approved for atopic dermatitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether dupilumab has received FDA approval for the treatment of atopic dermatitis. Dupilumab is a monoclonal antibody that inhibits interleukin-4 and interleukin-13, which are key drivers of type 2 inflammation. Atopic dermatitis is a chronic inflammatory skin condition characterized by itchy, red, and swollen skin. The FDA's approval of medications is based on clinical trials demonstrating safety and efficacy for specific conditions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has the companion diagnostic HercepTest received FDA approval?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The HercepTest is a diagnostic test used to detect the HER2 protein in breast cancer tissue. It is important to verify its FDA approval status to ensure its validity for clinical use.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is FKBP52 encoding a chaperone ?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"FKBP52 is a protein that belongs to the FK506-binding protein family, which are known to have chaperone activity. Chaperones assist in protein folding and prevent protein aggregation. Therefore, it is likely that FKBP52 functions as a chaperone.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is colistin an antibiotic?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Colistin is a medication that is used as a last-resort antibiotic for the treatment of infections caused by certain types of bacteria that are resistant to other antibiotics. It belongs to the polymyxin class of antibiotics.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Keutel syndrome a common genetic disorder?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Keutel syndrome is a rare genetic disorder characterized by abnormal calcium deposition in various tissues, distinctive facial features, and other skeletal abnormalities. Given its rarity, it is not considered a common genetic disorder.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Daprodustat effective for anemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Daprodustat is a medication that has been studied for its effectiveness in treating anemia, particularly in patients with chronic kidney disease. It works by stimulating the production of red blood cells. The question is whether it is effective for anemia, and based on clinical studies, it has shown promise in increasing hemoglobin levels in such patients.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an association between pyostomatitis vegetans and Crohn's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Pyostomatitis vegetans is a rare inflammatory disorder that is often associated with inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. Given this known association, it is reasonable to consider that there is a link between pyostomatitis vegetans and Crohn's disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Sotrovimab effective for COVID-19?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Sotrovimab is a monoclonal antibody that was authorized for emergency use by the FDA for the treatment of mild-to-moderate COVID-19 in certain high-risk patients. Its effectiveness is based on clinical trials showing a reduction in hospitalization or death among treated patients compared to placebo. However, its efficacy may vary against different variants of the virus.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Ozanimod effective for Ulcerative Colitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ozanimod is a medication that has been studied for its effectiveness in treating Ulcerative Colitis. Clinical trials have shown that it can be effective in inducing and maintaining remission in patients with moderate to severe Ulcerative Colitis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Cabotegravir effective for HIV prevention?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cabotegravir is a long-acting injectable antiretroviral medication that has been studied for HIV prevention. Clinical trials have shown that it is highly effective in reducing the risk of HIV infection when administered as an intramuscular injection every two months. The effectiveness of Cabotegravir for HIV prevention has been demonstrated in populations at high risk of HIV, making it a significant advancement in pre-exposure prophylaxis (PrEP) options.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is sacituzumab govitecan effective for breast cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Sacituzumab govitecan is an antibody-drug conjugate approved for the treatment of certain types of breast cancer, specifically metastatic triple-negative breast cancer (mTNBC) in adults who have received at least two prior therapies for metastatic disease. Its effectiveness is supported by clinical trials showing improved progression-free survival and overall survival rates in treated patients.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is rilonacept effective for pericarditis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Rilonacept is a medication that has been studied for its effectiveness in treating pericarditis, particularly recurrent pericarditis. It works by inhibiting interleukin-1, a key player in the inflammatory process. Clinical trials have shown promising results in reducing the recurrence of pericarditis episodes in patients treated with rilonacept.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Sotatercept effective for Pulmonary Arterial Hypertension?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Sotatercept is a novel therapeutic agent that has shown promise in the treatment of Pulmonary Arterial Hypertension (PAH) by targeting the underlying mechanisms of the disease. Clinical trials have demonstrated its potential to improve exercise capacity and reduce pulmonary vascular resistance in patients with PAH.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Belimumab used for lupus nephritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Belimumab is a monoclonal antibody that targets B-lymphocyte stimulator (BLyS). It is approved for the treatment of systemic lupus erythematosus (SLE), but its use specifically for lupus nephritis, a severe complication of SLE, has been more limited and was not initially approved for this indication. However, recent studies and approvals have expanded its use to include lupus nephritis in some regions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an association between Guillain–Barré syndrome and covid vaccine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Guillain–Barré syndrome (GBS) is a rare neurological disorder where the body's immune system mistakenly attacks part of its peripheral nervous system. There have been reports and studies investigating a potential association between GBS and COVID-19 vaccines. Some vaccines, particularly viral vector vaccines, have been associated with a small increased risk of GBS in certain populations. However, the overall risk remains very low, and the benefits of vaccination in preventing COVID-19, which itself can cause serious health complications, far outweigh the risks.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do mutations in KCNT2 only cause phenotypes with epilepsy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether mutations in the KCNT2 gene exclusively result in phenotypes associated with epilepsy. To answer this, we need to consider the known functions of KCNT2 and the range of phenotypes associated with its mutations. KCNT2 encodes a potassium channel subunit, and mutations in potassium channels can have diverse effects depending on their role in different tissues. While epilepsy is a notable phenotype associated with KCNT2 mutations, it's important to explore whether other phenotypes have been documented.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do only changes in coding regions of MEF2C cause developmental disorders?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether only changes in the coding regions of the MEF2C gene cause developmental disorders. To answer this, we need to consider that mutations in non-coding regions, such as regulatory regions, can also affect gene expression and potentially lead to developmental disorders. Therefore, it's not only changes in the coding regions that can cause such disorders.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Algenpantucel-L effective for pancreatic cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Algenpantucel-L is a cancer vaccine that was under investigation for the treatment of pancreatic cancer. It was designed to stimulate the immune system to attack pancreatic cancer cells. However, clinical trials have not conclusively proven its effectiveness in significantly improving survival rates for pancreatic cancer patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is tivantinib effective for MET-high hepatocellular carcinoma?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if tivantinib is effective for MET-high hepatocellular carcinoma, we need to consider clinical trial results and studies that have evaluated its efficacy in this specific patient population. Tivantinib is a selective MET inhibitor, and MET-high hepatocellular carcinoma patients are a subgroup that might benefit from MET-targeted therapies. Previous studies have shown mixed results, with some indicating potential benefits in progression-free survival for MET-high patients, while others may not have shown significant overall survival benefits. Therefore, the effectiveness can be context-dependent and may vary based on the study design and patient selection criteria.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can Isradipine slow progression of Early Parkinson Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Isradipine is a calcium channel blocker that has been studied for its potential effects on Parkinson's Disease. Research suggests that it might have neuroprotective properties that could slow the progression of early Parkinson's Disease. However, the evidence is not conclusive, and more research is needed to confirm its effectiveness.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is nerinetide effective for ischaemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Nerinetide is a neuroprotective agent that has been studied for its potential to reduce brain damage following an ischaemic stroke. It works by inhibiting the interaction between PSD-95 and nNOS, which is thought to reduce excitotoxicity and infarct volume. Clinical trials have been conducted to evaluate its efficacy in improving outcomes for patients with ischaemic stroke.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should perampanel be used for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Perampanel is an antiepileptic drug primarily used for the treatment of partial-onset seizures and generalized tonic-clonic seizures. Its use in amyotrophic lateral sclerosis (ALS) is not well-established, and there is limited evidence to support its efficacy in this condition. Therefore, the appropriateness of perampanel for ALS would depend on further clinical research and evidence.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are variants in FHF2 (also known as FGF13) associated with encephalopathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether variants in FHF2 (FGF13) are associated with encephalopathy. To answer this, we need to consider if there is scientific evidence linking genetic variations in FHF2 (FGF13) to encephalopathy. FGF13 is known to play a role in neuronal development and function, and mutations in this gene have been implicated in neurological disorders. However, the specific association with encephalopathy would require reviewing recent studies or genetic databases for documented cases or research findings.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Adamts18 deficiency associated with cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if Adamts18 deficiency is associated with cancer, we need to consider existing research and evidence linking the Adamts18 gene to cancer development or progression. Adamts18 is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family, which has been implicated in various biological processes including extracellular matrix remodeling, angiogenesis, and cancer. However, the specific role of Adamts18 in cancer is not as well-documented as some other members of the ADAMTS family. Some studies suggest that Adamts18 may act as a tumor suppressor in certain contexts, but the evidence is not conclusive. Therefore, the association between Adamts18 deficiency and cancer requires further investigation.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is Erythropoietin effective for neuroprotection of Preterm Infants.",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Erythropoietin (EPO) has been studied for its potential neuroprotective effects in preterm infants. Research suggests that EPO may have benefits beyond its primary role in erythropoiesis, including neuroprotection, due to its anti-inflammatory and anti-apoptotic properties. However, the effectiveness of EPO for neuroprotection in preterm infants is still under investigation, with some studies showing positive outcomes and others indicating the need for further research to confirm its efficacy and safety.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Should Intepirdine be used for Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Intepirdine was investigated as a potential treatment for Alzheimer's disease, but clinical trials did not show significant efficacy in improving cognitive function. Therefore, its use for Alzheimer's disease is not recommended.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should istiratumab be used for Pancreatic Cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Istiratumab is a monoclonal antibody that has been studied in various cancers, but its efficacy and approval status for pancreatic cancer specifically are not widely established. The use of istiratumab for pancreatic cancer would depend on clinical trial results and regulatory approvals.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is vocimagene amiretrorepvec effective for recurrent high-grade glioma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks about the effectiveness of vocimagene amiretrorepvec for recurrent high-grade glioma. To answer this, we need to consider clinical trial results or studies that evaluate its efficacy in this specific condition. Without specific data, it's challenging to definitively say yes or no. However, if we assume that the question is based on general knowledge or available research indicating its effectiveness, we might lean towards a positive answer. But since the question does not provide context or data, the safest answer would be no, indicating that it's not effective or there's insufficient evidence to say yes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Was ALVAC-HIV effective for HIV prevention in the HVTN 702 trial?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks about the effectiveness of the ALVAC-HIV vaccine in preventing HIV in the HVTN 702 trial. To answer this, we need to refer to the results of the HVTN 702 trial, which was a large-scale clinical trial conducted to evaluate the efficacy of the ALVAC-HIV vaccine. The trial's outcomes are crucial in determining whether the vaccine was effective in preventing HIV infection among participants.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does αCGRP have amyloidogenic properties?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about whether αCGRP (alpha calcitonin gene-related peptide) has amyloidogenic properties, meaning it can form amyloid fibrils. Amyloidogenic properties are typically associated with proteins that can misfold and aggregate into amyloid fibrils, which are implicated in various diseases. To answer this, we need to consider the structure and known behaviors of αCGRP. αCGRP is a neuropeptide involved in vasodilation and pain transmission, and there is no widely recognized evidence or studies suggesting that αCGRP has amyloidogenic properties.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Do SETD1A mutations predispose to schizophrenia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether mutations in the SETD1A gene are associated with an increased risk of developing schizophrenia. To answer this, we need to consider scientific research and studies that have investigated the link between SETD1A mutations and schizophrenia.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is covid-19 induced anosmia caused by disruption of nuclear architecture?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether COVID-19 induced anosmia (loss of smell) is caused by disruption of nuclear architecture. To answer this, we need to consider the current understanding of how COVID-19 affects the olfactory system. Research suggests that COVID-19 can lead to anosmia by infecting the sustentacular cells in the olfactory epithelium, which support the olfactory sensory neurons. This infection can cause inflammation and damage to these cells, indirectly affecting the olfactory neurons. However, there is no direct evidence to suggest that COVID-19 induced anosmia is caused by a disruption of nuclear architecture. The primary mechanism appears to be related to the infection and subsequent immune response rather than structural changes at the nuclear level.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there any role of the 'Greek islands' in olfactory receptor choice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the 'Greek islands' have any role in olfactory receptor choice. Olfactory receptors are proteins that play a key role in the sense of smell by detecting odor molecules. The term 'Greek islands' does not seem to be directly related to the biological or genetic mechanisms involved in olfactory receptor choice, which is primarily determined by genetic factors and evolutionary biology. Therefore, it's unlikely that the 'Greek islands' have any role in this process.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is HDAC1 required for GATA-1 transcriptional activity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if HDAC1 is required for GATA-1 transcriptional activity, we need to consider the role of HDAC1 in gene regulation and its interaction with GATA-1. HDAC1 is a histone deacetylase that can modify chromatin structure and repress gene expression. GATA-1 is a transcription factor that regulates genes involved in hematopoiesis. If HDAC1 interacts with GATA-1 and modulates its activity, then HDAC1 could be required for GATA-1 transcriptional activity. However, without specific evidence or studies confirming this interaction or requirement, we cannot definitively say yes.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there a dependence between chromatin organization and dorsoventral gene expression in Drosophila?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether there is a relationship between chromatin organization and dorsoventral gene expression in Drosophila. Chromatin organization plays a critical role in regulating gene expression by controlling access to DNA. In Drosophila, dorsoventral patterning is a well-studied process involving specific gene expression patterns. Given the importance of chromatin organization in gene regulation, it is plausible that there is a dependence between chromatin organization and dorsoventral gene expression in Drosophila.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Does atemoya juice inhibit the CYP1A2 enzyme?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if atemoya juice inhibits the CYP1A2 enzyme, we need to consider whether there is any scientific evidence or studies that have investigated the effects of atemoya juice on the CYP1A2 enzyme. CYP1A2 is an important enzyme involved in the metabolism of various drugs, and its inhibition can lead to altered drug levels in the body. Without specific studies or evidence on atemoya juice's effect on CYP1A2, it's challenging to conclude definitively.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does atemoya juice inhibit tye CYP3A4 enzyme?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if atemoya juice inhibits the CYP3A4 enzyme, we need to consider whether atemoya or its components have been shown to interact with CYP3A4 in any studies or research. CYP3A4 is a major enzyme in the liver that metabolizes many drugs, and its inhibition can lead to increased drug levels in the body. Without specific studies or evidence indicating that atemoya juice has components that inhibit CYP3A4, we cannot confirm its inhibitory effect.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does daily atemoya juice intake change the pharmacokinetics of CYP1A2 substrates?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if daily atemoya juice intake changes the pharmacokinetics of CYP1A2 substrates, we need to consider whether atemoya juice contains compounds that are known to inhibit or induce the CYP1A2 enzyme. CYP1A2 is involved in the metabolism of various drugs, and substances that affect its activity can alter the pharmacokinetics of its substrates. Without specific studies or evidence indicating that atemoya juice affects CYP1A2 activity, we cannot conclusively say it changes the pharmacokinetics of CYP1A2 substrates.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can bergapten cross the blood-brain barrier?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Bergapten is a furanocoumarin found in bergamot and other citrus oils. The ability of a compound to cross the blood-brain barrier (BBB) depends on its physicochemical properties, such as molecular weight, lipophilicity, and the presence of active transport mechanisms. While there is limited specific research on bergapten's ability to cross the BBB, furanocoumarins generally have moderate lipophilicity, which might suggest some potential for BBB penetration. However, without direct evidence, it's challenging to confirm.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can bergapten cause phototoxicity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bergapten is a naturally occurring furanocoumarin found in bergamot oil and other citrus oils. Furanocoumarins are known to cause phototoxicity when exposed to UV light, leading to skin reactions such as burns or hyperpigmentation. Therefore, it is important to analyze whether bergapten specifically has this property.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can whole genome sequencing be used for diagnosis of mitochondrial disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Whole genome sequencing (WGS) is a comprehensive method for analyzing entire genomes, including mitochondrial DNA (mtDNA). Mitochondrial diseases are often caused by mutations in mtDNA or nuclear genes affecting mitochondrial function. Since WGS can identify mutations in both nuclear and mitochondrial genomes, it has the potential to be used for diagnosing mitochondrial diseases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is AGO2 related to cytokinesis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if AGO2 is related to cytokinesis, we need to understand the roles of AGO2 in cellular processes. AGO2, or Argonaute 2, is primarily known for its role in the RNA-induced silencing complex (RISC) where it facilitates gene silencing through RNA interference. Cytokinesis, on the other hand, is the process of cell division following mitosis, where the cytoplasm of a single eukaryotic cell divides into two daughter cells. There is no direct evidence linking AGO2 to the process of cytokinesis.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does TIMELESS-TIPIN participate in replisome disassembly?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether TIMELESS-TIPIN is involved in the process of replisome disassembly. To answer this, we need to understand the role of TIMELESS-TIPIN in DNA replication and whether it has been documented to participate in the disassembly of the replisome, the complex of proteins that replicates DNA.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is METTL1 overexpression associated with better patient survival?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if METTL1 overexpression is associated with better patient survival, we need to consider studies or clinical data that correlate METTL1 expression levels with patient survival outcomes. If such data indicates that higher levels of METTL1 are linked to improved survival rates, then the answer would be 'yes'. Otherwise, it would be 'no'.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has CPX-351 been approved by the FDA and the EMA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CPX-351 is a liposomal formulation of cytarabine and daunorubicin. To determine if it has been approved by the FDA (U.S. Food and Drug Administration) and the EMA (European Medicines Agency), we need to check the approval status from official sources or reliable databases. As of my last update, CPX-351 has received approval from both the FDA and the EMA for specific indications related to acute myeloid leukemia (AML).\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is REGN5458 a single-targeted antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if REGN5458 is a single-targeted antibody, we need to understand its mechanism of action. REGN5458 is known as a bispecific antibody, which means it is designed to bind to two different targets simultaneously. This characteristic is contrary to the definition of a single-targeted antibody, which binds to only one specific target.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is MEDI2228 a bispecific antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if MEDI2228 is a bispecific antibody, we need to understand what a bispecific antibody is and whether MEDI2228 fits this definition. A bispecific antibody is an artificial protein that can simultaneously bind to two different types of antigens. Without specific information on MEDI2228's structure or mechanism of action, it's challenging to confirm its classification. However, based on available data, MEDI2228 is known as a BCMA-targeting antibody-drug conjugate (ADC), not a bispecific antibody.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a role for CADM1 in Myelodysplastic syndrome (MDS)?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if CADM1 has a role in Myelodysplastic syndrome (MDS), we need to consider the known functions of CADM1 and its relevance to MDS. CADM1, also known as Cell Adhesion Molecule 1, is involved in cell adhesion and has been implicated in various cancers. Myelodysplastic syndrome is a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy blood cells. Research has shown that CADM1 may play a role in the pathogenesis of MDS by affecting cell adhesion and signaling pathways that are crucial for the normal maturation of blood cells.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Does UBE4B promote renal cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if UBE4B promotes renal cancer, we need to consider existing research and evidence on the role of UBE4B in cancer progression, specifically in renal cancer. UBE4B is an E3/E4 ubiquitin ligase involved in protein degradation processes, which can influence cancer development. However, the specific impact of UBE4B on renal cancer would require reviewing studies or data that directly link UBE4B activity to renal cancer promotion or progression.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can IFNg induce the expression of IDO?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"IFNg, or Interferon-gamma, is known to play a significant role in immune responses and has been shown to induce the expression of indoleamine 2,3-dioxygenase (IDO) in various cell types. IDO is an enzyme involved in the metabolism of tryptophan and has immunomodulatory effects. Given this information, the question is whether IFNg can induce the expression of IDO.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Mycobacterium abscessus a human pathogen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mycobacterium abscessus is a species of rapidly growing mycobacteria that is known to cause a variety of infections in humans, including skin, soft tissue, and pulmonary infections. It is considered an opportunistic pathogen, particularly in individuals with compromised immune systems or underlying lung conditions such as cystic fibrosis. Given its ability to infect humans and cause disease, it is classified as a human pathogen.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do we find bacteriophages in the gut?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bacteriophages are viruses that infect bacteria. The gut is known to harbor a vast and diverse microbiome, including bacteria. Given that bacteriophages target bacteria, it is logical to consider their presence in the gut where their bacterial hosts reside.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is NfL (neurofilament light chain) a biomarker of neurodegeneration?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Neurofilament light chain (NfL) is a protein component of the neuronal cytoskeleton. Elevated levels of NfL in cerebrospinal fluid (CSF) and blood have been associated with neuronal damage and degeneration, making it a potential biomarker for various neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do the proteins Talin and Amot interact?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if the proteins Talin and Amot interact, we need to consider their known functions and interactions. Talin is a cytoskeletal protein involved in linking integrins to the actin cytoskeleton, playing a key role in cell adhesion and migration. Amot (Angiomotin) is involved in cell migration, angiogenesis, and maintaining cell polarity. While both proteins are involved in cell migration, there is no widely documented direct interaction between Talin and Amot in the literature.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is serotonin transported by platelets?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Serotonin is a neurotransmitter that is also found in the blood, where it is largely stored in platelets. Platelets take up serotonin from the plasma and store it in their dense granules. When platelets are activated, they release serotonin, which can then act on various tissues. Therefore, the question is asking whether platelets are involved in the transport of serotonin in the bloodstream.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Otolin-1 a matrix protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Otolin-1 is a matrix protein, we need to understand what matrix proteins are and the characteristics of Otolin-1. Matrix proteins are structural proteins that are part of the extracellular matrix, providing support and structure to tissues. Otolin-1 is known to be a major component of the otoconia, which are calcium carbonate crystals in the inner ear that are involved in balance. Given its structural role in the otoconia, it can be considered a matrix protein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein HOXA11 associated with endometrial disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"HOXA11 is a protein that plays a crucial role in the development of the female reproductive tract, including the endometrium. Given its importance in endometrial development and function, it is plausible that HOXA11 could be associated with endometrial diseases. Research has indeed suggested that alterations in HOXA11 expression or function may contribute to various endometrial pathologies, such as endometriosis or endometrial cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Lysozyme abundant in human tears?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Lysozyme is an enzyme that has antibacterial properties and is part of the innate immune system. It is known to be present in various bodily fluids, including tears, saliva, and mucus. The question is asking whether lysozyme is abundant in human tears specifically. Given its role in protecting the eye from bacterial infections, it is reasonable to hypothesize that lysozyme is indeed abundant in tears.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SMOC2 expressed during wound healing?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if SMOC2 is expressed during wound healing, we need to consider its known functions and expression patterns. SMOC2, or SPARC-related modular calcium-binding protein 2, is involved in extracellular matrix organization and cell adhesion processes, which are crucial for wound healing. Studies have shown that SMOC2 is upregulated during tissue repair and regeneration, suggesting its expression during wound healing.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is esophageal adenocarcinoma associated with aberrant glycosylation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Esophageal adenocarcinoma is a type of cancer that occurs in the esophagus. Aberrant glycosylation refers to abnormal glycosylation patterns that are often observed in cancer cells, including changes in the structure and function of glycoproteins and glycolipids. Given that aberrant glycosylation is a common feature in many cancers, it is plausible that esophageal adenocarcinoma could also be associated with such changes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is cytokeratin a tumor marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cytokeratin is a type of protein found in the cytoskeleton of epithelial cells. It is often used in immunohistochemistry to identify carcinomas, which are cancers of epithelial origin. Therefore, cytokeratin can be considered a tumor marker for certain types of cancers, particularly those arising from epithelial tissues.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there any R packages that help with visualizing data on spirals?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether there are any R packages specifically designed for visualizing data on spirals. To answer this, I need to consider the vast ecosystem of R packages and whether any of them offer functionality for spiral visualizations.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there roles for cohesin mutations in AML?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Acute Myeloid Leukemia (AML) is a complex disease with various genetic mutations contributing to its development and progression. Cohesin mutations have been identified in a subset of AML cases, suggesting a potential role in the pathogenesis of the disease. Cohesin is a protein complex that regulates chromosome segregation and gene expression, and mutations in this complex could disrupt these processes, leading to genomic instability and aberrant gene expression, which are hallmarks of cancer. Therefore, it is plausible that cohesin mutations play a role in AML.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Epoxyeicosatrienoic acids (EETs) synthesized by cytochrome P450 epoxygenases from arachidonic acid?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Epoxyeicosatrienoic acids (EETs) are indeed synthesized from arachidonic acid, but the question is whether this synthesis is specifically carried out by cytochrome P450 epoxygenases. To answer this, we need to confirm if cytochrome P450 epoxygenases are the enzymes responsible for converting arachidonic acid into EETs.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Epistaxis associated with dental implant placement?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Epistaxis, or nosebleed, is not commonly associated with dental implant placement as the primary procedure involves the jawbone and gums, not the nasal cavity. However, in cases where the dental implant is placed in the upper jaw and there is proximity to the maxillary sinus or if there is an accidental perforation into the nasal cavity, epistaxis could potentially occur as a rare complication.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are Tregs CD4(+)CD25(+) regulatory T cells a positive regulator of the immune response?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tregs (regulatory T cells) are a subset of CD4(+) T cells that express CD25 and the transcription factor Foxp3. They play a crucial role in maintaining immune tolerance and preventing autoimmune diseases by suppressing the immune response. Therefore, they are not positive regulators but rather negative regulators of the immune response.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Unlike DNA, RNA is not methylated, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about whether RNA is methylated, unlike DNA. DNA methylation is a well-known epigenetic modification, but RNA can also undergo methylation, such as the methylation of adenosine to form N6-methyladenosine (m6A), which is a common modification in mRNA. Therefore, the statement that RNA is not methylated is not accurate.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do RNA binding Proteins  that bind to adenine uridine (AU)-rich elements (AREs) in the 5' untranslated region (UTR) of mRNAs (AU-RBPs) regulate the DNA Damage Response?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether RNA binding proteins (AU-RBPs) that bind to adenine uridine (AU)-rich elements (AREs) in the 5' untranslated region (UTR) of mRNAs regulate the DNA Damage Response. To answer this, we need to consider the known functions of AU-RBPs and their potential roles in DNA damage response mechanisms. AU-RBPs are known to regulate mRNA stability and translation, which could indirectly affect the expression of proteins involved in the DNA damage response. However, direct regulation of the DNA damage response by AU-RBPs is not a widely documented or primary function of these proteins.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are G-quadruplexes(G4) possible drug targets for glioblastoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Glioblastoma is a highly aggressive brain tumor with limited treatment options. G-quadruplexes (G4) are nucleic acid secondary structures that can form in guanine-rich sequences of DNA and RNA. They play roles in key cellular processes such as gene expression and genome stability. Given their involvement in these processes and their presence in oncogenes and telomeres, G4 structures are considered potential therapeutic targets for various cancers, including glioblastoma. Targeting G4 structures could disrupt the proliferation of cancer cells by affecting gene expression or telomere maintenance. Therefore, exploring G4 as drug targets for glioblastoma is a plausible approach.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is CircRNA produced by back splicing of exon, intron or both, forming exon or intron circRNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether CircRNA is produced by back splicing of exon, intron, or both, and whether it forms exon or intron circRNA. CircRNA is primarily produced by back splicing of exons, leading to the formation of exon circRNA. However, there are also cases where introns are involved, leading to intron circRNA, but this is less common.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are circRNAs susceptible to degradation by RNase R?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"CircRNAs are known for their resistance to exonuclease degradation due to their covalently closed loop structure. RNase R is a 3' to 5' exoribonuclease that degrades linear RNAs but has limited activity on circRNAs because it cannot easily access the 3' end of circRNAs. Therefore, circRNAs are generally considered resistant to degradation by RNase R.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is RUNX1T1 associate with obesity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if RUNX1T1 is associated with obesity, we need to consider whether there is scientific evidence linking this gene to obesity-related processes or conditions. RUNX1T1 is known to be involved in hematopoiesis and has been implicated in certain cancers, but its direct association with obesity is not widely documented in the literature. Therefore, without specific studies or evidence pointing to a direct link between RUNX1T1 and obesity, it is unlikely to be associated.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can FTO promote pancreatic cancer development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about whether FTO (Fat mass and obesity-associated protein) can promote pancreatic cancer development. To answer this, we need to consider if there's any scientific evidence linking FTO to pancreatic cancer progression. FTO is known to play roles in obesity and metabolism, and obesity is a risk factor for several cancers, including pancreatic cancer. However, direct evidence of FTO promoting pancreatic cancer development would require specific studies linking FTO activity to pancreatic cancer cell growth or tumor progression.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Ameloblastoma (AB) a common benign tumor occurring in the brain?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Ameloblastoma (AB) is a benign tumor, but it primarily occurs in the jaw, not the brain. It is most commonly found in the mandible. Therefore, the question is asking if AB is a common benign tumor in the brain, which is not its typical location.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is disruption of immune regulation mechanisms associated with adverse pregnancy outcomes, including preeclampsia (PE)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the disruption of immune regulation mechanisms is linked to adverse pregnancy outcomes, specifically preeclampsia (PE). Immune regulation plays a critical role in pregnancy, ensuring the mother's immune system tolerates the fetus. Disruptions in these mechanisms could lead to adverse outcomes like PE, which is characterized by high blood pressure and often proteinuria after 20 weeks of pregnancy. Research suggests that immune dysregulation contributes to the pathogenesis of PE by affecting placental development and function.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can METTL3 methylate long noncoding RNAs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether the enzyme METTL3 has the capability to methylate long noncoding RNAs (lncRNAs). METTL3 is known to be a key methyltransferase involved in the N6-methyladenosine (m6A) modification of RNA, which is a common post-transcriptional modification in eukaryotic cells. While METTL3's role in methylating mRNAs is well-documented, its ability to methylate lncRNAs is less clear but has been suggested by some studies.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is PCAT6 a microRNA?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if PCAT6 is a microRNA, we need to understand what PCAT6 is. PCAT6 stands for Prostate Cancer Associated Transcript 6, which is a long non-coding RNA (lncRNA), not a microRNA. MicroRNAs are small non-coding RNAs that regulate gene expression post-transcriptionally, whereas lncRNAs are longer and have different functions.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can autophagy related lncRNAs be used for colorectal cancer prognosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Autophagy-related long non-coding RNAs (lncRNAs) have been studied for their roles in various cancers, including colorectal cancer. Their expression levels can influence cancer progression and patient survival, suggesting potential as prognostic markers. Research indicates that specific autophagy-related lncRNAs are associated with colorectal cancer outcomes, making them candidates for prognosis evaluation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are circular RNAs implicated in diseases of the eye?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Circular RNAs (circRNAs) are a type of non-coding RNA that have been implicated in various biological processes and diseases. Recent studies have suggested that circRNAs may play roles in the pathogenesis of several diseases, including those affecting the eye. Given their involvement in gene regulation and their presence in ocular tissues, it is plausible that circRNAs could be implicated in eye diseases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Ameloblastoma (AB) a benign tumor that never metastasizes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Ameloblastoma (AB) is generally considered a benign tumor, but it is known for its locally aggressive behavior. While it is rare, there have been reported cases of AB metastasizing, which is referred to as malignant ameloblastoma or ameloblastic carcinoma. Therefore, the statement that AB never metastasizes is not entirely accurate.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Acute Necrotizing Encephalopathy (ANE) which typically affects young, healthy children usually triggered by exposure to air pollution?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Acute Necrotizing Encephalopathy (ANE) is a rare disease that typically affects young, healthy children and is often triggered by viral infections. There is no strong evidence to suggest that exposure to air pollution is a common trigger for ANE.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is retinol binding protein 4 an adipokine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Retinol binding protein 4 (RBP4) is a protein that transports retinol (vitamin A) in the blood. It has been suggested to act as an adipokine, which is a cytokine secreted by adipose tissue that can influence metabolism and inflammation. The question is whether RBP4 is classified as an adipokine.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do Afamin bind Vitamin E?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Afamin binds Vitamin E, we need to consider the known functions and binding capabilities of Afamin. Afamin is a glycoprotein that belongs to the albumin family and has been identified as a carrier protein for Vitamin E, among other molecules. Therefore, it is known to bind Vitamin E.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is HYDIN (Hydrocephalus-inducing protein homolog) an axonemal protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if HYDIN is an axonemal protein, we need to understand its function and location. HYDIN is known to be involved in the structure and function of cilia and flagella, which are cellular projections that contain axonemes. The axoneme is the cytoskeletal structure of cilia and flagella, composed of microtubules and associated proteins. Given HYDIN's role in cilia and flagella, it is reasonable to consider its association with the axoneme.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is ASF1 phopshorylated by  the Tousled-like kinases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether ASF1 is phosphorylated by Tousled-like kinases. To answer this, we need to know if there is evidence or studies that show Tousled-like kinases phosphorylate ASF1.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is paxillin affected by RANKL?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if paxillin is affected by RANKL, we need to consider the biological pathways and interactions involving these two molecules. RANKL (Receptor Activator of Nuclear Factor κB Ligand) is known to play a critical role in osteoclast differentiation and activation. Paxillin is a focal adhesion adapter protein involved in cell adhesion and migration. There is evidence suggesting that RANKL signaling can influence the cytoskeleton and adhesion structures in osteoclasts, which may involve proteins like paxillin. Therefore, it is plausible that paxillin could be affected by RANKL through these pathways.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is taxilin a cancer marker?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Taxilin is not a widely recognized or established cancer marker in the medical or scientific community. Cancer markers are typically proteins or other substances that are produced by cancer cells or by the body in response to cancer. While there may be research exploring various molecules and their potential links to cancer, taxilin has not been prominently identified as a standard cancer marker.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can parasite infections by Schistosoma japonicum prevent or improve asthma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Schistosoma japonicum is a parasitic worm that can cause schistosomiasis, a disease affecting millions worldwide. There is some research suggesting that certain parasitic infections might modulate the immune system in a way that could reduce the severity of allergic diseases like asthma. However, the relationship between Schistosoma japonicum infection and asthma is not well-established, and the potential benefits would not outweigh the risks and negative health impacts of the infection itself.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does sphingosine-1 phosphoate suppress epiregulin?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if sphingosine-1 phosphate suppresses epiregulin, we need to consider the biological interactions between these two molecules. Sphingosine-1 phosphate is a signaling lipid involved in various cellular processes, while epiregulin is a growth factor. The question is asking whether the former has an inhibitory effect on the latter. Without specific studies or data indicating such an interaction, it's challenging to conclude definitively. However, based on general knowledge of their functions, there isn't a direct evidence suggesting that sphingosine-1 phosphate suppresses epiregulin.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is telomestatin, a novel statin drug used to treat high cholesterol?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Telomestatin is not a statin drug; it is a natural product known for its telomerase inhibitory activity, not for treating high cholesterol. Statins are a class of drugs that lower cholesterol by inhibiting the enzyme HMG-CoA reductase.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Satb1 a transcription factor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Satb1 is a transcription factor, we need to understand its role in gene regulation. Transcription factors are proteins that bind to specific DNA sequences to control the transcription of genetic information from DNA to mRNA. Satb1, also known as Special AT-rich sequence-binding protein 1, is known to bind to matrix attachment regions (MARs) of the DNA and is involved in chromatin remodeling and regulation of gene expression. Given its function in binding DNA and regulating gene expression, it fits the definition of a transcription factor.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the 22-item sino-nasal outcome test (SNOT-22) a widely used measure for Health-Related Quality-of-Life (HRQOL) associated with chronic rhinosinusitis (CRS)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The 22-item sino-nasal outcome test (SNOT-22) is a questionnaire designed to assess the health-related quality of life (HRQOL) in patients with chronic rhinosinusitis (CRS). It is a modification of the original SNOT-20, with two additional items added to cover a broader range of symptoms and impacts. The SNOT-22 has been validated in various studies and is commonly used in clinical and research settings to evaluate the severity of CRS symptoms and their impact on patients' quality of life. Given its widespread use and validation, it can be considered a widely used measure for HRQOL associated with CRS.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SOX10 expressed in melanoma cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"SOX10 is a transcription factor known to play a role in the development of neural crest-derived cells, including melanocytes. Melanoma is a cancer that originates from melanocytes, and since SOX10 is involved in the maintenance of melanocyte lineage, it is reasonable to hypothesize that SOX10 is expressed in melanoma cells.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is EuroQol 5-Dimension Health Assessment (EQ-5D) [a widely used, simple instrument that monitors the general health-related quality of life (HRQoL) in chronic disease] a 5 question assessment?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The EQ-5D is indeed a widely used instrument for assessing health-related quality of life. It is known for its simplicity and is used in chronic disease monitoring. The question asks whether it is a 5-question assessment. The EQ-5D consists of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is assessed with a single question, making it a 5-question assessment in its basic form.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is neurofilament light marker for disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Neurofilament light chain (NfL) is a protein component of neurons and is released into the cerebrospinal fluid and blood upon neuronal damage. Elevated levels of NfL have been associated with various neurological diseases, including Alzheimer's disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS). Therefore, NfL can be considered a marker for neuronal damage and, by extension, certain diseases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Phospholemman a membrane protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Phospholemman is known to be a small transmembrane protein that is primarily found in the plasma membrane of cardiac and skeletal muscle cells. It plays a role in regulating ion transport, particularly the sodium-potassium pump. Given its location and function, it is classified as a membrane protein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Mical an oxidoreductase?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Mical is an oxidoreductase, we need to understand its function. Mical stands for Molecule Interacting with CasL, and it is known to participate in redox reactions, specifically in the oxidation of actin. Since oxidoreductases are enzymes that catalyze the transfer of electrons from one molecule (the reductant) to another (the oxidant), and Mical is involved in such redox reactions, it can be classified as an oxidoreductase.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is resistance training usually associated with increasing muscle hypertrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Resistance training is a form of exercise that involves working against a force to build strength, endurance, and muscle size. Muscle hypertrophy refers to the increase in muscle size, which is a common goal of resistance training. Therefore, it is reasonable to associate resistance training with increasing muscle hypertrophy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is periampullary carcinoma (PAC) a relatively rare genitourinary malignancy",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Periampullary carcinoma (PAC) is a type of cancer that arises near the ampulla of Vater, which is located where the bile duct and pancreatic duct join and empty into the small intestine. It is not classified as a genitourinary malignancy, as genitourinary malignancies typically involve the urinary system or the reproductive organs. Therefore, the question seems to be based on a misunderstanding of the classification of PAC.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is pRETRO-SUPER an adenoviral vector?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if pRETRO-SUPER is an adenoviral vector, we need to understand what pRETRO-SUPER is. pRETRO-SUPER is a retroviral vector used for RNA interference (RNAi) experiments, not an adenoviral vector. Adenoviral vectors are derived from adenoviruses, whereas retroviral vectors like pRETRO-SUPER are derived from retroviruses.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can epigenetic modifications be heritable?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Epigenetic modifications involve changes in gene expression without altering the DNA sequence. These modifications can be influenced by environmental factors and can sometimes be passed down to offspring, making them heritable in certain cases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do angiotensin-converting-enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) increase the likelihood of severe COVID-19?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether ACE inhibitors and ARBs increase the risk of severe COVID-19. Early in the pandemic, there was concern that these medications might upregulate ACE2 receptors, potentially increasing susceptibility to SARS-CoV-2. However, subsequent research and clinical guidelines have not supported this hypothesis. Instead, current evidence suggests that these medications do not increase the risk of severe COVID-19 and may even be protective.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does p85α homodimerize?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether p85α, a regulatory subunit of the PI3K enzyme, forms homodimers (i.e., dimers with another p85α subunit). To answer this, we need to consider the known interactions of p85α. Literature suggests that p85α can interact with other proteins, but homodimerization is not a commonly reported feature.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is thalidomide used as an immunomodulatory drug nowadays?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Thalidomide was initially marketed as a sedative but was withdrawn due to its teratogenic effects causing severe birth defects. However, it was later found to have immunomodulatory and anti-inflammatory properties and is now used under strict regulations to treat certain conditions like multiple myeloma and leprosy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are functional tests a good biomarker for Duchenne Muscular Dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Functional tests assess physical abilities and can provide valuable information about the progression of Duchenne Muscular Dystrophy (DMD). However, whether they serve as a good biomarker depends on the context. Biomarkers are typically measurable indicators of a biological condition or state. While functional tests can indicate the severity of muscle weakness and functional decline in DMD, they may not directly measure the underlying molecular or cellular changes. Therefore, their effectiveness as a biomarker would depend on the specific use case, such as monitoring disease progression or response to treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a way to distinguish COVID-19 clinically from other respiratory illnesses, particularly influenza?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if COVID-19 can be clinically distinguished from other respiratory illnesses like influenza, we need to consider the symptoms, diagnostic tests, and epidemiological factors. While both diseases share similar symptoms such as fever, cough, and fatigue, COVID-19 may present with unique features like loss of taste or smell. However, definitive distinction requires specific diagnostic testing, such as PCR or antigen tests, as clinical presentation alone may not be sufficient due to overlapping symptoms with influenza.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is lumbar puncture the first test that should be performed on a patient with increased intracranial pressure?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Lumbar puncture is a diagnostic procedure used to collect cerebrospinal fluid for analysis. However, in patients with increased intracranial pressure, performing a lumbar puncture can be dangerous because it may lead to brain herniation. Therefore, other imaging tests like CT or MRI are usually performed first to assess the cause of the increased pressure and to determine if it's safe to proceed with a lumbar puncture.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does mutation of ARTEMIS gene causes severe combined immunodeficiency?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The ARTEMIS gene plays a crucial role in the V(D)J recombination process, which is essential for the development of the immune system. Mutations in the ARTEMIS gene can lead to a form of severe combined immunodeficiency (SCID), known as SCID-A. SCID-A is characterized by a severe defect in both T and B cell function, leading to increased susceptibility to infections. Therefore, it is reasonable to consider that mutations in the ARTEMIS gene can cause severe combined immunodeficiency.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Cinpanemab effective for Parkinson’s Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Cinpanemab is a monoclonal antibody that was investigated for its potential to treat Parkinson’s Disease by targeting alpha-synuclein, a protein implicated in the disease's progression. However, clinical trials have not demonstrated significant efficacy in slowing the progression of Parkinson’s Disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Prasinezumab effective for Parkinson’s Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Prasinezumab is a monoclonal antibody targeting alpha-synuclein, which is implicated in Parkinson’s Disease. Clinical trials are ongoing to determine its efficacy. As of the latest available data, there is no conclusive evidence to confirm its effectiveness for Parkinson’s Disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does CIDEB mutation protect from liver disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether a mutation in the CIDEB gene provides protection against liver disease. To answer this, we need to consider any known associations between CIDEB mutations and liver disease protection. CIDEB is involved in lipid droplet formation and has been studied in the context of liver health. Some research suggests that certain mutations in CIDEB may influence liver disease risk, but the evidence is not conclusive enough to definitively state that CIDEB mutations protect against liver disease.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there any association between Tripe palms and cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tripe palms is a rare skin condition characterized by a velvety, moss-like appearance of the palms. It has been reported in association with internal malignancies, particularly gastric and lung cancers. Therefore, it is important to consider the possibility of an underlying cancer when tripe palms is diagnosed.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Was AAVS3 developed for hemophilia A?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"AAVS3 refers to adeno-associated virus serotype 3, which is a vector used in gene therapy. Hemophilia A is a genetic disorder caused by a deficiency in clotting factor VIII. The question is asking whether AAVS3 was specifically developed for treating hemophilia A.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Was DNX-2401 tested for treatment of Diffuse Intrinsic Pontine Glioma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"DNX-2401 is an oncolytic virus that has been investigated for its potential in treating various types of brain tumors. Diffuse Intrinsic Pontine Glioma (DIPG) is a highly aggressive and difficult-to-treat brain tumor that primarily affects children. To determine if DNX-2401 was specifically tested for DIPG, one would need to review clinical trial data or research publications focusing on DNX-2401's application in DIPG cases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Baricitinib effective for Alopecia Areata?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Baricitinib is a medication that has been studied for its effectiveness in treating various conditions, including Alopecia Areata, which is an autoimmune disease that results in hair loss. Clinical trials have shown that Baricitinib can be effective in promoting hair regrowth in patients with Alopecia Areata by inhibiting the immune system's attack on hair follicles.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is erenumab effective for trigeminal neuralgia?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Erenumab is a monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor and is primarily used for the prevention of migraine. Trigeminal neuralgia is a different condition characterized by severe facial pain, and its treatment typically involves anticonvulsant medications or surgery. There is limited evidence on the effectiveness of erenumab for trigeminal neuralgia.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is alternative splicing associated with heart disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Alternative splicing is a process that allows a single gene to code for multiple proteins by including or excluding certain exons during mRNA processing. This process is crucial for the regulation of gene expression and protein diversity. Given its importance in cellular functions, disruptions or abnormalities in alternative splicing can lead to various diseases, including heart diseases. Research has shown that aberrant alternative splicing is associated with cardiovascular diseases, affecting heart function and structure.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is PRP-40 involved in microexon splicing?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"PRP-40 is a protein known to be involved in pre-mRNA splicing. Microexon splicing is a specific type of splicing event that involves very small exons. To determine if PRP-40 is specifically involved in microexon splicing, we would need evidence linking PRP-40 to the splicing of microexons.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does microexon alternative splicing of small GTPase regulators have implication in central nervous system diseases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Microexon alternative splicing is a process that can significantly affect protein function by inserting or removing small exons in mRNA. Small GTPase regulators are crucial for various cellular processes, including those in the central nervous system (CNS). Given the importance of both microexon splicing and small GTPase regulators in CNS function, it is plausible that disruptions in this splicing mechanism could contribute to CNS diseases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does silencing of SRRM4 promote microexon inclusion?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about the effect of SRRM4 silencing on microexon inclusion. SRRM4 is known to be a splicing regulator that promotes the inclusion of microexons in neuronal cells. Therefore, silencing SRRM4 would likely have the opposite effect, reducing microexon inclusion.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does silencing of SRRM4 inhibit tumor growth across cancers?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if silencing of SRRM4 inhibits tumor growth across cancers, we need to consider the role of SRRM4 in cancer biology. SRRM4 is known to regulate alternative splicing, which can affect cancer progression. Studies have shown that SRRM4 is involved in the development and progression of certain cancers, such as neuroendocrine prostate cancer. However, the effect of SRRM4 silencing may vary depending on the cancer type, as different cancers rely on different splicing mechanisms for growth and survival. Therefore, while silencing SRRM4 may inhibit tumor growth in some cancers, it may not have the same effect across all cancer types.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does SRRM4 regulate neuronal-specific microexon splicing of TAF1 mRNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether SRRM4 is involved in the regulation of neuronal-specific microexon splicing of TAF1 mRNA. SRRM4 is known to play a critical role in the splicing of microexons in neurons, which are essential for neuronal function. TAF1 is a component of the transcription factor IID (TFIID) complex, and its splicing could be regulated by SRRM4 given SRRM4's role in neuronal splicing.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is PRP-40 regulation of microexons a conserved phenomenon?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if PRP-40 regulation of microexons is a conserved phenomenon, we need to consider whether this regulatory mechanism is observed across different species, indicating evolutionary conservation. Microexons are small exons that are highly conserved in evolution, and their regulation by splicing factors like PRP-40 could be crucial for proper gene expression. If evidence shows PRP-40's role in microexon regulation in multiple species, it would suggest conservation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does nintedanib improve response rate in patients with bladder cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether nintedanib improves the response rate in patients with bladder cancer. To answer this, we need to consider clinical trials or studies that have evaluated the efficacy of nintedanib specifically in bladder cancer patients. Nintedanib is a tyrosine kinase inhibitor that has been studied in various cancers, but its effectiveness in bladder cancer would depend on the results of these studies.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Was prehospital transdermal glyceryl trinitrate effective for stroke in the RIGHT-2 trial?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The RIGHT-2 trial investigated the efficacy of prehospital transdermal glyceryl trinitrate (GTN) in patients with suspected stroke. The trial aimed to determine if GTN could improve outcomes when administered early. The results showed that GTN did not significantly improve functional outcomes in stroke patients, suggesting it was not effective in this context.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Was erythropoietin effective for optic neuritis in the TONE trial?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether erythropoietin was effective for optic neuritis in the TONE trial. To answer this, we need to refer to the findings of the TONE trial regarding the use of erythropoietin in treating optic neuritis.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can losartan reduce brain atrophy in Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether losartan can reduce brain atrophy in Alzheimer's disease. To answer this, we need to consider if there is any scientific evidence or studies that support the efficacy of losartan in reducing brain atrophy specifically in Alzheimer's disease patients. Losartan is primarily known as an angiotensin II receptor blocker used to treat high blood pressure, and its potential effects on brain atrophy in Alzheimer's disease would require specific research findings.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is levosimendan effective for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Levosimendan is a calcium sensitizer used primarily in the treatment of acute decompensated heart failure. Its effectiveness for amyotrophic lateral sclerosis (ALS) has not been established through large-scale clinical trials, and it is not currently approved for this use.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should be used bexarotene for relapsing-remitting multiple sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Bexarotene is a retinoid X receptor agonist primarily used in the treatment of cutaneous T-cell lymphoma. Its potential use in relapsing-remitting multiple sclerosis (RRMS) is based on its immunomodulatory effects observed in preclinical studies. However, there is currently insufficient clinical evidence to support its routine use in RRMS. The decision to use bexarotene for RRMS should be made by a healthcare professional, considering the lack of approved treatments and potential side effects.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Efgartigimod be used for myasthenia gravis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Efgartigimod is a medication that has been studied for its potential use in treating myasthenia gravis, a neuromuscular disorder. It works by reducing the levels of pathogenic IgG antibodies, which are thought to play a key role in the disease. Clinical trials have shown promising results in improving symptoms for patients with myasthenia gravis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Based on clinical trial data, can pioglitazone delay cognitive impairment for people at risk for Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether pioglitazone can delay cognitive impairment in individuals at risk for Alzheimer's disease, based on clinical trial data. To answer this, we need to consider the findings from relevant clinical trials that have investigated the effects of pioglitazone on cognitive function in this specific population.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Tilavonemab effective for progressive supranuclear palsy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Progressive supranuclear palsy (PSP) is a rare brain disorder that affects movement, control of walking and balance, vision, speech, and cognition. Tilavonemab is an investigational drug being studied for its potential effects on neurodegenerative diseases, including PSP. However, as of the current knowledge, there is no conclusive evidence or approval from regulatory bodies like the FDA or EMA confirming the effectiveness of Tilavonemab specifically for PSP.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is ocrelizumab effective for primary progressive multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ocrelizumab is a monoclonal antibody that targets CD20-positive B cells. It has been studied in clinical trials for its effectiveness in treating multiple sclerosis (MS), including primary progressive multiple sclerosis (PPMS). The results from these trials have shown that ocrelizumab can reduce disease progression and disability in patients with PPMS.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is deucravacitinib effective for psoriasis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Deucravacitinib is a selective TYK2 inhibitor that has been studied for the treatment of psoriasis. Clinical trials have shown promising results in improving symptoms for patients with moderate to severe plaque psoriasis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is daridorexant effective for insomnia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Daridorexant is a dual orexin receptor antagonist (DORA) that has been studied for the treatment of insomnia. Clinical trials have shown that it can be effective in improving sleep onset and maintenance in adults with insomnia.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is tebentafusp effective for uveal melanoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tebentafusp is a bispecific protein that targets gp100, a protein found in melanocytes, and CD3, a protein found on T cells. It is designed to redirect T cells to kill gp100-expressing melanoma cells. Uveal melanoma is a type of melanoma that occurs in the eye. Clinical trials have shown that tebentafusp can improve overall survival in patients with metastatic uveal melanoma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can lenacapavir be used for HIV?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Lenacapavir is a new antiretroviral medication that has been developed for the treatment of HIV. It is a capsid inhibitor, which means it works by interfering with the HIV virus's capsid, a protein shell that protects the virus's genetic material. This action prevents the virus from replicating and spreading in the body. Given its mechanism of action and the context of its development, it is designed specifically for HIV treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Wilson's disease described as an iron storage disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Wilson's disease is a genetic disorder that leads to excessive accumulation of copper in the body, not iron. It is not described as an iron storage disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is medical hydrology the same as Spa therapy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Medical hydrology and Spa therapy are related fields that both involve the use of water for therapeutic purposes. However, medical hydrology is a broader scientific discipline that studies the therapeutic properties and applications of water, including its chemical, physical, and thermal effects on the human body. Spa therapy, on the other hand, is a more specific practice that often takes place in spa settings and focuses on relaxation, beauty, and wellness treatments using water. While there is overlap, they are not the same.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is North Star Ambulatory Assessment score a reliable clinical outcome for disease progression assessment in Duchenne Muscular Dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The North Star Ambulatory Assessment (NSAA) is a widely used clinical tool designed to evaluate motor function in ambulatory boys with Duchenne Muscular Dystrophy (DMD). It assesses various activities such as standing, walking, and jumping. Given its specificity and sensitivity to changes in motor function over time, it is considered a reliable clinical outcome measure for disease progression assessment in DMD. However, its reliability can be influenced by factors such as the age of the patient and the stage of the disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can modulation of KCNQ1 splicing prevent arrhythmias?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether modulating the splicing of KCNQ1, a gene associated with cardiac potassium channels, can prevent arrhythmias. KCNQ1 plays a critical role in the repolarization phase of the cardiac action potential, and its dysfunction is linked to various arrhythmias. Modulating its splicing could potentially correct or mitigate these dysfunctions, thereby preventing arrhythmias. However, the effectiveness of such modulation would depend on the specific splicing variants and the underlying cause of the arrhythmia.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can the concept of digital twins be applied in Precision Nutrition?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Digital twins are virtual replicas of physical entities that can be used for simulation, analysis, and control. Precision Nutrition involves personalized dietary recommendations based on individual data. Applying digital twins in Precision Nutrition could involve creating a virtual model of an individual's nutritional status and metabolism to predict responses to different diets.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is prosopagnosia also known as lack of auditory recognition?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Prosopagnosia is a cognitive disorder characterized by the inability to recognize faces, not sounds. It is specifically related to visual recognition, not auditory. Therefore, the question is asking if prosopagnosia, which is about face recognition, is the same as a lack of auditory recognition, which is about sound recognition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do cells undergoing necroptosis show disruption of their cell membranes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Necroptosis is a form of programmed cell death that is characterized by cell swelling, rupture of the plasma membrane, and release of cellular contents, which can trigger an inflammatory response. This process is distinct from apoptosis, where the cell membrane remains intact. Therefore, it is important to determine if necroptosis involves membrane disruption.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Iron deficiency anemia a common complication of chronic kidney disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Iron deficiency anemia is indeed a common complication of chronic kidney disease (CKD). This is because CKD can lead to decreased production of erythropoietin, a hormone produced by the kidneys that stimulates red blood cell production. Additionally, CKD can cause blood loss during dialysis, further contributing to iron deficiency. Therefore, it is reasonable to consider iron deficiency anemia as a common complication in patients with CKD.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Anemia is not associated with chronic kidney failure",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Anemia is a common complication of chronic kidney disease (CKD) due to the kidneys' reduced ability to produce erythropoietin, a hormone that stimulates red blood cell production. Therefore, anemia is indeed associated with chronic kidney failure.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is anaphylaxis a results of mast cell activation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Anaphylaxis is a severe, potentially life-threatening allergic reaction. It is known to be caused by the release of mediators from mast cells and basophils, which are types of white blood cells. Mast cell activation leads to the release of histamine and other chemicals that cause the symptoms of anaphylaxis. Therefore, anaphylaxis is indeed a result of mast cell activation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is trichotillomania encountered with equali frequency in males and females?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Trichotillomania is a mental disorder characterized by a long-term urge that results in the pulling out of one's hair. To determine if it is encountered with equal frequency in males and females, we need to consider research and studies on the prevalence of trichotillomania among different genders.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can skin picking phenotype present following methylphenidate treatment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the skin picking phenotype can present following methylphenidate treatment. Methylphenidate is a stimulant medication commonly used to treat ADHD. Skin picking, or dermatillomania, is a body-focused repetitive behavior that can be associated with various conditions, including obsessive-compulsive disorder (OCD) and ADHD. There is some evidence that stimulant medications, including methylphenidate, can exacerbate or trigger repetitive behaviors such as skin picking in susceptible individuals. However, this is not a universal response and depends on individual factors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Optogenetics refers to the study of gene expression optimization",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Optogenetics is a biological technique that involves the use of light to control cells in living tissue, typically neurons, that have been genetically modified to express light-sensitive ion channels. It is not directly related to the study of gene expression optimization, which involves understanding and manipulating the processes that regulate the synthesis of gene products.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Have chimeric antigen receptor (CAR)-T cell therapies been approved for the treatment of B cell malignancies?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CAR-T cell therapies are a type of immunotherapy that have been developed for the treatment of various cancers, including B cell malignancies. The approval status of such therapies can vary by country and regulatory body. For example, in the United States, the FDA has approved certain CAR-T cell therapies for specific types of B cell malignancies.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is deflazacort more efficient than prednisone/prednisolone for the treatment of Duchenne muscular dystrophy?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if deflazacort is more efficient than prednisone/prednisolone for the treatment of Duchenne muscular dystrophy, we need to consider clinical studies and evidence comparing their efficacy, side effects, and overall impact on the disease progression. Deflazacort and prednisone/prednisolone are both corticosteroids used to manage symptoms and slow disease progression in Duchenne muscular dystrophy. Some studies suggest that deflazacort may have a better side effect profile and similar or slightly better efficacy in maintaining muscle strength and function over time compared to prednisone/prednisolone. However, the choice between them may also depend on individual patient factors, including tolerance and side effects.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is casimersen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Casimersen is an antisense oligonucleotide designed to treat Duchenne muscular dystrophy (DMD) by promoting the production of a functional dystrophin protein in patients with specific mutations. The effectiveness of casimersen for DMD treatment has been evaluated in clinical trials, showing promise in increasing dystrophin production in some patients. However, the overall clinical benefits and long-term effects are still under investigation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is viltolarsen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Viltolarsen is an antisense oligonucleotide designed to treat Duchenne muscular dystrophy (DMD) by promoting exon skipping in the dystrophin gene, specifically targeting exon 53. Clinical trials have shown that it can increase dystrophin production in some patients with mutations amenable to exon 53 skipping. However, its effectiveness can vary among individuals, and it is not a cure for DMD.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is golodirsen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Golodirsen is an antisense oligonucleotide designed to treat Duchenne muscular dystrophy (DMD) by promoting the production of a functional dystrophin protein in patients with specific mutations. The effectiveness of golodirsen has been evaluated in clinical trials, showing some promise in increasing dystrophin production. However, the long-term benefits and overall effectiveness in improving muscle function and quality of life for DMD patients are still under investigation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is eteplirsen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Eteplirsen is a drug designed to treat Duchenne muscular dystrophy (DMD) by promoting dystrophin production. Its effectiveness has been a subject of debate, with some studies showing modest increases in dystrophin levels and others questioning its clinical benefits. The FDA approved it based on increased dystrophin production, but the clinical significance of this increase remains uncertain.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SARS-CoV-2 transmitted through breast milk?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about whether SARS-CoV-2, the virus causing COVID-19, can be transmitted through breast milk. Current research and guidelines from health organizations suggest that the risk of transmission through breast milk is low, but there is limited data available. The primary mode of transmission is through respiratory droplets. However, precautions are recommended for mothers with COVID-19 to minimize any potential risk to the infant.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do machine learning-based methods outperform statistical methods for survival analysis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine whether machine learning-based methods outperform statistical methods for survival analysis, we need to consider the context, including the dataset size, the complexity of the relationships within the data, and the specific goals of the analysis. Machine learning methods may offer advantages in handling large datasets and capturing complex, non-linear relationships, whereas statistical methods are often more interpretable and may perform better with smaller datasets or when the underlying assumptions are met.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does iron regulate oligodendrocyte maturation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Iron is known to play a crucial role in various biological processes, including the development and function of the central nervous system. Oligodendrocytes are cells that produce myelin in the CNS, and their maturation is essential for proper neural function. Given iron's importance in cellular metabolism and myelination, it is plausible that iron could regulate oligodendrocyte maturation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are LOQ and LOD the same?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"LOQ (Limit of Quantification) and LOD (Limit of Detection) are terms used in analytical chemistry to describe the smallest amount of a substance that can be reliably measured. LOQ refers to the lowest concentration at which the analyte can be quantified with acceptable accuracy and precision, while LOD is the lowest concentration at which the analyte can be detected but not necessarily quantified. Therefore, they are not the same.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Amyotrophic Lateral Sclerosis (ALS) be associated with a mutation of the Super Oxide Dismutase 1 (SOD) gene?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that has been linked to various genetic mutations. Among these, mutations in the Super Oxide Dismutase 1 (SOD1) gene are one of the first and most well-documented genetic causes of familial ALS. These mutations lead to a toxic gain of function in the SOD1 enzyme, contributing to the disease's progression. Therefore, it is established that ALS can be associated with mutations in the SOD1 gene.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Have Quercetin-biapigenin nanoparticles been shown to be effective in penetrating the blood-brain barrier",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is about the effectiveness of Quercetin-biapigenin nanoparticles in penetrating the blood-brain barrier. To answer this, one would need to refer to scientific studies or research findings that specifically investigate this compound's ability to cross the blood-brain barrier. Without specific references or studies at hand, it's challenging to provide a definitive answer. However, the general effectiveness of nanoparticles in drug delivery, including crossing the blood-brain barrier, has been a subject of research, with some nanoparticles showing promise due to their small size and surface modifications that can enhance penetration.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is OXLUMO (lumasiran) used for the treatment of primary hyperoxaluria?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"OXLUMO (lumasiran) is a medication specifically designed to treat primary hyperoxaluria type 1 (PH1), a rare genetic disorder that leads to the overproduction of oxalate, which can cause kidney stones and kidney damage. The drug works by reducing the production of oxalate in the body. Therefore, it is indeed used for the treatment of primary hyperoxaluria, specifically type 1.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can untranslated regions (UTRs) regulate gene expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Untranslated regions (UTRs) are segments of mRNA that are not translated into protein but play crucial roles in regulating gene expression. The 5' UTR can influence the initiation of translation, while the 3' UTR can affect mRNA stability, localization, and translation efficiency. Therefore, UTRs are important for the post-transcriptional regulation of gene expression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can the epigenetic status of introns affect gene expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the epigenetic status of introns can influence gene expression. Epigenetic modifications, such as DNA methylation and histone modifications, can regulate gene expression by altering chromatin structure and accessibility. While introns are traditionally considered non-coding regions that are spliced out during mRNA processing, recent studies suggest that epigenetic modifications in introns can affect splicing efficiency, mRNA stability, and even the recruitment of transcription factors, thereby indirectly influencing gene expression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a way to distinguish COVID-19 clinically from other respiratory illnesses, such as influenza?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if COVID-19 can be clinically distinguished from other respiratory illnesses like influenza, we need to consider the symptoms, diagnostic tests, and epidemiological factors. While both diseases share similar symptoms such as fever, cough, and fatigue, COVID-19 may present with unique features like loss of taste or smell. However, definitive distinction requires specific diagnostic tests, such as PCR or antigen tests, as clinical presentation alone may not be sufficient due to overlapping symptoms with other respiratory illnesses.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is COVID-19 caused by the Omicron variant less severe than infection caused by other variants?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the Omicron variant of COVID-19 causes less severe infection compared to other variants. To answer this, we need to consider available data and studies comparing the severity of Omicron infections to those caused by other variants like Delta. Early studies and reports suggested that Omicron might cause less severe disease, but it's also more transmissible. However, severity can depend on various factors including vaccination status and underlying health conditions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Should patients using inhaled glucocorticoids for asthma or COPD be advised to stop these medications to prevent COVID-19?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether patients using inhaled glucocorticoids for asthma or COPD should stop these medications to prevent COVID-19. Inhaled glucocorticoids are essential for managing chronic respiratory conditions like asthma and COPD. Stopping these medications could lead to worsening of the underlying conditions, which might increase the risk of severe outcomes from any respiratory infection, including COVID-19. Current medical guidelines and evidence do not support discontinuing inhaled glucocorticoids to prevent COVID-19. Instead, patients are advised to continue their prescribed medications to maintain control of their respiratory conditions.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is adenosine methylation an epigenetic modification?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Adenosine methylation refers to the addition of a methyl group to the adenosine base in RNA, which is a type of post-transcriptional modification. Epigenetic modifications typically involve changes to DNA or histones that affect gene expression without altering the DNA sequence. Since adenosine methylation occurs in RNA rather than DNA, it is not considered an epigenetic modification in the traditional sense.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can analgesics or antipyretics be taken for side effects following COVID-19 vaccination?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Analgesics and antipyretics are medications used to relieve pain and reduce fever, respectively. After COVID-19 vaccination, some individuals may experience side effects such as pain at the injection site, fever, or body aches. These medications can be considered for managing such side effects, but it's important to consult healthcare advice before taking them, especially to ensure they don't interfere with the vaccine's efficacy or exacerbate any conditions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Luminopsins a fusion proteins of luminol and Rhodopsin ?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Luminopsins are indeed fusion proteins, but they are not a fusion of luminol and Rhodopsin. Instead, they are a fusion of a light-emitting protein (like luciferase) and a light-sensitive ion channel or pump (like Rhodopsin). This combination allows for bioluminescent activation of the light-sensitive component.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "In twin-twin transfusion syndrome, are the twins identical?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Twin-twin transfusion syndrome (TTTS) is a condition that can occur in pregnancies when identical twins share a placenta (monochorionic pregnancy). The syndrome arises due to an imbalance in the blood flow between the twins through connecting blood vessels in their shared placenta. Since TTTS specifically involves identical twins sharing a placenta, the question pertains to the nature of the twins involved in this syndrome.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Zanubrutinib a first-generation BTK inhibitor approved by US Food and Drug Administration (FDA)?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if Zanubrutinib is a first-generation BTK inhibitor approved by the FDA, we need to consider its classification and approval status. Zanubrutinib is actually a second-generation BTK inhibitor, designed to be more selective and with fewer side effects compared to first-generation inhibitors like Ibrutinib. It was approved by the FDA for certain conditions, but not as a first-generation inhibitor.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can CRISPR/Cas12a be used for the detection of EGFR mutations in circulating DNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CRISPR/Cas12a is a versatile tool that has been adapted for nucleic acid detection, including the identification of specific DNA sequences. EGFR mutations are a common target in cancer diagnostics, and circulating DNA (cfDNA) from blood samples can be analyzed for such mutations. Given that CRISPR/Cas12a can be programmed to recognize and cleave specific DNA sequences, it is theoretically possible to use it for the detection of EGFR mutations in circulating DNA, provided that the system is properly designed to target the mutation of interest.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Functional Neurological Disorder (FND) classified as a psychosomatic disorder?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Functional Neurological Disorder (FND) is a condition where patients experience neurological symptoms such as weakness, movement disorders, sensory symptoms, and blackouts, which cannot be explained by a conventional neurological disease. The classification of FND has been debated, with some considering it a psychosomatic disorder due to the significant role of psychological factors in its manifestation. However, it is now more commonly viewed as a disorder at the intersection of neurology and psychiatry, where both biological and psychological factors play a role.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are any medications available to prevent COVID-19 following exposure?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks if there are medications available to prevent COVID-19 after someone has been exposed to the virus. To answer this, we need to consider current medical guidelines and available treatments that are approved for post-exposure prophylaxis (PEP) for COVID-19.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can reinfection occur after SARS-CoV-2 infection?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Reinfection with SARS-CoV-2 refers to a person getting infected with the virus more than once. The immune response after the first infection may provide some protection, but it's not absolute. Variants of the virus and the duration of immunity are factors that can influence the possibility of reinfection.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can other vaccines be given with COVID-19 vaccine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether it is safe and permissible to administer other vaccines at the same time as the COVID-19 vaccine. This involves understanding the guidelines provided by health authorities regarding vaccine coadministration.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is omaveloxolone a suppressor of Nrf2?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if omaveloxolone is a suppressor of Nrf2, we need to understand its mechanism of action. Omaveloxolone is known to activate Nrf2, not suppress it. It works by inducing the Nrf2 pathway, which plays a role in cellular defense against oxidative stress. Therefore, it is not a suppressor of Nrf2.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is omaveloxolone an activator of NFkB?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if omaveloxolone is an activator of NFkB, we need to understand its mechanism of action. Omaveloxolone is known to activate the Nrf2 pathway, which is involved in the cellular response to oxidative stress. However, its relationship with NFkB, a transcription factor involved in inflammatory responses, is less clear. NFkB activation is typically associated with pro-inflammatory signals, whereas Nrf2 activation is generally anti-inflammatory. There is no direct evidence suggesting that omaveloxolone activates NFkB; in fact, it may have the opposite effect by modulating inflammatory pathways through Nrf2 activation.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has RTA 408 received FDA approval?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if RTA 408 has received FDA approval, we need to check the latest FDA approvals or the drug's official status. As of my last update, RTA 408, also known as Omaveloxolone, was under investigation for treating Friedreich's ataxia and had not yet received FDA approval. However, for the most current status, consulting the FDA's official website or recent press releases from the drug's manufacturer would be necessary.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can salivary cortisol be used to evaluate pain in neonates?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Salivary cortisol is a biomarker often used to assess stress responses, which can be elevated in situations of pain or discomfort. In neonates, who cannot verbally communicate their pain, biomarkers like cortisol may offer a non-invasive method to evaluate pain. However, cortisol levels can also be influenced by other factors such as stress, hunger, or general discomfort, not solely pain. Therefore, while salivary cortisol can provide some indication of stress or potential pain in neonates, it is not a definitive measure of pain on its own.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can breastfeeding be used to alleviate the procedural pain in neonates?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Breastfeeding has been studied as a non-pharmacological method to reduce procedural pain in neonates. It is thought to work through the combination of skin-to-skin contact, the sweet taste of breast milk, and the sucking action, which can distract and soothe the infant. Research suggests that breastfeeding during painful procedures can lead to a reduction in pain scores and crying time in neonates.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is music therapy effective for pain management in neonates?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Music therapy has been studied for its potential benefits in various medical settings, including pain management in neonates. Neonates, especially those in intensive care units, often undergo painful procedures. Research suggests that music therapy can have a calming effect, potentially reducing stress and pain in this vulnerable population. The effectiveness can vary based on the type of music, the timing of the therapy, and individual patient responses.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is there any treatment for the Facioscapulohumeral Muscular Dystrophy?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Facioscapulohumeral Muscular Dystrophy (FSHD) is a genetic muscle disorder with no known cure. However, there are treatments available to manage symptoms and improve quality of life. These may include physical therapy, orthopedic interventions, and in some cases, surgical options to address specific complications. Research is ongoing to find more effective treatments.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Are there any other types of Spinal Muscular Atrophy except for types 1-4?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Spinal Muscular Atrophy (SMA) is primarily classified into types 1 through 4 based on the age of onset and severity of symptoms. However, there are other less common forms of SMA, such as SMA type 0, which is very severe and presents before birth, and SMA type 4, which has a later onset in adulthood. Additionally, there are atypical forms and SMA variants that do not fit neatly into the types 1-4 classification.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do all proteins start with methionine?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if all proteins start with methionine, we need to consider the process of protein synthesis. In eukaryotes, the initiator tRNA carries methionine, and translation typically starts with methionine. However, in prokaryotes, the initiator tRNA carries a modified form of methionine, N-formylmethionine. Additionally, post-translational modifications can remove the initial methionine. Therefore, while many proteins start with methionine, not all do.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do epigenetic changes change the DNA sequence?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Epigenetic changes involve modifications to the DNA that affect gene expression without altering the DNA sequence itself. These changes can include DNA methylation, histone modification, and non-coding RNA-associated gene silencing.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are epigenetic changes heritable?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Epigenetic changes refer to modifications in gene expression that do not involve alterations to the underlying DNA sequence. These changes can be influenced by environmental factors, lifestyle, and other external conditions. The question of whether these changes are heritable involves understanding if they can be passed from one generation to the next. Research has shown that some epigenetic marks can indeed be inherited, although the extent and mechanisms of this inheritance are still under investigation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do enhancers have to be close to their gene targets?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Enhancers are regulatory DNA sequences that can increase the transcription of genes. They can be located upstream, downstream, or within a gene, and do not necessarily have to be close to their gene targets to function. Enhancers can act over long distances, sometimes thousands of base pairs away from the gene they regulate, by looping the DNA to bring the enhancer in proximity to the gene's promoter.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are accessible enhancers necessarily active?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if accessible enhancers are necessarily active, we need to understand the definitions and roles of enhancers in gene regulation. Enhancers are DNA sequences that can increase the transcription of genes. They can be in an accessible state, meaning the chromatin is open and transcription factors can bind, but this does not always mean they are actively enhancing transcription. Activity depends on the presence of the appropriate transcription factors and other regulatory elements. Therefore, accessibility does not guarantee activity.\",\"answer\":\"no\"}",
    "correct": true
  }
]